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ABSTRACT 
The following body of work is the result of collaborative efforts between 
researchers at Clemson University and a team of practicing orthopedic surgeons. It begins 
with the identification of an inadequately addressed clinical need, the treatment of severe 
knee dysfunction, in the practices of our clinical collaborators. A case report, reviewing 
the condition of five affected patients, is presented to provide initial evidence for the 
existence of this need. A thorough review of the causes and currently available treatment 
options for knee dysfunction, including arthrodesis, is provided to clarify the need and 
establish its widespread significance, and a novel treatment model is proposed and 
discussed with respect to existing treatments.  
In spite of a large number of recently published clinical case reports, the total 
number of affected patients has been heretofore unreported. In order to establish this 
figure in further support of the need for an alternative treatment, a large database of 
hospital discharge records is analyzed. An estimate of the frequency of knee arthrodesis 
is provided, and the affected patients are characterized.  
Having quantified the incidence of the primary treatment method, and thus 
provided an estimate of the affected patient subpopulation, the effect of this treatment on 
lower body biomechanics is addressed. A gait analysis study was designed to simulate 
knee arthrodesis in normal, healthy subjects, providing a comprehensive quantification of 
joint kinematics and kinetics and allowing for the investigation of further hypotheses 
regarding the effects of treatment.  
 iii 
In spite of a number of reported cases of mechanical failure in knee arthrodesis 
implant designs, the robustness of these designs against such failure has been a neglected 
subject in literature. Data obtained from a previously conducted gait analysis study is 
used to estimate the loading conditions at an immobilized knee through the construction 
of a computational biomechanical model. The purpose of this model is to estimate the 
resultant effects of knee immobilization on the musculoskeletal system during gait, and 
estimates of muscle and joint loading patterns are provided.  
Together, this knowledge is used to assist in the design and development of a 
novel treatment model, in the form of a salvage total knee replacement. This patent 
pending treatment is designed to subsume existing, less constrained treatment methods as 
well, broadening its applicability. It has been refined over the course of several design 
cycles, which were informed by the regulatory guidelines for medical device design in 
the United States. Prototyping techniques have been used throughout the design process 
to demonstrate proof of concept.  
This work is intended to establish the significance of an unmet clinical need, 
characterize the patient subset and treatment patterns affected by the need, quantify the 
biomechanical conditions in the bodies of affected patients, and ultimately facilitate the 
translation of a proposed medical device from concept to clinical use. 
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CHAPTER ONE 
INTRODUCTION 
 
The present body of work is introduced and its structure explained.  
 
The central focus of this dissertation is the clinical treatment of severe knee 
dysfunction; its provenance was a meeting between researchers of the Laboratory of 
Orthopedic Design and Engineering at Clemson University and practicing orthopedic 
surgeons from the Moore Center for Orthopedics (Kim Chillag, M.D.) and the University 
of South Carolina School of Medicine (Frank Voss, M.D.). At this meeting, the clinicians 
identified an unmet clinical need among their patients and expressed a desire to further 
understand and address it. Thus began the series of research and design work documented 
herein. This dissertation is a culmination of that work, and it is divided into ten chapters. 
At the first collaborative meeting, on August 10, 2010, Dr. Frank Voss and Dr. 
Kim Chillag conveyed the inadequacy of their armamentarium in addressing severe knee 
dysfunction among patients in their practice. The etiological origins of patients with this 
condition were diverse, but the available treatment options – high risk salvage knee 
replacement, transfemoral amputation, and knee arthrodesis – were limited. The 
conditions of five exemplary patients were subsequently reviewed to provide initial 
evidence of the existence of this limitation, and a Case Report of the findings is reported 
in Chapter 2. Limitations of existing treatment options are discussed, and development of 
an alternative treatment model is broached.  
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Having provided preliminary evidence for the existence of a clinical need through 
the Case Report, a thorough background analysis was conducted to document the various 
etiologies and currently available treatment options. The ideal treatment for knee 
dysfunction, from a patient’s and surgeon’s perspective, is salvage knee replacement. The 
nature of severe knee dysfunction, however, often means that this treatment option is 
inadequate or inappropriate. Alternative approaches include transfemoral amputation and 
knee arthrodesis, but these are undesirable and generally used as a last resort. In Chapter 
3, a review of current literature is presented to clarify the etiologies of severe knee 
dysfunction, show that these etiologies often preempt salvage knee replacement, and 
discuss current surgical treatment options. A novel treatment model is proposed as an 
alternative to traditional knee arthrodesis. Under this model, an otherwise functional 
salvage knee replacement is capable of temporarily simulating knee arthrodesis. This 
model is intended to address the affected patient subpopulation by providing the benefits 
of a salvage knee replacement with the required stability of a knee arthrodesis.  
The widespread applicability of any alternative treatment, however, is dependent 
on the overall size of the need. Despite the existence of a significant body of research on 
the various etiologies and treatment methods used to address knee dysfunction and knee 
arthrodesis, the number of patients who meet these criteria has been heretofore 
unquantified in published literature. Having established the existence of an unmet clinical 
need among a small number of patients, the next step was to quantify the overall size of 
this need. A large, nationally representative database of inpatient hospital records is 
analyzed in Chapter 5, and an estimate of the number of affected patients in the United 
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States is presented. In order to better understand this clinical need, the affected patients 
are further characterized by demographic and other clinically meaningful attributes. 
Characteristics of the hospitals where these patients received treatment are also analyzed, 
providing a deeper understanding of the condition through the identification of attributes 
that are common among hospitals where these patients seek treatment.  
Rigid knee immobilization, such as in the existing application of knee arthrodesis 
or in the proposed treatment model, necessarily alters the kinematics and kinetics of gait. 
This appears to be well understood, but few publications have discussed these changes; of 
those discussions, gait changes are only described in abstract terms. No publications have 
quantified changes to gait kinematics or kinetics after knee arthrodesis in detail. Several 
studies have investigated rigid knee gait by other means, but these have been limited, and 
they have not fully quantified altered knee kinematics or kinetics. Those biomechanical 
changes have important implications, however, and knowledge of them is essential to 
fully understanding the consequent effects of such a treatment. One area where this is 
apparent is the suggested link between knee arthrodesis and early induced arthritis in 
other joints, such as the contralateral hip. While causation has been asserted, it has not 
been tested; such testing would require full consideration of biomechanical changes 
induced by such a treatment. A gait analysis study, simulating knee arthrodesis in normal, 
healthy subjects, was conducted in order to obtain this information, and this study is 
presented in Chapter 6. 
Knee fusion by means of arthrodesis is generally assumed to be robust, which 
may explain why there is a dearth of information on the loading conditions of a fused 
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knee. Additionally, the difficulty of obtaining in vivo data measurements may contribute 
to the neglect of this subject. Regardless of this assumption of robustness, or the 
difficulty in obtaining data, there are a number of published reports of arthrodesis failure 
due to implant fracture or other mechanical failure modes. In order to predict and prevent 
failure in any engineered system, it is imperative to have an accurate understanding of the 
imposed loading conditions. In the study detailed in Chapter 7, kinematic and kinetic data 
obtained from the gait analysis study of Chapter 6 is used to drive a computational 
analysis consisting of dynamic simulations of a musculoskeletal model. The use of this 
model allows for estimates of joint loading conditions, the accuracy of which have been 
validated against instrumented joint replacements in other applications. In this chapter, 
the loading conditions at a rigidly immobilized knee are reported.  
In parallel with investigations of the unmet clinical need, the treatment model 
proposed in Chapter 4 was explored and developed in the form of an implantable medical 
device. This work is documented in Chapter 8. Alternative designs, as well as the 
constraints of the treatment model itself, were investigated over the course of several 
design cycles. Recent advances in rapid prototyping techniques were used extensively to 
assist in design iterations and establish proof of concept. The resulting salvage total knee 
replacement design enables a patient to lock the knee in full extension with the use of a 
simple, handheld key, providing the passive flexibility of an existing knee replacement 
design in combination with the stability if an arthrodesis. This treatment is designed to 
subsume existing treatment methods, including knee arthrodesis and standard fully 
constrained salvage knee designs. Intellectual property created as part of this work fences 
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out this conceptual area and protects against others doing the same. Protection of this 
intellectual property has been secured with two separate patent applications through the 
United States Patent and Trademark Office. This work provides support for the 
translation of a proposed treatment solution to clinical use through intellectual property 
license.  
A holistic discussion of the research described above is presented in Chapter 9. In 
Chapter 10, insight gained from this research is used to provide recommendations for 
future work. 
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CHAPTER TWO 
RESEARCH OBJECTIVES 
 
The content of this dissertation supports four specific aims. 
 
Aim I: Establish the existence and quantify the size of the affected clinical 
population 
Chapter 3 – Clinical Etiologies in the Loss of Knee Function: A Case Report 
Chapter 4 – Background and Review  
Chapter 5 – Quantifying the Affected Patient Population 
Aim II: Quantify the changes to gait biomechanics induced by knee immobilization 
Chapter 6 – Changes to Gait Kinematics and Kinetics Induced by Rigid Knee Constraint  
Aim II: Estimate the joint loading patterns of a rigidly constrained knee 
Chapter 7 – Estimated Joint Loading at a Rigidly Constrained Knee 
Aim IV: Design an implantable device to serve as a proposed clinical treatment 
Chapter 8 – Design of an Implantable Device to Satisfy the Proposed Treatment Model 
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CHAPTER THREE 
CLINICAL ETIOLOGIES IN THE LOSS OF KNEE FUNCTION: A CASE REPORT 
 
A local unmet clinical need is introduced and explored through the analysis of 
representative patients. The intention of this report is to present preliminary evidence of 
said need. 
 
Abstract 
In the course of collaborative research efforts, two practicing orthopedic surgeons 
describe an unmet clinical need among patients in their local practice. The commonality 
between these patients is severe knee dysfunction, defined as a loss of functional knee 
motion; the knee may become stiff with extreme limitation of flexion, or the extensor 
mechanism can become nonfunctional, resulting in a loss of the ability to actively flex 
and extend the knee. This condition is often irreversible, treatment options are limited, 
and the outcome is often poor quality of life. Five patients with lost functional knee 
motion, from diverse etiologies, are presented. These examples serve to demonstrate the 
limitations of existing treatment methods and the demand for a clinical solution. The 
potential for an alternative treatment approach is discussed. 
Introduction 
A loss of functional knee motion may be attributable to a variety of etiologies, 
including failed primary or revision total knee arthroplasty, osteosarcoma, virulent 
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infection, trauma, or neuromuscular disease, such as polio. Loss of knee function can be 
debilitating, limiting a patient’s ability to engage in activities necessary for a satisfactory 
quality of life. Compromised knee function can inhibit mobility, including walking, 
standing, and stair climbing, and can hinder basic activities of daily living such as 
bathing, dressing, and sitting [1]. Physical therapy is sometimes incapable of addressing 
the root causes of dysfunction, even when these causes are muscular weakness or 
inflexibility [2]. 
Total knee replacement is often contraindicated in the presence of knee 
dysfunction due to related factors, including lost anatomy, instability, infection, or 
muscular weakness [3]-[5]. The armamentarium available to orthopedic surgeons in these 
cases is typically limited to transfemoral amputation and knee arthrodesis. While knee 
arthrodesis can salvage the limb and enable a patient to walk independently, knee motion 
is completely eliminated. The resulting loss of knee function significantly interferes with 
activities of daily living, complicating activities as common as sitting. Reduced quality of 
life is associated with depression in patients following both amputation or arthrodesis [6], 
[7]. In a South Korean study, 30 patients with fused knees insisted on undergoing 
desarthrodesis (reversal) to a total knee replacement design to accommodate knee 
mobility; 17 of these patients had previously attempted suicide [7].  
When faced with the prospects of these treatments, patients may adamantly insist 
on undergoing high risk salvage total knee replacement, in spite of the low chance of 
success. Treating physicians “have a responsibility to present their patients with treatment 
choices that have a reasonable chance of succeeding without causing undo harm,” 
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however, and knee arthrodesis or amputation may be the most appropriate treatment 
approach for these patients. This can result in an ethical dilemma for the physician, as 
these cases raise considerations of “informed consent, patient education, autonomy, 
decisional capacity, paternalism, and physician responsibilities” [8].  
Current available treatment methods for lost knee function, regardless of cause, 
are unsatisfactory to surgeons and patients alike. This dissatisfaction indicates an 
opportunity for an improved treatment approach. The following case examples 
demonstrate patients with severe knee dysfunction resulting from various causes. 
Case Description 
Patient 1 is a 69-year-old male who first underwent arthrodesis for osteoarthritis 
at age 51. This surgery was conducted at the US Department of Veteran Affairs, and 
fusion was performed using a Neff femorotibial nail.  
 
Figure 1 - Neff Femorotibial Nail (Zimmer, Warsaw, Indiana) 
Subsequent to knee fusion, the patient developed osteoarthritis of the right hip, 
requiring a total hip replacement. The patient then developed osteoarthritis of the left hip, 
requiring a total hip replacement for that joint. While the left total hip replacement was 
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principally successful, the patient exhibits painful left hip range of motion. The right total 
hip replacement has failed, requiring revision.  
Other medical problems include diabetes, hypothyroidism, hypertension, and 
gastroesophageal reflux disease. Patient was diagnosed with prostate cancer in 2007 and 
was treated with a series of 40 radiation treatments.  
The patient is currently presenting with a stiff, fused knee and secondary pain. 
 
Patient Two is a 70-year-old obese (BMI: 45, and Weight > 300 lbs.) male, and 
has undergone multiple failed total knee replacement surgeries. Other medical problems 
have included gastroesophageal reflux disease, hypertension, hyperlipidemia, and morbid 
obesity (but not diabetes.) Patient exhibited a 25 degree extensor lag, and his left knee 
was larger than his right.  
Initial surgery was in 2001 for a primary total arthroplasty of the left knee. In 
2003, patient underwent total knee arthroplasty for the right knee. Patient had a stroke in 
2007, but did not have much residual deficit. Difficulties with the left knee began to 
accelerate in June 2009 when the femoral component was revised due to generalized pain, 
and the femur fractured at the end of the new femoral component’s stem in July 2009. 
Left knee pain continued, and the tibial component was revised in February 2010. During 
surgery, the patellar tendon was detached at the tibial tubercle and reattached with a 
Stone staple.  
Two months later, in April 2010, the patient presented with loose femoral and 
tibial components, and was referred to a specialist. Specialist noted induration and 
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tenderness at the tibial tubercle, and aspiration revealed a purulent infection. The staple 
was removed, and the patient was given two days of IV antibiotics, followed up with 7 
days of Keflex oral antibiotic. Gross purulence continued along with chronic avulsion of 
the patellar tendon.  
Infected tibial and femoral components were removed, and ‘artificial fusion’, as 
described previously in the literature [9], was performed. Complex stabilization of the 
knee was achieved using a combination of an intramedullary rod and a large mass of 
PMMA, which was used to bridge the gap between the femur and tibia resulting from 
severe bone loss.  
 
Figure 2 - Radiographs of the (A) Anteroposterior and (B) Mediolateral view of the knee (Patient 2) 
  
A B 
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Patient 3 had a severe traumatic injury to the knee, requiring subsequent surgery 
for fracture. Patient underwent total knee replacement after the development of severe 
joint arthritis. Patient developed ankylosis at the knee, losing all mobility, and currently 
walks with a stiff leg gait. Heterotropic bone has formed posterior and medial to the knee, 
which can be seen in radiographs. 
 
Figure 3 - Radiographs of the (A) Anteroposterior and (B) Mediolateral view of the knee (Patient 3) 
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Patient 4 suffers from a congenital disease, which has resulted in knee problems, 
including a size differential between the left and right knees. The patient underwent total 
knee replacement, but subsequently developed severe postoperative joint stiffness. The 
subsequent surgical procedures were performed, but stiffness has not resolved. The knee 
has spontaneously fused in full extension, and heterotopic bone formation can be 
observed posteriorly.  
 
Figure 4 - Radiographs of the (A) Anteroposterior and (B) Mediolateral view of the knee (Patient 4) 
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Patient 5 originally presented with an osteosarcoma, which was addressed with a 
total knee replacement. The primary total knee replacement procedure was complicated 
by the occurrence of infection, and required subsequent revision. Multiple surgeries have 
scarred the quadriceps muscle, and the patient has lost function of the joint. The patient 
currently has a hinged, rotating bearing total knee replacement, but has lost all flexion 
due to stiffness. The patient can walk with the knee in full rigid extension. 
 
Figure 5 - Radiographs of the (A) Anteroposterior and (B) Mediolateral view of the knee (Patient 5) 
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Discussion 
Two patients, Patients 1 and 2, present with a knee arthrodesis (traditional and 
“artificial” [9]). For these two patients, there is no current treatment available to improve 
the condition of the leg. The joint is pain-free, and there is no method of adjusting range 
of motion. Desarthrodesis to a total knee replacement, even one of constrained design, is 
not a viable option, especially without an intact extensor mechanism.  
Treatment options for the three patients with an intact joint replacement (but 
without actual movement) are not significantly better. All three patients have formed 
heterotopic bone, and total knee replacement is contraindicated. The only appropriate 
treatment option available for these patients is knee arthrodesis, which would introduce 
surgical risks without any substantial benefit in outcome. The course of action with the 
most probable chance of success is to avoid surgical intervention.  
Knee dysfunction manifests itself as immobilization of the joint in each of the 
presented cases, whether the joint is physically or functionally fused. Little to no flexion 
of the knee is achievable, but all patients are ambulatory with a stiff-knee gait. In this 
sense, all patients have the functional equivalence of knee arthrodesis. While this 
permanent extension enables these patients to be mobile, this mobility comes at the 
expense of the flexion required for some activities, such as sitting in close-quarter 
locations (vehicles, theaters), the ability to sit or lie comfortably, or the ability to engage 
in other activities of daily living [10], [11].  
Knee desarthrodesis may offer these patients the ability to passively bend the knee, 
but it has a high risk of complications (upwards of 86%) and poor outcomes [12], [13]. 
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Even in the presence of a functioning knee extensor mechanism, muscular weakness and 
joint stiffness may limit range of motion, and the loss of passive knee stability may 
prevent patients from standing or ambulating independently.  
The present cases underscore the need for an alternative treatment method to 
address severe joint dysfunction. Without a functional knee extensor mechanism, current 
approaches force patients to choose (when they have a choice) between passive knee 
flexion and rigid knee stability. In all cases, patients would conceivably benefit from the 
ability to both passively bend the knee, such as while sitting or lying down, while 
maintaining the stability of rigid knee extension while standing and ambulating. A 
treatment that offered such an ability would be required to operate within the confines 
defined by the patient subset, whose knee extensors are weakened or completely missing. 
The treatment would necessarily include, at a minimum, an implantable medical device. 
Such a treatment would allow locomotion while reducing or eliminating the pain 
associated with the presented pathologies.  
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CHAPTER FOUR 
BACKGROUND AND REVIEW 
 
The etiologies of knee dysfunction are addressed, current treatment methods are 
reviewed, and the potential for novel surgical treatments is discussed. 
 
Abstract 
A review of current literature suggests that total knee replacement surgery 
contributes to knee dysfunction, and that the additive dysfunction resulting from multiple 
failed total knee replacement surgeries is sometimes irreversible. The treatment options 
for severe knee dysfunction are limited; when surgery is required and total knee 
replacement is contraindicated, the options are typically limited to knee arthrodesis or 
transfemoral amputation. Knee arthrodesis has severe functional limitations, and is the 
subject of a relatively large number of published reports. Several alternative surgical 
approaches to traditional knee arthrodesis have been developed, but they all share the 
same functional limitations. A novel treatment model is proposed. 
Rise in Primary Total Knee Replacement  
Total knee replacement has proven to be a highly effective and successful means 
of treating joint disease, and the number of primary knee replacement surgeries has 
dramatically increased over time. According to Ong et al., 5 year survivorship of primary 
total knee arthroplasty is 97.2% [14], a high success rate and contributing factor to the 
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ready adoption of the surgery. Kurtz et al. estimated the number of arthroplasty surgeries 
in the United States between 1990 and 2002 using the Nationwide Inpatient Sample, and 
estimated that rate of total knee arthroplasties per 100,000 persons tripled in that time 
[15]. This increase can be attributed to a number of factors, including increased 
implantation in younger patients, an aging population, increased prevalence of obesity, 
and an “increased recognition [of need] by [both] the candidates for surgery and members 
of the orthopaedic community”.  
Implicit in the high degree of success of total knee arthroplasty, however, is the 
fact that it is not an infallible treatment. In “Why Knees Fail,” Kelly Vince proposes nine 
causes of primary knee replacements failure [16]. These causes are aseptic loosening with 
or without osteolysis, tibial femoral instability due to ligament instability, patellar 
complications and malrotation, no diagnosis, structural failure of the implant, sepsis, 
extensor mechanism rupture, stiffness, and fracture. When a primary total knee 
replacement surgery fails, revision surgery is required. According to Vince, revision knee 
arthroplasty is not merely a repeat surgery, but “an opportunity to correct the 
shortcomings that lead to the initial failure [16].” This addresses a potential shortcoming 
of revision knee surgery: If the reason for the original prosthetic failure is not addressed, 
there remains a chance that it will also affect the results of the revision procedure. 
Rise in Revision Total Knee Replacements 
As the number of primary TKR surgeries in the United States has continued to 
rise towards a projected 3.48 million in 2030 [17], there has been a concomitant increase 
in the number and rate of revision procedures [15]. According to Kurtz et al., the 
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prevalence of revision total knee replacement surgery increased “by 5.4 procedures per 
100,000 persons per decade,” increasing from 12,000 in 1990 to 35,000 in 2002. Without 
proper perspective, the growth of the sheer number of revision surgeries could indicate an 
alarming trend toward increasing failures of primary knee replacement. The authors 
account for this in the study through the calculation of “revision burden,” defined as the 
ratio of revisions to the sum of revision and primary procedures, and estimate the change 
in its rate over time.  
While there are limitations to its use, revision burden is a measure of the quality 
of the primary treatment. Revision burden would increase over time if the primary 
treatment had an increased tendency to fail, including if treatment was expanded to use in 
patients less suited for treatment, or if the surgical implants reduced in quality over time. 
Revision burden would decrease over time with improvements of surgical technique, 
improvements implantable devices, or improved identification of appropriate patients for 
surgery. One shortcoming of this measurement is that revision burden also decreases if 
the rate of primary intervention increases in the short term, as the number of revisions is a 
lagging figure, based on historical primary intervention surgeries that occurred at the 
smaller intervention rate.  
The Kurtz et al. study found that the revision burden for total knee replacement 
has remained constant over time for all patients except women in the 65-74 age group, 
who experienced a statistically significant annual increase of 0.5%. The authors thus 
attribute the increase in revision surgery to the large increase in primary procedures. This 
would indicate that the success rate of primary procedures has not improved, and that the 
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corresponding rate of patients who must undergo revision surgery has not been reduced. 
Kurtz et al. do not address the fact that the increases in primary surgery, which was 
identified, could have pushed down the revision burden, indicating the possibility that 
revision rate is actually increasing. It is noted that since revision burden is not decreasing 
(by their measure), a “greater number of revisions” should be expected without 
implementation of “some limiting mechanism… to reduce the future revision burden.” 
[15] This appears to be an appropriate assumption, and would indicate a growing 
population of patients undergoing revision. 
In fact, in a subsequent 2007 study, Kurtz et al. projected a steep increase in the 
number of primary and revision arthroplasty surgeries between 2005 and 2030 [17]. The 
authors predict that revision knee arthroplasty will grow from 38,300 patients in 2005 to 
268,299 patients in 2030. The group’s predictions were calculated by determining 
surgery prevalence by sub-group, and then applying those prevalence rates to “projected 
population data for each subgroup.” Subgroup covariates included age, gender, race, and 
census region, and the authors used projected population data from the United States 
Census Bureau. If these predictions prove accurate, there will be a sevenfold increase in 
the number of patients undergoing revision knee arthroplasty by 2030.  
Poorer Outcomes after Repeated Surgery 
In a meta-analysis of 42 articles published between 1973 and 1994, Saleh et al. 
investigated the long term outcomes of revision knee arthroplasty patients using Global 
Knee Scores (GKS) [18]. GKS were defined as “an instrument that measured patient 
outcomes in the domains of pain, function, and range of motion and combined these 
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domains in a summary scale,” [19] and include the Hospital for Special Surgery (HSS) 
and Knee Society (KS) scores. In their analysis, they found that patients undergoing 
revision surgery had a significant increase in GKS after their procedure, without a 
significant correlation between pre-revision surgery and post-revision surgery scores. 
This study supports the consensus that revision knee arthroplasty provides favorable 
outcomes when compared to no surgery at all. 
The success of revision knee arthroplasty, however, has not matched that of 
primary knee arthroplasty, as outcomes after revision knee arthroplasty are typically 
worse than primary knee arthroplasty by every measure. Greidanus et al. assessed the 
outcomes of 159 patients undergoing primary and revision total knee arthroplasty using 
standardized and validated measures: The Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC), the Oxford-12 Knee Score, the Short Form-12, and 
patient reported satisfaction [20]. Deehan et al. studied the outcomes of 94 patients 
undergoing revision knee arthroplasty using standardized and validated measures: the 
Nottingham Health Profile (NHP) and Knee Society (KS) scores. The WOMAC, Oxford-
12, NHP, and KS scores are each designed to capture health outcomes, though they do so 
in different ways. The WOMAC, Oxford-12, and KS specifically address knee 
arthroplasty, while the Short Form-12 and NHP measure generic quality of life. The 
conclusions of these studies show that results of revision knee arthroplasty are inferior to 
those of primary knee arthroplasty, even while adjusting for confounding factors [21]. 
The authors conclude “most revision patients will never experience an outcome as 
favorable as their primary procedure.” A number of physical and physiological factors 
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may contribute to diminished outcomes, including the compounding effects of multiple 
surgeries, increased loss of natural anatomy, and the difficulty of revision surgery. Other 
“factors that may contribute to this difference [may include] deconditioning, muscle 
impairment or atrophy, scar tissue, instability, and joint stiffness. [20]” With outcomes of 
revision knee arthroplasty measurably worse, patients whose primary surgery fails are 
subject to a reduced quality of life. 
In addition to poorer functional scores after revision knee arthroplasty, Patients 
undergoing revision TKR are more likely to have complications such as periprosthetic 
fracture (0.78% vs. 0.08%), wound infection (0.78% vs. 0.12%), deep prosthetic infection 
(0.47% vs. 0.06%), major systemic complications (7.44% vs. 4.91%), and mortality 
(0.62% vs 0.12%) [14]. In addition to complications, revision knee arthroplasty is 
generally more likely to fail. While primary total knee arthroplasty has a 5-year 
survivorship of 97.2%, the same 5-year survivorship of revision knee arthroplasty is only 
87.4% [14]. Ong et al. analyzed Medicare claims data to determine the “relative risk of 
revision surgery for primary and revision” total joint arthroplasty, and found that patients 
with a revision knee arthroplasty were 5.71 times more likely to undergo rerevision. 
Successive surgeries exacerbate damage as native anatomy is weakened, compromised, 
or removed. The result is a subset of patients who undergo a number of failed procedures 
and end up with severe and irreversible knee dysfunction. 
With a growing population of patients undergoing revision knee arthroplasty, 
combined with poorer outcomes resulting from revision and the increased likelihood of a 
 23 
subsequent surgery being necessary, the number of patients with serious complications, 
including severe knee dysfunction, is expected to rise as well.  
Knee Dysfunction and Weakness 
Weakness of the knee extensor mechanism is a debilitating condition that limits a 
patient’s ability to actively extend the knee, and thus the ability to stand, rise from a chair, 
and walk without assistance. In addition to allowing for independence, sufficient 
quadriceps strength is also essential in preventing injuries due to falls [22]. Extensor 
mechanism weakness can occur in patients with tumors, muscular diseases, neurological 
diseases, osteoarthritis of the knee, or in patients who have undergone knee replacement 
surgery. Quadriceps weakness has been closely linked to osteoarthritis of the knee, and it 
has been suggested that it may be a result, a risk factor, or both [23], [24].  
To make matters worse, knee replacement surgery itself results in profound 
quadriceps weakness. While TKR is able to address pain associated with the disease, it 
does not address deficits in quadriceps function [25]. Physical therapy following TKR is 
standard care, but it is frequently unable to rehabilitate patients to full preoperative 
strength [2]. Walsh et al. examined the effect of TKR on 29 patients versus an age 
matched control group of 40 patients, and found that even one year after surgery patients 
exhibited strength deficits, physical impairments, and functional limitations, including 
reduced walking and stair climbing ability [26]. Mizner et al. subsequently demonstrated 
that reduced quadriceps strength correlated with reduced functional performance, loading, 
and moving patterns [1]. Loss of quadriceps strength can be significant after TKR 
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surgery; Mizner et al. studied a group of twenty patients and found an average loss of 
62% of quadriceps strength after 1 month [27].  
The causes of quadriceps weakness after knee surgery are multifactorial. In their 
investigation, Mizner et al. examined the causes of weakness, and found that failure of 
voluntary activation was the predominant cause, with muscle atrophy only a secondary 
cause. Together, failure of voluntary activation and atrophy caused 85% of postoperative 
weakness [27]. However, in another study, Lewek et al. examined 12 patients with 
osteoarthritis who had not undergone TKR, and found no statistically significant decrease 
in voluntary activation. 
In cases where successive revision surgeries are required, weakness is 
exacerbated as damage to native anatomy is compounded. Severe weakness is often 
irreversible and prevents patients from walking without the use of assistive devices such 
as braces, canes, crutches, or wheelchairs. For these patients, activities of daily living 
become difficult or impossible, significantly reducing quality of life [25]. 
Extensor mechanism weakness is poorly addressed with reconstructive surgery, as 
existing total knee replacement designs require adequate muscular strength and joint 
stability to function. While some TKR systems are engineered to compensate for a loss of 
joint stability, no existing TKR designs compensate for a weakened, damaged, or missing 
quadriceps extensor mechanism. To date, the number of patients affected by this 
condition has not been well characterized in the literature. 
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Transfemoral Amputation 
There are approximately 185,000 total lower limb amputations performed each 
year in the United States, and the procedure is associated with reduced function, reduced 
quality of life, and depression [6], [28], [29]. Transfemoral amputation is sometimes 
required after failed total knee replacement; one study of twenty-five patients showed that 
approximately 37% of amputations were attributable to complications of the replacement 
procedure itself [28]. If these figures are extrapolated to nationwide incidence, using 
projections of total knee replacement procedures, an estimated 4,900 amputations per 
year may occur as a result of complications attributable to knee replacement by 2030 [17].   
Knee Arthrodesis 
Arthrodesis, or complete fusion of the knee joint, is preferable to amputation but 
is still a treatment of last resort in patients where total knee replacement is 
contraindicated. While arthrodesis has an extensive history of use, it is currently most 
often used to treat pain and instability in the knee in cases of multiple failed total knee 
replacement surgeries, bone loss, infection, or loss of the quadriceps extensor mechanism 
[10], [11]. Arthrodesis maintains the anatomical structure of the lower limb, enabling 
patients to maintain mobility independent of assistive devices such as a braces or 
wheelchairs.  
While arthrodesis allows for patient mobility, it requires an altered gait as a result 
of the inflexibility of the knee and subsequently increased moment of the leg. It has been 
suggested that changes associated with arthrodesis include increased pelvic tilt, increased 
ipsilateral hip abduction, and increased ipsilateral ankle dorsiflexion [10], though the data 
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supporting this is unpublished. Walking with an arthrodesis is more physically 
demanding, with oxygen consumption shown to be 20% greater when walking with an 
immobilized knee[30], and energy use demonstrated to be 25-30% higher than that of 
normal walking [10]. However, arthrodesis is still preferable to amputation, however, 
which requires an additional 25% energy expenditure compared to arthrodesis.  
Arthrodesis is not considered an entirely positive outcome, and it is often 
performed only because it is unavoidable or advisable compared with the alternatives, 
including amputation. Presence of arthritis in other joints of the leg are a contraindication 
for arthrodesis, as the altered gait may increase stresses in the hip and ankle [11] and may 
induce secondary arthritis. The permanence of the extended knee position complicates a 
number of activities of daily living. Simple tasks such as bathing, tying shoelaces, or 
sitting in close quarters become difficult or impossible. Travel can be significantly 
affected, as an extended leg interferes with the ability to sit in cars or planes. 
Arthrodesis has been performed using a number of techniques and fixation 
methods, including bony fusion assisted by means of internal or external fixation devices 
[11]. Traditional arthrodesis is a technically demanding procedure, and can result in 
significant blood loss and operative time [10], [31]. In some cases, such as massive loss 
of bone stock, fusion with bone-to-bone contact is difficult or impossible. Traditionally, 
the loss of natural bone has been compensated with the use of allografts or autografts, 
which entails additional surgical time and associated difficulties [10], [11]. 
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Alternative Surgical Approaches to Arthrodesis 
Fusion can be performed without direct bone-to-bone contact, and several 
alternative approaches have been established to achieve full fusion. Voss demonstrated an 
‘artificial fusion’ performed with an implantable rod passing through the intramedullary 
canal of both the femur and tibia, with polymethyl methacrylate cement used as a ‘spacer’ 
between the bones [9]. The rod and cement provided sufficient fixation for full weight 
bearing the day after surgery, and was still successful at four years, the latest follow up 
available. This technique was first shown by Campanacci and Casta [32] and has been 
subsequently used by a number of surgeons. One patient who underwent fusion by means 
of this technique is presented in Chapter 3. Success of this alternative to bone-to-bone 
arthrodesis is promising, as it demonstrates the potential for successful fusion using 
completely non-native materials to bridge the joint. 
Following the development of “artificial fusion,” a number of implantable knee 
prosthetics have been designed specifically for knee arthrodesis [33]. At least one such 
device has taken a similar form to that of total knee replacement designs. Bartlett et al. 
reviewed ten cases of patients who underwent an arthrodesis using a Stanmore Custom 
Arthrodesis Prosthesis [31], consisting of cobalt chrome femoral and tibial components 
with stems that are mechanically locked together by means of an axle and circlip. This 
device compares favorably to traditional arthrodesis, as it allows for fusion using a less 
technically demanding technique and reduced blood loss. Additional benefits of using a 
device for knee fusion include allowing for the establishment of a precise limb length, 
deliberate limb alignment, and avoidance of amputation in patients who would be 
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otherwise unable to undergo fusion. Considering the success of these alternative 
procedures, it appears that good fusion results are possible with implanted orthopedic 
devices. 
Discussion 
With the recent success of implantable orthopedic joint devices designed for knee 
fusion, coupled with the long term success of standard total knee replacement designs, 
the prospects for a more fully functioning device appear promising. Such a device could 
be designed to address the previously defined patient subset, those with severe knee 
dysfunction. 
The limitations imposed by knee dysfunction, as discussed in Chapter 3, have 
meant that some patients must choose between a treatment that offers little stability and a 
treatment that fully and permanently constrains the knee. The former, a total knee 
replacement of some form, enables a patient to bend the knee, but lacks the stability to 
provide adequate support in the presence of knee dysfunction. The latter, knee arthrodesis, 
provides the full stability needed to ambulate, but precludes any ability to bend the knee.  
With consideration of the aforementioned limitations, we propose a novel 
treatment model. This treatment would take the form of a total knee replacement, but 
would incorporate an ability to simulate fusion by temporarily maintaining rigid 
extension. In this manner, this treatment model would eliminate many of the current 
limitations imposed on this patient group. Patients lacking knee stability or a knee 
extensor mechanism could stand and ambulate independently without forgoing the ability 
to otherwise bend the knee. The work of this dissertation, including the quantification of 
 29 
the affected patient subset, the kinematics and kinetics of gait, and the resulting joint and 
muscle forces, supports the development of such a proposed treatment model. This 
proposed treatment model is explored and developed further in Chapter 8.  
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CHAPTER FIVE 
QUANTIFYING THE AFFECTED PATIENT POPULATION 
 
The number of patients undergoing knee arthrodesis in the United States is quantified 
and described in clinically relevant ways. The hospitals where these procedures are 
performed are further characterized. 
 
Hypothesis 
The number of patients undergoing knee arthrodesis in the United States, 
heretofore unquantified, is significant (greater than 100 procedures per year).  
Abstract 
Treatment options for severe knee dysfunction are limited, and include knee 
arthrodesis. Patient satisfaction after knee arthrodesis is generally low, making it a 
treatment of last resort. There is a high level of clinical interest in this procedure, 
however, as evidenced by the large number of recently published clinical case reports and 
reviews in peer reviewed orthopedic focused journals. In spite of this high degree of 
clinical interest, specific details about the affected patient population are largely unknown. 
The number of patients undergoing knee arthrodesis has not been previously quantified, 
the types of patients undergoing the procedure have not been characterized, and the 
hospitals where the procedure is performed have not been characterized. Two patients 
with a knee arthrodesis, from two clinical practices, were presented in Chapter 3 of this 
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dissertation. These patients provide initial evidence of an unmet clinical need, but the 
prevalence of similar patients is unknown. In Chapter 5, we investigate the incidence of 
knee arthrodesis procedures in the United States over the past two decades in order to 
further support this need. We further characterize the patients undergoing the procedure 
by demographic, and characterize the hospitals where the procedure is performed. Our 
estimates are based on data obtained from the Nationwide Inpatient Sample, a database of 
inpatient hospital discharge records, using the International Classification of Disease-
Revision 9 medical billing code for knee arthrodesis (ICD-9-CM 81.22). We also 
estimate the per capita procedural rates for individual patient demographics using 
population data from the United States Census. We found that the annual number of 
patients undergoing knee arthrodesis un the United States remained relatively unchanged 
from 1993 to 2011, the latest year for which data was available, at a mean of 1,014 
(Standard Deviation: 113) procedures per year. Over 80% of patients were aged 45 or 
above. Approximately 65% of patients utilized governmental payers for reimbursement, 
including 54% using Medicare, which cannot be accounted for by age alone. Nearly all of 
the procedures were performed in metropolitan area hospitals (92.5%), and a significant 
majority of the procedures were performed in teaching hospitals (62%). We conclude that 
the number of knee arthrodesis procedures performed in the United States is significant. 
Introduction 
Treatment options for patients suffering from severe knee dysfunction are limited. 
Salvage total knee replacement surgery is often contraindicated, requiring patients to 
choose between forgoing surgery, transfemoral amputation, or knee arthrodesis. While 
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the functional outcomes of knee arthrodesis are better than those of amputation, the 
outcomes of both are low. This often leaves arthrodesis as the best of poor alternatives. 
Historically, knee arthrodesis has had a wide range of clinical indications, 
including advanced osteoarthritis, posttraumatic osteoarthritis, rheumatoid arthritis, 
tuberculosis, poliomyelitis, and syphilis[10], [34]. With the development and success of 
total knee replacement (TKR) surgery, along with advances in medicine eliminating the 
later stages of some diseases, the indications for arthrodesis have narrowed [10], [34], 
[35]. Current indications for this treatment include damage, weakness, or loss of the knee 
extensor mechanism, inadequate ligamentous constraint, substantial bone loss or defects, 
osteosarcoma, posttraumatic arthritis, arthrofibrosis, or infection [10], [11] and the 
procedure is often performed after the failure of total knee replacements [5], [34], [36], 
[37]. 
Perhaps due to a combination of the undesirability of knee arthrodesis and the 
limited treatment alternatives, there is a high degree of clinical interest in the procedure, 
as evidenced by the publication of more than 60 case reports and review articles on the 
subject in peer reviewed, orthopedic journals in the past five years. These include review 
articles [5], [10], [11], [36]-[38] and case reports, some of which have focused on 
methods of achieving fusion, including external fixation [39] and internal fixation by 
means of intramedullary nails [40], [41] or dynamic compression plates [42]. Alternative 
methods of achieving fusion have been proposed [9], including implantable prosthetics 
dedicated to knee arthrodesis [31], [33], [36], [43]. These dedicated implants can serve as 
a rigid spacer in the absence of sufficient bone stock and may improve the surgical 
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success rate, but they offer patients no functional advantages over traditional knee 
arthrodesis techniques. The functional limitations of knee arthrodesis have driven a 
strong desire among patients for desarthrodesis, or reversal of a previous fusion, in spite 
of its high complication and poor success rate [12], [44], [45].  
Even with such a high level of clinical interest, there are no published estimates of 
the incidence of knee arthrodesis; the figures are completely neglected in all six review 
articles referenced above. Evaluating and quantifying patient subsets is critical to fully 
understanding unique patient needs. In some cases, quantifying a patient subset provides 
justification for the development of new and improved treatments. There have been 
numerous estimates and characterizations of orthopedic patient populations published in 
the literature in recent years, including the number of patients undergoing primary and 
revision total knee, hip, and shoulder replacement surgery [15], [46]. That work has been 
influential, and has enabled further studies, such as estimations of economic burden[47], 
to build upon it. This type of study is also prevalent outside of orthopedics, such as in 
estimates of heart disease in the United States [48].  
These estimates are most commonly made by searching inpatient hospital 
discharge records. When searching through this data, researchers may take advantage of 
the ubiquitous nature of the International Classification of Disease-Revision 9 (ICD-9) 
medical billing codes. Nearly all procedures and patient diagnoses have their own 
specific ICD-9 code, and each patient medical record contains their diagnoses and 
procedures listed by code. When patients medical records are aggregated, researchers can 
search these records to determine prevalence or trends in diseases or procedures.  
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Patient records may be aggregated in a number of ways and by a number of 
different entities, such as internally within a hospital system for their own records. A 
number of patient discharge records have been aggregated into larger and readily 
available databases, allowing for similar studies to be conducted using databases such as 
the Nationwide Inpatient Sample [49], the National Hospital Discharge Survey [15], or 
the Medicare claims database [50].  
The Nationwide Inpatient Sample (NIS) is the “largest publically available all 
payer inpatient care database in the United States,” and is a part of the Healthcare Cost 
and Utilization Project (HCUP) of the Agency for Healthcare Research and Quality. The 
NIS database contains approximately 8 million inpatient hospital discharge records from 
approximately 1000 hospitals, and is intended to represent a 20% sample of community 
hospitals in the United States [51]. The NIS uses a two-stage stratified cluster design with 
five strata, consisting of hospital characteristics. These strata are hospital 
ownership/control (private or public), bed size, teaching status (teaching or non-teaching), 
urban/rural location, and U.S. region (Northeast, Southeast, Midwest, or West). A 
random sample of hospitals is selected from each stratum. Each individual hospital is 
considered a cluster, and every discharge record from selected clusters is included in the 
sample. Over one hundred data elements are included with each patient discharge record 
(case), including patient age, sex, payment method, diagnoses and procedures performed, 
and teaching status, location, and size of the admitting hospital. The latest available NIS 
dataset (2011) contains “all discharge data from 1,045 hospitals located in 46 states.” 
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Materials and Methods 
Data from all available years of the Nationwide Inpatient Sample (1988-2011) 
was obtained from the Agency for Healthcare Research and Quality (AHRQ), a part of 
Healthcare Cost and Utilization Project (HCUP). The NIS sample design was changed in 
2001, and supplementary data was provided to accommodate the investigation of trends 
spanning beyond that year. Linked patient and hospital database files were merged, and 
further merged with the provided supplementary files where appropriate. HCUP 
recommends against using data from years 1988 to 1992 for trends analysis due to its 
smaller sample size, and it was omitted from all final analyses. 
The database was searched for all instances of knee arthrodesis by searching the 
procedural variables of all cases (inpatient records) for the presence of the ICD-9-CM 
medical billing code 81.22 – “Knee Arthrodesis,” and we distinguished cases where 
arthrodesis was coded as a primary or secondary procedure. This code does not 
distinguish between differing methods or types of implants used in knee fusion, such as 
external fixation or internal fixation using plates or nails. Our search was assumed to 
capture all instances of knee arthrodesis in the sample, as it was well established for all 
years of the study and was not prone to underreporting.  
Cases including a knee arthrodesis procedure were further analyzed for the 
following information: 
 Arthrodesis as a primary (PR1) or secondary procedure 
 Patient demographic data:  
o Gender 
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o Age – Binned into six groups 
 0 to 44 years 
 45 to 54 years 
 55 to 64 years 
 65 to 74 years 
 75 to 84 years 
 85+ years 
 Characteristics of hospital stay: 
o Length of stay 
o Total number of procedures performed 
o Associated diagnoses 
o Associated procedures 
 Payment: 
o Total hospital charges 
o Reimbursement method 
 Hospital data:  
o Teaching status 
o Hospital location (urban/rural) 
o Region of the country 
All data analysis for this work was performed using SAS software (Version 9 of 
the SAS System for Windows. Copyright 2013 SAS Institute Inc. SAS and all other SAS 
Institute Inc. product or service names are registered trademarks or trademarks of SAS 
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Institute Inc., Cary, NC, USA.) A complete program was coded in the SAS programming 
language to simplify analysis, and to facilitate future investigations of similar nature. 
Values of p<0.05 were considered statistically significant for all measures. 
 
Figure 6 – Master SAS Program for running NIS Analysis. The user can select the ICD-9-CM Code he 
wishes to investigate, select the cutoff ages for six age groups, and select the years of study. 
 
Nationwide estimates for each year of the study were determined with account for 
the NIS study design. The appropriate weighting factors were used for each case, and 
standard errors are reported with consideration of the stratified sample design using the 
SURVEYMEANS statement (See example code).  
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Figure 7 – SAS code used to analyze the Nationwide Inpatient Sample. The SURVEYMEANS procedure 
takes account of stratified sample design using CLUSTER and STRATA variables. 
 
In cases where knee arthrodesis was recorded as a secondary procedure, 
frequency analysis was used to determine the most commonly performed primary 
procedures. 
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A Poisson distribution [15] was assumed for the total number of arthrodesis 
procedures, population based procedure rates, the total number of procedures on each 
discharge record, and the total length of stay. Procedure rates for each patient 
demographic were further analyzed by age and gender using publically available 
population figures from the United States Census Bureau. Estimates from July of each 
intercensal year were used. Poisson regression analysis allowed for the use of age and sex 
as covariates in determining the rate and rate ratio of knee arthrodesis, and provided age-
gender specific procedure rates. An analysis of rate ratios across all years of study was 
used to determine the presence of annual trends. 
The nature of our search and our use of an inpatient record database meant that 
there were no zero values for either length of stay or the total number of procedures 
within each discharge record of interest; our search for records with an arthrodesis 
procedure meant that no records had less than one procedure, and inpatient records, by 
definition, require a minimum length of stay of one. Zero-truncated Poisson regression 
was used to analyze these items to account for this. 
Payment method, total hospital charges, hospital teaching status, hospital location, 
and hospital region were investigated, and trends were determined using linear regression. 
The diagnoses and procedures that were most commonly present in cases of knee 
arthrodesis were examined using frequency analysis. 
Results 
There were an average of 1,014 knee arthrodesis procedures performed in the 
United States each year from 1993 to 2011 (Table 1). Knee arthrodesis was recorded as 
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the primary procedure in over two-thirds of all cases (Figure 8); when recorded as a 
secondary procedure, the most commonly recorded primary procedure was “Arthrotomy 
for Removal of Prosthesis Without Replacement, Knee” (ICD-0-CM 80.06) and the 
second most commonly recorded primary procedure was “Excisional Debridement of 
Wound, Infection, or Burn” (ICD-9-CM 86.22). There was no statistically significant 
increase or decrease in the total number of knee arthrodesis procedures performed in this 
time. 
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Table 1 – Estimated total number of knee arthrodesis procedures (ICD-9-CM 81.22) and those coded as 
the primary procedure, by year. 
Estimate Std. Error Estimate Std. Error
1993 1,180 97 789 75
1994 952 98 642 72
1995 1,044 93 700 72
1996 1,021 91 729 74
1997 895 95 621 75
1998 922 88 684 73
1999 952 90 659 73
2000 1,021 117 740 93
2001 928 139 687 98
2002 1,131 124 845 92
2003 1,293 162 879 97
2004 963 109 639 81
2005 1,022 133 682 87
2006 1,032 101 745 80
2007 902 107 660 79
2008 1,111 115 843 85
2009 895 89 661 76
2010 858 83 516 65
2011 1,122 163 652 77
Avg. 1,013 * 704 *
All Procedures Primary Procedure
Estimated Number of Knee Arthrodesis 
Procedures in the United States from 1993 
to 2011
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Figure 8 – Number of knee arthrodesis procedures performed in the United States. 
 
The total population of the United States grew 19.9% over this time, from 260.0M 
in 1993 to 311.6M in 2011. Taking annual population data from the United States Census 
Bureau into account, there was a decrease in the per capita procedure rate observed 
during the years of this study (p<0.05) (Figure 9). 
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Figure 9 – Per capita knee arthrodesis procedural rate in the United States 
 
Patient Demographics 
Both age and gender significantly affected the relative rate of knee arthrodesis 
procedures, with age having the largest influence. The procedure rate increased with 
increasing age group, and the relative risk was 15 times greater for persons aged 75 to 84 
than for persons aged 0 to 45 (the absolute number of knee arthrodesis procedures in 
patients aged 85 and up was insufficient to allow for analysis.) Men are at greater risk of 
knee arthrodesis – the procedure rate was significantly higher for males than females at 
each age group (Table 2, Table 3).  
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Table 2 – Rate ratio of knee arthrodesis by age, gender 
 
Table 3 – Rate of knee arthrodesis procedures per 1,000,000 people 
 
Although there was no significant change in the overall number of procedures, 
and there was a significant reduction in overall per capita rate of knee arthrodesis over 
the years of study, patient demographics significantly affected these trends. Both the total 
number and per capita rate of knee arthrodesis dropped significantly in younger patients 
Rate Ratio 95% C.I.
Gender
Male 1.00 -
Female 0.83 (0.80, 0.85)
Age Group
0 to 44 1.00 -
45 to 54 3.97 (3.78, 4.17)
55 to 64 7.32 (6.99, 7.66)
65 to 74 11.64 (11.13, 12.16)
75 to 84 15.00 (14.32, 15.71)
85+ * *
Knee Arthrodesis Rate Ratios
Results of Poisson Regression Analysis - 
Rate Ratios by Age, Gender
Age Group Male (95% C.l.) Female (95% C.I.)
0 to 45 1.13 (1.09, 1.17) 0.93 (0.90,0.97)
45 to 54 4.42 (4.25, 4.59) 3.66 (3.52, 3.80)
55 to 64 8.10 (7.82, 8.38) 6.70 (6.47, 6.94)
65 to 74 13.06 (12.64, 13.50) 10.81 (10.46, 11.17)
75 to 84 16.82 (16.22, 17.44) 13.92 (13.44, 14.42)
85+ * * * *
Rate of Knee Arthrodesis per 1,000,000 Persons
Rate of Knee Arthrodesis Procedures per 1M Persons
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(0 to 44) over the years of study (p<0.001 and p<0.001), while the total number of 
procedures rose in patients aged 45 to 54 and 55 to 64 (p<0.01). There was no significant 
change in the total number procedures in older patients (aged 65 to 74 and 75 to 84), but 
the per capita procedure rate of this demographic dropped over the time of the study 
when accounting for population growth (p=0.02). 
The average hospitalization length for patients undergoing knee arthrodesis was 
significantly affected by age (p<0.001), increasing by an average of 1.04 days with each 
increase in age group. Length of stay was not significantly affected by gender. There was 
a significant decrease in the overall average length of stay over the study period (p<0.01) 
(Figure 10). 
 
Figure 10 – Average length of stay for a person undergoing knee arthrodesis. 
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Associated Procedures and Diagoses 
The total number of procedures that a patient undergoing knee arthrodesis will 
undergo (including knee arthrodesis itself) during his hospital discharge is positively 
correlated with age (p=0.014), but is not influenced by sex. The average number of 
procedures per discharge record also rose over the years of study, at a rate of 0.067 
procedures per year (p<0.01) (Figure 11). 
 
Figure 11– Average number of procedures on discharges that include a knee arthrodesis procedure. 
 
The diagnoses most commonly associated with knee arthrodesis in discharge 
records are “unspecified hypertension” (ICD-9-CM 4019), “infection and inflammatory 
reaction due to internal joint prosthetic” (ICD-9-CM 99666), and “acute posthemorrhagic 
anemia” (ICD-9-CM 2851). The procedure most commonly recorded alongside knee 
arthrodesis was “packed cell transfusion” (ICD-9-CM 9904), and the second most 
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commonly recorded procedure was “arthrotomy for removal of a prosthesis without 
replacement” (ICD-9-CM 8006). 
 
Reimbursement and Charges 
The charges associated with each hospital stay increased dramatically over the 
years of study (p<0.001), increasing from an average of $33k per stay to an average of 
$111k per stay in 2011 (Figure 12). 
 
Figure 12 – Average hospital charges for a discharge that includes a knee arthrodesis procedure. 
 
A significant majority of reimbursements came from government sources, 
including Medicare and Medicaid, while private insurance accounted for approximately 
26% of payments (Figure 13). 
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Figure 13 – Number of discharge records billed to the top three payors from 1993 to 2011. 
 
Figure 14 – Percentage of discharges including a knee arthrodesis procedure, by payor 
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Procedure Location 
Knee arthrodesis was performed in a metropolitan hospital in nearly all cases 
(92%), and a significant majority (62%) of the admitting hospitals were classified as 
“Teaching” hospitals [“has an AMA-approved residency program, is a member of the 
Council of Teaching Hospitals (COTH) or has a ratio of full-time equivalent interns and 
residents to beds of .25 or higher”] (Figure 15). There were no significant trends over 
time.  
 
Figure 15 – Percentage of knee arthrodesis procedures performed in a teaching hospital 
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There were fewer procedures performed in hospitals in the Western region of the 
United States (Figure 16, Figure 17, Table 4), even when accounting for population 
differences, than any other region of the country (p=0.05) (Figure 18).  
 
Figure 16 – Average annual number of knee arthrodesis procedures, by region of the country 
172
419
122
219
Northeast
South
West
Midwest
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Figure 17 – Regions of the United States (Nationwide Inpatient Sample) 
 
Regions of the United States (Nationwide Inpatient Sample) 
Northeast Connecticut, Maine, Massachusetts, New Hampshire†, New Jersey, 
New York, Pennsylvania, Rhode Island, Vermont 
Midwest Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, 
Nebraska, North Dakota, Ohio, South Dakota, Wisconsin 
South Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, 
Kentucky, Louisiana, Maryland, Mississippi, North Carolina, 
Oklahoma, South Carolina, Tennessee, Texas, Virginia, West Virginia 
West Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, 
Nevada, New Mexico, Oregon, Utah, Washington, Wyoming 
Table 4 – Regions of the US as defined by the NIS 
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Figure 18 – Per capita knee arthrodesis procedural rate, by region of the country 
 
Discussion 
The purpose of this work, having first identified an unmet need in the local 
practices of our clinical collaborators in Chaper 3, was to determine the broader 
significance of said need. This need – the limited number and undesirability of options 
available to patients with severe knee dysfunction – has been discussed in the literature 
from a number of perspectives. In one such publication, the most appropriate course of 
treatment is addressed as an ethical dilemma [8]. Knee arthrodesis is advocated as an 
option that will salvage the limb and allow for independent ambulation, but it is generally 
undesirable to patients. In spite of the large number of publications on knee arthrodesis in 
peer-reviewed journals, there are no reports or estimates of the actual number of 
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procedures performed. No recent review articles cite the commonness of the procedure 
[10], [11], [38], in stark contrast to those of other orthopedic procedures.  
This study provides a robust estimate of the number of knee arthrodesis 
procedures performed in the United States, and was conducted by adopting and adapting 
methods used to quantify other patient population subsets. While there are relatively few 
knee arthrodesis procedures performed relative to total knee replacement procedures 
(0.14%), this study establishes that the number of procedures, at approximately 1,014 per 
year, is not insignificant. The results of this study further indicate, however, that the 
number of arthrodesis procedures performed in the United States has not significantly 
changed over the past two decades. A small reduction in the absolute number of 
procedures may have been prevented by population growth, as the per capita rate of knee 
arthrodesis procedures has fallen or remained unchanged for each individual age/gender 
demographic group. The continued use of knee arthrodesis as treatment, in spite of its 
undesirability, indicates an otherwise unmet need in the affected patients. This merits a 
closer look by clinicians, researchers, and medical device manufacturers. 
The success of primary and revision total knee arthroplasty has significantly 
marginalized knee arthrodesis as treatment of choice in most cases[10], but has not 
completely eliminated it. Arthrodesis is indicated in patients with deficient or missing 
extensor mechanisms, as total knee replacement designs cannot compensate for the loss 
of function and stability and the risk of graft transfer may be unacceptably high [8]. Knee 
arthrodesis often follows failed knee arthroplasty, as determined by our procedure 
analysis, and it could be hypothesized that the incidence of arthrodesis will increase as 
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the number of revision arthroplasty procedures increases. This must be balanced against 
patients increasing expectations for higher quality of life, function, and mobility, however, 
for which arthrodesis technology has not kept pace. This could account for both the 
decrease in per capita arthrodesis rates and the observation that arthrodesis rates do not 
mirror increases in total knee revision rates. Given the steady number of knee arthrodesis 
procedures, it is likely that reconstructive knee replacement is already performed in as 
many cases as is feasible. It is also possible that high risk reconstructions are performed 
too often, and that knee arthrodesis should be attempted earlier in some cases to preserve 
bone stock and ensure the greatest chance of success [4].  
We found that patients who do undergo arthrodesis are generally older, with over 
80% of all patients above the age of 45, and over 41% of patients above the age of 65. 
Age alone does not fully explain the prominence of Medicare as a payment method, 
however. Assuming that all patients above the standard eligibility age of 65 utilized 
Medicare as a primary payment method, there was still a significant proportion (12.3%) 
of younger patients utilizing it. These patients most likely received Social Security 
Disability benefits prior to their knee arthrodesis procedure, an indication of the 
debilitating nature of the knee dysfunction and injuries that are present in patients who 
undergo the procedure.  
We also found that a significant majority of arthrodesis patients obtained 
treatment in metropolitan areas and at teaching hospitals. This may be indicative of the 
complicated nature of the procedure, the severity of the negative side effects, and the 
severity of the potential complications. It is possible that only a small number of 
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orthopedic surgeons perform the majority of these procedures, but this was not explored 
in the current study. Patients appear to be much more likely to either receive referrals or 
actively seek out specialists in knee reconstruction.  
Arthrodesis can enable a patient to ambulate independently, but permanent rigid 
knee extension has severe functional limitations and can make sitting uncomfortable. 
Simple activities of daily living, such as bathing or tying one’s shoes, can become 
difficult or impossible. Independence may be lost as patients have difficulty sitting in cars, 
busses, or planes, and patients may find it difficult to engage in activities in public such 
as in theaters. Some surgeons may request that a patient give fusion a test run by wearing 
a full leg brace for an extended period of time prior to surgery to see if permanent 
extension of the limb is acceptable, and it often isn’t.  
These patients often face poor alternatives, however, including transfemoral 
amputation and resection knee arthroplasty [5]. Some patients may voice a preference for 
amputation, but functional outcomes are typically worse than those of arthrodesis [10]. 
And while resection arthroplasty both salvages the limb and enables a patient to bend the 
knee and sit comfortably, patients are typically unable to walk. At least one knee implant 
type design has been developed to address this population [31], but it offers patients no 
functional advantage over traditional fusion methods. When compared against these 
options, arthrodesis often offers the best combination of function and risk. Based on 
personal communication with orthopedic surgeons experienced in knee reconstruction 
and arthrodesis, we estimate that only one quarter to one third the number of patients who 
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are suitable candidates for knee arthrodesis actually undergo the procedure, often in an 
attempt to avoid its limitations. 
This investigation shows that there is a relatively small, but significant number of 
knee arthrodesis procedures performed each year, and that this number has remained 
relatively steady over the past two decades. The average cost of these discharges has 
more than tripled (Figure 12) in that time, even as the average length of stay has gone 
down (Figure 10). The high level of interest in knee arthrodesis, as evidenced by the 
number of published articles, is likely due to both the undesirability of the procedure and 
the significant number of affected or candidate patients seen by publishing/researching 
clinicians.  
Looking forward, we expect the number of knee arthrodesis procedures to remain 
steady and the associated costs to continue to rise. These trends could be affected by the 
development of technological or procedural advances to address the affected patient 
subpopulation. This could include implants specifically designed to provide limited knee 
function or modular implant systems to improve outcomes following massive knee 
reconstruction. The quantification and characterization of patients undergoing knee 
arthrodesis and the characterization of hospitals where it is performed provides 
researchers, clinicians, and medical device manufacturers with information critical to 
assessing the demand for new treatment approaches and implant design in this area. 
The results of this study support the significance of the need. 
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CHAPTER SIX 
CHANGES TO GAIT KINEMATICS AND KINETICS INDUCED BY RIGID KNEE 
CONSTRAINT 
 
In which the kinematics and kinetics of rigid knee gait are quantified. 
“The true method of knowledge is experiment.” – William Blake Read 
 
Hypothesis 
Rigid immobilization of a single knee will induce immediate changes in gait 
kinematics and kinetics. Further, acclimation to rigid knee immobilization will have a 
continued effect on these kinematic and kinetic changes. 
Abstract 
The purpose of this study is to determine and quantify differences in human gait 
due to a ‘learning effect’ after complete constraint of a single knee. We hypothesize that 
with increased immobilization time, patients with a single immobilized knee will undergo 
changes in movement and muscular force generation (as measured by kinematics and 
ground reaction forces.) Ten healthy subjects (M/F, n=5/5; aged 18-23) with no history of 
gait abnormalities were recruited for this study, and knee arthrodesis was simulated for 0 
through 24+ hours using an immobilizing knee brace. Gait analysis was conducted during 
level walking on a 15-meter walkway using an eight-camera motion tracking system with 
a six-axis ground reaction force platform. Normal gait served as each subject’s control, 
and multiple measurements of braced gait were taken immediately following fitting of the 
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brace, after walking 0.4 kilometers (0.25 miles) on a treadmill, after walking 1.2 
kilometers (0.75 miles) on a treadmill, and after wearing the brace for 24 hours. 
Additionally, the percentage of lean muscle and fatty tissue were recorded for each body 
segment using dual energy x-ray absorptiometry. Results showed that simulated knee 
arthrodesis caused statistically significant and interrelated changes to gait kinematics 
when compared to normal gait, including increased ankle dorsiflexion and pelvic 
obliquity during swing phase of the braced limb, increased abduction of the left and right 
hip during stance of the braced limb, and an increase in the net joint reaction force at the 
contralateral hip. These changes facilitated ground clearance of the braced limb and 
minimized displacement of the center of gravity of the pelvis. Increased acclimation time 
was not found to significantly alter braced gait kinematics, supporting the use of short 
term bracing as a model for longer-term immobilization of the knee. 
 
Introduction 
Knee arthrodesis, or permanent fusion of the knee, is performed to treat pain and 
instability in cases of multiple failed knee replacement surgeries, bone loss, traumatic 
injury, infection, or loss of the quadriceps extensor mechanism [10], [11]. Knee 
arthrodesis can enable a patient to walk independently, and approximately one to two 
thousand procedures are performed in the United States each year. The inability to bend 
the knee can significantly affect patient quality of life, however, as patients can no longer 
bend their leg during activities such as sitting, bathing, and driving. In addition, the 
procedure necessarily affects gait biomechanics. Clinically, knee arthrodesis has been 
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hypothesized to increase loading and induce degeneration of the adjacent joints and spine 
[5], [11], [38]. There has been a high level of clinical interest in the procedure in the past 
five years, with over sixty case reports and review articles published in that time. The 
availability of detailed information on the resulting kinematic and kinetic changes, 
however, is limited [52], [53], potentially due to the  difficulty in accessing the affected 
patient population. In addition, the diverse range of clinical indications for arthrodesis 
can introduce confounding factors that make meaningful comparison of the resulting 
pathologic gait difficult. This combination of current clinical interest, significant patient 
morbidity, and lack of quantitative biomechanical data necessitate the further study of 
this condition to improve treatment options and patient outcomes.  
One potential, documented method of conducting arthrodesis studies is to 
temporarily simulate knee arthrodesis in normal, healthy subjects by applying an 
immobilizing brace or cast. This allows researchers to examine the effects of knee 
immobilization without the presence of confounding gait abnormalities, and increases the 
number of potential subjects. Subject-specific control data can be collected from the 
normal gait of each subject, enabling researchers to isolate changes solely attributable to 
joint immobilization. Some preliminary work has been done in this area, but most studies 
have focused on energy expenditure and there is a notable lack of reporting of 
comprehensive kinematic and kinetic data. The few studies that have included kinematic 
and kinetic data have limited their reporting to an undefined sagittal plane, and none have 
taken account of the importance of defining joint rotations [54], [55]. They have been 
limited by 2D data capture methods [56] or have otherwise not included kinematic and 
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kinetic measures outside of the “sagittal” plane [57], [58]. A comprehensive and well-
defined account of lower body knee kinematics and kinetics is thus needed.  
While immobilizing the knee will induce immediate biomechanical changes, it is 
possible that changes will continue to occur with long-term immobilization as subjects 
become accustomed to the newly immobilized joint. No studies, however, have 
investigated the potential for these changes. In nine studies involving gait after 
immobilization of the knee, the methods accounted for acclimation in only a limited 
manner (Table 5). Subjects walked until they reached a steady-state heart rate in three of 
these studies [30], [59], [60], subjects walked until they reached steady state oxygen 
consumption in two studies [57], [58], and subjects were given various, but limited 
accommodation in four studies [58], [61]-[63]. Given the absence of study into changes 
in gait kinematics with increased knee immobilization time, an appropriate acclimation 
protocol is unknown. If gait adaptation continues to cause kinematic changes after short-
term immobilization of the knee, as could be the case with clinical knee arthrodesis, it is 
possible that the methods used in the above studies were insufficient to capture these 
changes. The poor functional outcomes in patients with arthrodesis necessitate the 
development of an immobilization protocol to appropriately model stiff knee gait. 
 
Peer-reviewed research studies utilizing knee immobilization in gait 
analysis 
Study Acclimation Method Length 
Hanada and 
Kerrigan[59] 
Walk on treadmill until steady-state heart 
rate 
No time 
given 
Abdulhadi et al. [30] 
Walk down 20ft. data collection area at least 
5x until steady-state heart rate 
Approx. 
3 min 
Mattson and Walk until steady-state heart rate > 4 min 
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Brostrom[60] 
Lewek et al.[57] 
Walk on treadmill until “metabolic” 
“steady-state” 
5 min 
Kerrigan et al.[64] Walk until steady-state oxygen consumption <2 min 
Senden et al.[63] Familiarize with limitation 
Approx. 
1 min 
Boone[62] 
“The subjects were previously familiarized 
with the treadmill.” 
10 min 
Kerrigan et al.[58] 
“To allow some accommodation time, each 
subject walked up and down the length of 
the walkway approximately five times 
before data was collected.” 
No time 
given 
Waters et al.[61] 
“The subjects were instructed to become 
accustomed to walking” 
No time 
given 
Table 5 – Peer reviewed publications utilizing knee immobilization in gait 
 
The objective of this research is to provide a definitive dataset quantifying the 
changes to gait kinematics and kinetics resulting from immobilization of the knee, as well 
as to quantify the influence of these changes on loading at the affected knee. To add to 
previous work utilizing short-term immobilization using a brace or cast, we will evaluate 
changes over distance and time to establish a robust model for representing long-term 
immobilization, as would be the case with clinical knee arthrodesis.  
 
Materials and Methods 
This study received approval from the Institutional Review Board (IRB) of 
Greenville Health System, Clemson University, and Furman University, and informed 
consent was obtained from each study subject. Gait analysis trials were conducted within 
the Molnar Human Performance Laboratory of Furman University (Figure 19), which 
was equipped with an 8-camera motion capture system (ProReflex MCU 240, Qualsys, 
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Gothenburg, Sweden)(Figure 20) and 6-axis force platform (LG6-4-1, Advanced 
Mechanical Technology, Inc., Newton, Massachusetts). 
 
Figure 19 – Gait analysis pathway instrumented with six-axis force platform 
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Figure 20 – One of eight ProReflex infrared motion capture cameras used to conduct the study 
 
A total of ten subjects [(n=10), five male (n=5) and five female (n=5); Age range 
18 to 23] with no history of joint or gait abnormalities were recruited for this study from 
a volunteer sample, which was solicited through Clemson University and Furman 
University campus email and bulletin posts. 
Subjects were instructed to wear compression athletic clothing and low-cut 
athletic shoes prior to testing, which were provided if unavailable. Upon arrival at the gait 
laboratory, subjects were given all appropriate literature, including an informed consent 
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form. Testing did not proceed until any questions the subject had were answered, and the 
informed consent form was signed. 
Designated anthropometric measurements of the subject, including age, mass, 
height, and body segment dimensions were taken and recorded. Tissue composition 
measurements were recorded using Dual Energy X-ray Absorptiometry equipment, 
including segmental tissue mass, fat mass, and lean mass. The provided report is included 
in each subject’s file. 
Bony landmarks were identified with the assistance of a provided diagram. 
  
Figure 21 – Diagrams identifying bony anatomic landmarks used to locate and place reflective markers 
 
Reference Landmarks were marked with a ½” solid black dot using a permanent 
marker, mascara pen, or other method. 
 Sacral Vertebrae 
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 Anterior Spina Iliaca Superior 
 Crista Iliaca 
 Greater Trochanter 
 Superior part of the Patella 
 Lateral side of the Patella 
 Medial Condylis of the Femur 
 Medial Malleolus 
 Lateral Malleolus 
 
Reflective markers were placed over the following anatomic landmarks to 
facilitate motion capture:  
 Sternum 
 C7 spine 
 L5 spine  
 Acromium (left and right) 
 Humerus (left and right) 
 Elbow(left and right) 
 Radius (left and right) 
 Ulna (left and right) 
 Hand (left and right)  
 Anterior spine of the iliac crest (left and right) 
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 Greater trochanter (left and right) 
 Medial and lateral condyles of the knee (left and right) 
 Medial and lateral malleoli (left and right) 
 Proximal, distal, and lateral sides of the heel (left and right) 
 First and fifth metatarsals(left and right) 
 Toes (left and right)  
A rigid polymer shell with four rigidly attached markers was secured to each 
thigh and shank via an elastic band (Figure 22).  
 
Figure 22 – Researcher demonstrating placement of reflective tracking markers while wearing the 
immobilizing brace. 
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Data from each subject was collected on two consecutive days. The force plate 
and motion tracking equipment were calibrated each day prior to subject data collection. 
Six groups of trials were conducted. Prior to the start of each group of trials, the subject 
was asked to stand motionless in the anatomic position for the collection of calibration 
data. 
 
Table 6 – Experimental trial names, conditions, and the day on which they occured. 
 
The subject was first asked to walk normally (at a self-selected speed) along a 15-
meter, straight, level pathway for the collection of control data (C1 – Control Trial 1). 
Subjects were asked to repeat this motion until data was collected from five left and five 
right clean and complete foot strikes on the force platform were recorded. This data was 
used to establish the normal gait of each subject. 
Upon completion of the first control trial, knee arthrodesis was simulated in the 
right knee of each subject using a locking knee brace (Telescoping IROM, DJO Global, 
Vista, California). The length of the brace was adjusted to extend from the ankle to the 
inseam of each subject, and the flexion angle was set to 0 degrees for all trials and all 
subjects. Data capture commenced immediately upon fitting the subject with the brace, 
preventing the subject from gaining any familiarity to walking with the brace. The subject 
Experimental Condition Day
C1 Control Trial 1 Normal gait, before fitting the immobilizing brace Day 1
B1 Brace Trial 1 Immediately after subject is fitted with the brace Day 1
B2 Brace Trial 2 After walking on treadmill for 0.402 kilometers (0.25 miles) Day 1
B3 Brace Trial 3 After walking additional 0.805 kilometers (0.50 miles) on treadmill Day 1
B4 Brace Trial 4 After wearing the brace for 24 hours Day 2
C2 Control Trial 2 Normal gait, after removing the immobilizing brace Day 2
Trials
 69 
walked along the 15-meter pathway for data collection, as during the control trial. After 
completion of this experimental trial (B1), the subjects were instructed to walk on a level 
treadmill for 0.25 miles at 2.5 miles per hour.  
After walking 0.25 miles in the brace on the treadmill, the second experimental 
trial (B2) was conducted in the same manner and data collection sequence as the first two 
trials. The subject was then instructed to walk an additional 0.50 miles on the treadmill, 
for a total of 0.75 miles, after which additional data was captured (B3). Motion tracking 
markers were removed and their locations marked. The subjects were instructed to wear 
the brace, which was fitted with a pedometer, for an additional 24 hours pending a return 
visit and additional trial measurements the next day. 
Motion tracking markers were replaced on the second day, and a final set of 
experimental data was collected (B4.) The brace was then removed, the subject was 
asked to acclimate to normal gait for at least three minutes, and a second set of control 
data was then collected (C2.) 
Three-dimensional motion capture and ground reaction force data was collected 
and processed using Qualisys Track Manager (Qualsys, Gothenburg, Sweden) and 
exported to Visual3D (C-Motion, Germantown, Maryland) for analysis. A rigid body 
model was created to correlate the location of motion tracking markers with anatomical 
landmarks, and was scaled to match subject-specific measurements. The Cardan rotation 
sequence described by Cole was used to describe hip, knee, and ankle joint rotations [65], 
while the convention proposed by Baker was used for the pelvis [66]. Net reaction forces 
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and moments of the ankle, knee, and hip were calculated using an inverse dynamics 
approach, and were normalized to subject mass[67]. 
 
Figure 23 – Model constructed in Visual3D for the purpose of associating motion tracking markers with 
subject anatomy. The local coordinate systems of each rigid segment are shown (x=red, y=green, 
z=blue). In this figure, the local coordinate systems of the feet are rotated about the x axis by 90 degrees 
from the orientation used in all calculations.  
 
The following kinematic and kinetic data was normalized to the gait cycle (0-
100%) and output from Visual3D: 
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 Walking velocity (meters/second) 
 Stance duration (seconds and percent of gait cycle) 
 Swing duration (seconds and percent of gait cycle) 
 Sagittal (x), Frontal (y), and Transverse (z) plane movement of the center of 
gravity of the pelvis 
 Sagittal (x), Frontal (y), and Transverse (z) plane kinematics of the pelvis with 
respect to the lab 
 Sagittal (x), Frontal (y), and Transverse (z) plane joint rotations of the hip, knee, 
and ankle 
 Sagittal (x), Frontal (y), and Transverse (z) plane net reaction forces of the hip, 
knee, and ankle 
 Sagittal (x), Frontal (y), and Transverse (z) plane net joint moments of the hip, 
knee, and ankle 
 
Data from each subject (1-10), joint (pelvis, hip, knee, ankle), side (left/right), 
experimental trial (C1, C2, B1, B2, B3, B4), and rotation plane (x, y, z) were calculated 
for the entire gait cycle of each trial repetition. Data analysis was performed using SAS 
software (Version 9 of the SAS System for Windows. Copyright 2013 SAS Institute Inc. 
SAS and all other SAS Institute Inc. product or service names are registered trademarks 
or trademarks of SAS Institute Inc., Cary, NC, USA.) A complete SAS program was 
coded to simplify analysis and to facilitate future investigations of similar nature, and is 
provided in the Appendices.  
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Figure 24 – Master program coded in SAS to analyze gait data 
 
Kinematic and kinetic values of interest (e.g. peak knee flexion during stance 
phase) were calculated by determining the minimum, maximum, mean, or range of values 
within a specific range of the gait cycle. The times where minimum and maximum values 
occurred (in percent gait cycle or percent stance phase) were also recorded and compared. 
(e.g. peak knee flexion during stance was determined by finding the maximum value of 
knee flexion between 0% and 40% of the gait cycle for each trial.) Each value of interest 
was determined for every motion capture trial. Comparison of experimental conditions 
(C1, B1, B2, B3, B4, and C2) and sides (left/right) was performed using analysis of 
variance followed by Fisher’s Pairwise Comparison. Experimental conditions were 
compared against same-day control trials (C1 vs. B1, B2, B3; C2 vs. B4). Values of 
p<0.05 were considered statistically significant for all measures. 
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Figure 25 – SAS Program showing 24 of the 76 subfiles used to search for areas of statistically significant 
differences 
 
Figure 26 – SAS code used to identify data to search for statistically significant differences 
(PelvicCGRight) 
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Table 7 – Kinematic values of interest that were analyzed to find statistically significant differences. 
Values that differed between "Control" and "Brace" trials are indicated with a "*" in the right column 
Joint Plane Value of Interest
Range (% 
Gait Cycle)
 (p<0.05)
Peak pelvic sway to the Right side 0% to 50%
Peak pelvic sway to the Left side 50% to 100%
Overall range of pelvic sway 0% to 100% *
Minimum after Right Heel Strike 0% to 25%
Maximum during Left Swing 10% to 50%
Minimum after Left Heel Strike 35% to 75%
Maximum during Right Swing 60% to 100% *
Peak towards Left side 0% to 50%
Peak towards Right side 25% to 75% *
Minimum at Left Toe Off 0% to 25%
Maximum during Left Swing 0% to 45%
Maximum at Right Toe Off 50% to 75% *
Minimum during Right Swing 50% to 95% *
Maximum at Left Toe Off 5% to 30%
Minimum at Right Toe Off 55% to 75% *
Mean during Right Swing 55% to 100% *
Peak Extension 25% to 75%
Peak Flexion before Heel Strike 75% to 100% *Right
Peak Adduction in early stance 0% to 30% *Left
Mean during Single Limb Support 12% to 50% *
Peak Abduction in late stance 50% to 75% *Left
Internal(+) / External(-) Rotation Mean Rotation Angle 75% to 100%
Peak Flexion during early stance 0% to 40% *Right
Peak Flexion during Swing 50% to 100% *Right
Peak Abduction in early swing 60% to 80%
Peak Adduction in late swing 70% to 100% *Right
Internal(+) / External(-) Rotation Peak External Rotation in late swing 75% to 100% *Right
Peak Plantarflexion after Heel Strike 0% to 25% *Right
Peak Plantarflexion at Toe Off 50% to 75% *Right
Mean during Single Limb Support 12% to 50%
Peak Inversion at Toe Off 50% to 75%
Peak Abduction at Contralateral Toe Off 0% to 25%
Peak Adduction at Toe Off 50% to 75%
Peak Adduction before Heel Strike 90% to 100%
Ankle
Dorsiflexion(+) / Plantarflexion(-)
Inversion(+) / Eversion(-)
FF Adduction(+) / FF 
Abduction(-)
Hip
Flexion(+) / Extension(-)
Adduction(+) / Abduction(-)
Knee
Flexion (+)
Adduction(+) / Abduction(-)
Pelvic 
Center of 
Gravity
Side to Side Displacement 
[Right(+) / Left(-)] 
Vertical Displacement
Pelvis
Rotation [CCW(+) / CW(-)]
Obliquity
Rear(+) / Forward(-) Tilt
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Table 8 – Kinetic values of interest (Net Joint Reaction Force) that were analyzed to find statistically 
significant differences. Values that differed between "Control" and "Brace" trials are indicated with a "*" 
in the right column 
Net Joint 
Reaction 
Force
Axis Value of Interest
Range (% 
Stance)
 
(p<0.05)
Peak after Heel Strike 0% to 13% *Left
Minimum in early stance 15% to 25% *Left
Mean in midstance 25% to 75% *Left
Peak in late stance 75% to 95% *Left
Peak in early stance 8% to 30% *Left
Mean in midstance 35% to 65%
Minimum in late stance 65% to 90%
Peak in early stance 10% to 35%
Mean in midstance 40% to 65% *
Peak in late stance 65% to 90%
Peak in early stance 10% to 35%
Peak in late stance 65% to 90%
Peak in early stance 10% to 35%
Peak in late stance 65% to 90%
Peak in early stance 10% to 35%
Mean in midstance 40% to 65% *
Peak in late stance 65% to 90%
Peak in early stance 10% to 35%
Mean in late stance 75% to 90%
Peak in late stance 65% to 90%
Mean in early stance 15% to 35% *Right
Peak in late stance 65% to 90% *Right
Peak in early stance 10% to 35%
Mean in midstance 35% to 65% *
Peak in late stance 65% to 90%
Net Ankle 
Reaction 
Force
Medial / Lateral Shear
Anterior / Posterior Shear
Axial Compressive
Net Hip 
Reaction 
Force
Medial / Lateral
Anterior / Posterior
Axial
Net Knee 
Reaction 
Force
Medial / Lateral Shear
Anterior / Posterior Shear
Axial Compressive
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Table 9 – Kinetic values of interest (Net Joint Moment) that were analyzed to find statistically significant 
differences. Values that differed between "Control" and "Brace" trials are indicated with a "*" in the right 
column 
Results 
Kinematic and kinetic data was quantified, and mean values for combined data 
from Control (C1, C2) and Brace trials (B1, B2, B3, B4) are visualized with respect to the 
gait cycle for kinematics (Figure 27, Figure 28) and with respect to stance phase for 
kinetics (Figure 29, Figure 30). Statistically significant changes to gait kinematics and 
kinetics were observed when the knee was immobilized, and remained significant across 
all experimental trials (B1- B4) (Table 7, Table 8, Table 9). A small number of changes 
were only significant immediately after immobilization (Control vs. B1), but were no 
longer significantly different from control values in subsequent trials (Table 10). No 
significant differences were observed between braced trials (B1 vs. B2 vs. B3 vs. B4). 
Net Joint 
Moment
Plane Value of Interest
Range (% 
Gait Cycle)
 
(p<0.05)
Flexion (+) / Extension (-) Peak Extension Moment 6% to 25% *Left
Peak Adduction Moment in early stance 10% to 30% *
Peak Adduction Moment in late stance 60% to 90%
Peak Internal Rotation Moment 10% to 40%
Peak External Rotation Moment 60% to 85%
Peak Flexion Moment 6% to 40% *Right
Peak Extension Moment 60% to 90%
Peak Abduction Moment in early stance 10% to 30% *Left
Peak Abduction Moment in late stance 65% to 85%
Peak Internal Rotation Moment 15% to 35%
Peak External Rotation Moment 60% to 85%
Peak Plantarflexion Moment 5% to 25%
Peak Dorsiflexion Moment 60% to 95%
Peak Inversion Moment 15% to 35%
Peak Eversion Moment 65% to 90%
FF Adduction(+) / FF 
Abduction(-)
Mean Adduction Moment 0% to 100%
Ankle
Adduction(+) / Abduction(-)
Internal(+) / External(-) 
Rotation
Flexion (+)
Adduction(+) / Abduction(-)
Internal(+) / External(-) 
Rotation
Dorsiflexion(+) / 
Plantarflexion(-)
Hip
Knee
Inversion(+) / Eversion(-)
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Figure 27– Mean values (shaded regions represent standard deviation) of the pelvic center of gravity 
and pelvic rotation in three planes (Columns A-C). (Gait cycle displayed from ipsilateral heel strike to 
ipsilateral heel strike.) 
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Figure 28 – Joint Rotation Angle. Mean values (shaded regions represent standard deviation) of the Hip 
Rotation Angle (Row 1), Knee Angle (Row 2), and Ankle Angle (Row 3) in three planes (Columns A-C). 
(Gait cycle displayed from ipsilateral heel strike to ipsilateral heel strike.) 
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Figure 29 – Joint Reaction Forces. Mean values (shaded regions represent standard deviations) of the 
normalized (to subject mass) net joint reaction force of the hip (Row 1), knee (Row 2), and ankle (Row 
3). (Legend: Control Trials – Right=Red, Left=Blue; Braced Trials: Right=Purple, Left=Cyan) (Stance 
phase displayed from ipsilateral heel strike to ipsilateral toe off.) 
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Figure 30 – Joint Net Moments. Mean values (shaded regions represent standard deviations) of the 
normalized (to subject mass) net moment of the hip (Row 1), knee (Row 2), and ankle (Row 3). (Stance 
phase displayed from ipsilateral heel strike to ipsilateral toe off.) 
When braced, each subject’s self-selected gait speed and stride length was 
reduced (p<0.0001), while stride width was increased (p=0.0103). Right (braced) stance 
time, right (braced) swing time, and left stance time were increased (p<0.0001), but there 
was no difference in swing time of the left (unbraced) leg (p=0.6168). Some of the 
differences in kinematics can be observed relatively easily by overlaying a model of the 
braced subject on a model of the same subject during normal gait (Figure 32).  
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Figure 31 – A visual comparison of the relative stance and swing times of the left and right side during 
Control (C1, C2) and Experimental Trials (B1, B2, B3, B4). 
 
Table 10 – The above values of interest were significantly different from Control values during the first 
brace trial (B1) but were no longer significantly different in subsequent trials 
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Figure 32 – Posterior view visualization of a braced subject model (lighter) overlaid on the normal gait 
of the same model (darker) during (A) midstance and (B) midswing of the right leg. The left hip is more 
abducted and the pelvis is rotated obliquely during midswing, resulting in a rise of the center of gravity 
of the pelvis and the right hip joint center, helping the right foot to clear the ground as it is brought 
forward. Subject’s right and left feet are further away from the centerline of the body during their 
respective swing phases. 
 
Significant kinematic differences between normal gait and immobilized trials 
(B1-B4) are listed below in the order in which they occur during a single gait cycle (The 
right knee was immobilized in all cases, and the gait cycle is listed from Right Heel 
Strike to Right Heel Strike).  
 Following Right Heel Strike, the right foot plants flat on the ground with a 
greater degree of ankle plantarflexion (p=0.0014) 
 Following Left Toe Off, the left hip abducts more than normal gait 
(p=0.0397) 
 The right hip is more abducted through single leg stance (p=0.0020) 
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 Clockwise pelvic rotation reaches a greater peak immediately after Left 
Heel Strike (p=0.0143) 
 The oblique pelvic dip towards the right foot is attenuated (p=0.0005) 
 The right hip continues to extend longer into the gait cycle, until toe off 
(p<0.0001) 
 With reduced heel rise, maximum plantar flexion of the right ankle is 
reduced (p<0.0001), and reaches its peak at Right Toe Off 
 Dorsiflexion of the right ankle begins earlier, immediately at Right Toe 
Off rather than afterwards (p<0.0001) , and neutralizes ankle plantar 
flexion more rapidly (Figure 8) 
 The left hip is much more abducted through single leg stance (p<0.0001) 
 Pelvic obliquity decreases (left side down, right side up) dramatically 
during right swing (p<0.0001) 
 The center of gravity of the pelvis rises to a higher peak (along the vertical 
axis) as the rigidly extended right leg moves through swing phase 
(p=0.0093) 
 The left ankle is more inverted as the right leg begins swing phase 
(p=0.0059) 
 Pelvic tilt is reversed during right swing, tilting forward rather than 
towards the rear (p<0.0001)  
 Maximum hip flexion prior to Right Heel Strike is reduced (p=0.0496) 
and occurs much closer to heel strike (p<0.0001) 
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Significant kinetic differences between normal gait and the immobilized trials 
(B1-B4) are listed below with respect to right and left stance phases: 
Right Side  – Early Stance 
 Right ankle peak M/L force decreased (p=0.0046) 
 Right ankle A/P force decreased (p=0.0007) 
 Right hip peak adduction moment decreased (p=0.0004) 
 Right knee peak flexion moment decreased (p=0.0109) 
Right Side  – Midstance 
 Right hip axial compressive force increased (p<0.0001) 
 Right knee axial compressive force increased (p<0.0001) 
 Right ankle axial compressive force increased (p<0.0001) 
Right Side  – Late Stance 
 Right ankle M/L force decreased (p=0.0063) 
 Right ankle A/P force decreased (p=0.0003) 
Left Side – Early Stance 
 Left hip M/L force increased immediately after LHS (p=0.0010) 
 Left hip M/L force remains increased as load transferred (p<0.0001) 
 Left hip peak A/P force increased (minimum goes more negative) 
(p=0.0235) 
 Left ankle peak M/L force decreased (p=0.0014) 
 Left hip peak extension moment increased (p=0.0030) 
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 Left hip peak adduction moment decreased (p<0.0001) 
 Left knee peak abduction moment decreased (p=0.0061) 
Left Side – Midstance 
 Left hip M/L Force increased (p<0.0001) 
 Left hip axial compressive force increased  (p<0.0001) 
 Left knee axial compressive force increased (p<0.0001) 
 Left ankle axial compressive force increased (p<0.0001) 
Left Side - Late Stance 
 Left hip M/L force increased (p=0.0031) 
 
Discussion 
This data confirms that gait kinematics and kinetics undergo immediate changes 
upon immobilization of a single knee. The most obvious change in kinematics is at the 
immobilized knee itself, which loses all range of motion. The effective length of the limb 
(the distance from the hip to most distal point of the foot) cannot be significantly reduced 
with the knee unable to bend, requiring subjects to compensate with kinematic changes in 
order for the foot to clear the ground during the swing phase of gait. While it may seem 
intuitive that increased adduction of the hip of the brace limb could help swing the leg out 
to assist in ground clearance, this does not occur. (In fact, there is slightly more abduction, 
though it is not statistically significant.) 
The purpose of gait is forward motion, but the normal physiological modus 
operandi is to optimize energy expenditure by minimizing excess vertical and lateral 
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movement of the body’s center of gravity [68], [69]. Constraints on normal gait, such as 
an immobilized knee, will require simultaneous compensations to minimize energy use, 
and the gait alterations observed in this study may be understood as interrelated within 
this paradigm[69]. The most immediate impact of immobilizing the knee in full extension 
was during the two phases of gait where the knee normally flexes the most: midstance 
and swing phase (Figure 33). This is consistent with the fact that most of the statistically 
significant changes to gait kinematics correspond with these parts of the gait cycle 
(Figure 35). 
 
Figure 33 – Knee flexion during Brace trial, showing the significant difference in knee flexion between 
the left and right sides. 
 
Kinematic compensations are required to assist in clearing the floor with the limb, 
as noted previously [70], while simultaneously working to minimize energy expenditure. 
This is observable as a delay in the initiation of hip flexion in the right (braced) leg, 
immediate dorsiflexion of the ankle following Toe Off, left hip abduction, and a dramatic 
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increase in pelvic obliquity. Hip flexion typically occurs prior to Toe Off as the knee 
breaks, but when the knee is braced the hip cannot begin extending until the foot is lifted 
from the floor. Right ankle dorsiflexion minimizes the contribution of the foot to overall 
limb length as the leg begins swing phase, and pelvic obliquity helps ‘lift’ the limb over 
the ground. Although there is a significant increase in abduction of the left (unbraced) hip 
and obliquity of the pelvis, which serve to lift the right limb, this results in a wider stance, 
which keeps the body’s center of gravity low and centered. These observations are 
consistent with the conclusion that the observed gait changes minimize excess movement 
of the center of gravity.  
 
Figure 34 – Plantarflexion of the ipsilateral ankle during normal gait (purple) and with simulated knee 
arthrodesis (red); Triangles denote Right Toe Off events. 
 
Kinetic changes included a dramatic increase in the left hip extension moment, 
medial shear reaction force, and posterior shear reaction force during early stance as the 
opposite, braced leg was lifted from the ground and brought forward. The net medial 
reaction force in the left hip increased across the entire stance phase. In addition, axial 
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compressive loading during midstance increased in all joints. All other significant 
changes to joint kinetics were reductions in the magnitudes of joint reaction forces and 
moments. This suggest that contralateral hip extensors play an outsized role in the gait 
compensations required to bring forward an immobilized limb, and may help explain 
subsequent degeneration of this joint in patients with an arthrodesed knee [5], [11], [38]. 
Several kinematic and kinetic measures differed significantly from control values 
immediately after initial knee immobilization (C1 vs. B1), but were attenuated and no 
longer significantly different from control values in subsequent trials (Table 10). This 
suggests that acclimation has a limited effect on gait, but that directing subjects to 
ambulate 0.4 kilometers (0.25 miles) is sufficient to account for changes that would occur 
over a 24 hour immobilization time. This would appear to support the use of short-term 
bracing as a model (Table 5) for simulating long term knee immobilization, such as with 
knee arthrodesis. One limitation of this model, however, is that it does not take into 
account long-term, chronic changes in adjacent joint conditions that could affect patient 
kinematics. It is possible that long-term brace immobilization (greater than 24 hours) 
would result in significantly altered gait compared to the immediately braced and +24 
hour braced knee, although no trends were noted in this study to support this hypothesis.  
In spite of the high level of clinical interest in knee arthrodesis, as evidenced by 
the large number of published reviews and case reports, there is a notable lack of 
available information on the changes to gait kinematics and kinetics induced by the 
procedure, and a consequent lack of information on loading patterns at the affected knee. 
The goal of traditional methods of knee arthrodesis has been to fuse the femur and tibia 
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directly or with bone graft, and these fusions have generally been robust. This robustness 
has meant that there has been little need or benefit to quantifying the loading patterns of a 
fused knee, and may explain why there has been little interest in this subject.  
When patients lack significant bone stock, however, new approaches to spanning 
the joint have been required [9], [33], and at least one total knee replacement like design 
has been developed to address knee arthrodesis [31]. With the development of these new 
implants, there have been examples of implant failure due to fracture [31], [33], which 
may suggest that the loading conditions used to design and test implants for use in knee 
immobilization were inadequate. There may be a question of quantifying the mechanics 
of knee arthrodesis to be used in the design of such devices. It is likely that the altered 
kinematics of arthrodesis gait play a significant role in altering the loading patterns at the 
knee. The development of detailed musculoskeletal models, using gait kinematics, has 
enabled researchers to create better informed finite element analysis models, and has 
been used in the testing of orthopedic implants [71]. Data from this study provides a 
robust account of the kinematic and kinetic gait resulting from knee immobilization, and 
can be used to assist in future computational modeling and testing of arthrodesis implants 
or implants that temporarily simulate arthrodesis. 
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Figure 35 –Phases of the gait cycle where lower body joint kinematics differed significantly from those of 
normal gait. Each row represents a joint of the lower body as it progresses through a single gait cycle, 
and is shaded in phases where the joint kinematics of the Experimental condition (right knee braced) 
differed significantly, in any plane, from the joint kinematics of the Control condition (normal gait). The 
gait cycle begins and ends with Right Heel Strike events, and Left Toe Off, Left Heel Strike, and Right Toe 
Off events are indicated with dashed lines. Significant differences at the right knee, which was braced, 
are more darkly shaded to emphasize its primacy in causing the other changes. 
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CHAPTER SEVEN 
ESTIMATED JOINT LOADING AT A RIGIDLY CONSTRAINED KNEE 
 
In which the joint loading patterns of a rigidly constrained knee are estimated using a 
computational model incorporating musculoskeletal features and geometry. 
 
Hypothesis 
Knee joint reaction forces and moments during gait are significantly altered when 
the knee is fully constrained.  
Abstract 
Having established an unmet clinical need in support of a novel implantable 
medical device model in Chapters 3 through 5 of this dissertation, and having examined 
the kinematic and kinetic changes to gait that such a treatment model would induce in 
Chapter 6, this Chapter quantifies the mechanical loading patterns that would be present 
at such an implant.  
Introduction 
Knee arthrodesis, as reviewed in detail in Chapter 4, is a treatment in which the 
bones of the upper and lower leg are permanently fused, and may be used to salvage a leg 
that would otherwise require amputation. By imposing permanent rigidity at the knee, 
arthrodesis provides patients with the stability necessary to ambulate independently. This 
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independence can provide a greater level of function than amputation, as well as a better 
quality of life [38]. 
The inability to bend the arthrodesed knee, however, necessarily affects gait 
biomechanics. Some secondary effects of the biomechanical changes resulting from stiff-
knee gait have been demonstrated, including increased energy expenditure and oxygen 
consumption [30], [57]-[59], [61], [62], [70], and pain in other joints and the lower back 
have been associated with knee arthrodesis. It has been asserted that knee arthrodesis may 
induce arthritis in other joints, including the contralateral hip, but no studies have 
established this causation or shown a conclusive link between the procedure and 
subsequent joint degeneration.  
In addition to effects at other joints, there is a question of the robustness of a 
rigidly fused joint to bear the loading patterns produced by daily activity, such as during 
gait. The long term viability of some methods of knee fusion and their ability to 
withstand these loads has been questioned [9], and there have been published cases of 
knee arthrodesis implant fracture [31], [33]. It is common for orthopedic implants to 
undergo testing, but the in vivo mechanical failure of these implantable medical devices 
suggests that the parameters used for testing may have been inadequate. There have been 
no publications to date providing estimates of the loading patterns at an immobilized 
knee, and it is therefore necessary to undertake this quantification.  
Measuring in vivo loading conditions, including the forces in muscles, ligaments, 
and joints, however, is often difficult or impossible. Instrumented total hip and total knee 
implant designs have been developed and used to acquire in vivo loading data in some 
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patients undergoing hip or knee arthroplasty, but this approach has not been used in knee 
fusion. Simplified net joint reaction forces and moments (net effect, neglecting 
musculature) can be calculated to balance a given load using an inverse dynamics 
approach with knowledge of the following information: 
 Body/Segment mass properties:  
o Mass, m 
o Mass moment of inertia, I 
 Body segment kinematics (from 3D motion capture data): 
o Position 
o Linear velocity 
o Linear acceleration 
o Angular Velocity 
o Angular acceleration 
 External forces (such as from force platform data) 
This approach underestimates actual joint loads, however, by neglecting the 
contributions of musculature. Co-contraction, or simultaneous contraction of antagonist 
muscles about a joint, is physiologically common, and increases the magnitude of joint 
reaction forces without changing measured kinematics. This increase in magnitude goes 
undetected when musculature is ignored [72], [73]. 
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Figure 36 – A model with the addition of musculature 
 
The complexity of a biomechanical model can be increased to include 
musculature and detailed skeletal geometry Figure 36) using a system of equations of the 
following form: 
𝐶𝑓 = 𝑟 
Where f is a vector of joint and muscle forces, r is a vector representing the external and 
inertial forces, and C is a matrix of equation coefficients. In addition to the large increase 
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in computational complexity, however, the redundant nature of musculature increases the 
number of unknowns beyond that of the number of equilibrium equations needed to 
balance a given set of loading conditions; the result is an unlimited number of potential 
solutions. An optimization function based on the minimization of muscle forces, and 
requiring that muscle forces are positive (can only contract), takes the following form: 
Minimize: 𝐺(𝑓𝑀) 
Subject to: 𝐶𝑓 = 𝑟  ;  𝑓𝑖
(𝑀)
≥ 0, 𝑖 = 1. . 𝑛(𝑀) 
In order to solve this set of equations in a physiologically meaningful way, 
assumptions must be made about how the central nervous system recruits muscle 
activation. Published musculoskeletal models address this problem with the use of an 
optimization function that minimizes the overall muscle forces or muscle stress of the 
modeled system [74]-[77]. These functions have generally taken a single form, but with 
differences in polynomial order: (linear: p=1 , quadratic: p=2, cubic: p=3 [78]-[80] … 
Min/Max: p essentially infinite) (Table 11): 
𝐺 =  ∑ (
𝑓𝑖
𝑁𝑖
)
𝑝
𝑖
 
Where fi is muscle force, Ni is a normalization factor (such as muscle strength), and p is 
the order of polynomial. Put simply, the higher the order of polynomial, the more load 
sharing by synergistic muscles is predicted, as more highly loaded individual muscle 
terms are punished.  
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Optimization Functions in Published Musculoskeletal Modeling Simulations 
Publication Type 
Grujicic, 2010; [81] Min/Max 
Grujicic, 2010; [82] Min/Max 
Carbone, 2012; [78] Cubic 
Eltoukhy, 2011; [83] Unspecified - “Postpone fatigue” 
Grujicic, 2011; [71] Unspecified – same as above 
Anderson, 2011; [84] Unknown 
Damsgaard, 2006; [77] All of them – balance, none proven 
superior 
Wagner, 2010; [85] Min/Max – “Minimum effort” 
Holmberg, 2008; [76] Min/Max 
Erdemir, 2007; [86] Review – Third Order Common for lower 
body 
Crowninshield, 1981; [79] Third Order 
Seireg, 1975 [87] Linear + 4M + Joint Force 
Crowninshield, 1978 [88] Linear 
Patriario, 1981  Second Order + Power Output 
Rohrle, 1984 Linear 
Brand, 1986 Third Order 
Collins, 1995;  Second Order, Linear, Etc. 
Pederson, 1997 Third Order 
Table 11 – Optimization functions in peer reviewed publications 
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A number of analytical software packages have been developed over the past 
several years to assist in the creation and simulation of musculoskeletal models. These 
include AnyBody [77], LifeMod [89](since purchased by Smith & Nephew and no longer 
publically available), SIMM [90], and Open SIMM [91]. These software packages 
facilitate the construction of models and enable dynamic simulations of those models 
using motion capture data. 
The relevance of any musculoskeletal model is its ability to accurately predict in 
vivo loading conditions. Confidence in the ability to do this requires validation of the 
model, which is complicated by the fact that models are often constructed to predict 
conditions that are difficult or impossible to measure in vivo. The assumptions, 
limitations, and uncertainties of a particular model must be assessed for its intended use 
[92]. Force and moment data acquired from subjects with instrumented joint 
replacements has been published, and this data has been used to validate and improve the 
construction of musculoskeletal models for gait analysis that are available to others [74]. 
Expected loading patterns are an important design parameter in engineered 
systems, and have been essential to the design and material selection of modern 
orthopedic implants. Musculoskeletal models have allowed researchers to predict how 
implanted prosthetics will perform [81], [93], [94], and have been used to assist in the 
design of new orthopedic implants [81], [82]. In order to either investigate the 
biomechanical effect of knee arthrodesis on other joints, or to accurately predict the 
mechanical failure of a knee arthrodesis implant due to local loading conditions, the 
 98 
altered joint biomechanics resulting from knee arthrodesis must be known. These open 
questions demonstrate a compelling need for this data, which musculoskeletal modeling 
techniques are well suited to provide.  
We hypothesize that joint reaction forces and moments at the knee in a patient 
with a single fully constrained knee are significantly different from the forces and 
moments at the knee in a patient without a fully constrained knee. Changes to gait 
kinematics and kinetics resulting from rigid knee immobilization were investigated and 
quantified in a study described in Chapter 6, and the kinematic and kinetic data gathered 
in that study was then used to construct a computational biomechanical model. This 
model was then used to drive a series of dynamic simulations, providing estimates of 
lower body reaction forces, including those at the immobilized knee, during walking with 
and without a single fully constrained knee.  
Materials and Methods 
The AnyBody Modeling System (Version 5.2.0) was used to construct a 
musculoskeletal model, which was subsequently driven through a series of dynamic 
simulations. These simulations were driven by three-dimensional kinematic and kinetic 
data obtained from a previously conducted gait analysis study, described in detail in 
Chapter 6. That study was designed and conducted to simulate arthrodesis in normal, 
healthy subjects using an adjustable locking knee brace, and three dimensional data was 
captured using an 8-camera motion capture system (ProReflex MCU 240, Qualsys, 
Gothenburg, Sweden) and a ground reaction force platform (LG6-4-1, Advanced 
Mechanical Technology, Inc., Newton, Massachusetts).  
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In that study, subjects were first instructed to walk normally, and the gait 
kinematics and kinetics captured were used as Control trials. Subjects were then fitted 
with an immobilizing brace on their right knee in all cases, and a series of trials were 
captured immediately after fitting of the brace, after walking 0.25 miles on a treadmill, 
and after walking an additional 0.50 miles on a treadmill. These distances were evaluated 
for effects due to acclimation to the immobilization. Three-dimensional motion capture 
data and force platform data from the preliminary Control trials (C1) and the third set of 
Brace trials (B3) was selected to create and drive a musculoskeletal model through 
dynamic simulations, providing estimates of knee joint reaction forces and moments 
during gait. 
The musculoskeletal model constructed for the purpose of this study was based 
upon the Twente Lower Leg Model [95] (Figure 37) consisting of: 
 19 Rigid Segments – This included 5 segments in each of the lower extremities, 1 
pelvis segment, and 8 segments in the spine, thorax, and skull.  
 8 Joints – The joints provide a total of 72 kinematic constraints to the model, and 
allow for 36 axes of rotation. 
 450+ Muscles – Muscle recruitment works both synergistically and 
antagonistically in order to reduce the total effort required by the system and to 
provide joint stabilization. 
 
Model attributes, including total height and mass, were set to match those of the 
gait subjects from which kinematic and kinetic data was drawn, and the following model 
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segments were scaled to match subject anthropometry based on the placement of motion 
tracking markers: 
 Upper Arm Lengths 
 Lower Arm Lengths 
 Trunk Height 
 Pelvis Width 
 Thigh Lengths 
 Shank Lengths 
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Figure 37 – Musculoskeletal model consisting of 19 rigid segments, 18 joints, and 450+ muscles. The 
force platform, ground reaction force vector, and motion tracking markers are also visualized. 
 
The model was used to run a series of dynamic simulations, including both 
normal and immobilized-knee gait. Fused knee conditions were simulated using a driver 
that locked the rotation of the right thigh and shank with respect to each other, and 
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determined the resultant joint moments.  
Static optimization was used to calculate muscle activation at each time step of 
the simulation by minimizing the following fifth order objective function: 
𝐺 = ∑ (
𝑓𝑖
𝑁𝑖
)
5
𝑖
 
Where fi is force of the muscle and Ni is the normalization factor of the muscle 
[77]. The following lower limb muscle forces, joint reaction forces, and joint moments 
were collected for each trial (Control and Brace). 
Ankle  
 Joint Contact Forces 
o Proximal-Distal  
o Medial-Lateral  
o Anterior-Posterior 
 Joint Moments 
o Plantarflexion/Dorsiflexion 
o Subtalar Inversion/Eversion 
o Axial (Forefoot Adduction/Abduction)  
Knee  
 Joint Contact Forces 
o Proximal-Distal 
o Medial-Lateral 
o Anterior-Posterior 
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 Joint Moments 
o Flexion/Extension 
o Adduction/Abduction 
o Internal/External Rotation 
Hip 
 Joint Contact Forces 
o Proximal-Distal  
o Medial-Lateral  
o Anterior-Posterior  
 Joint Moments 
o Flexion/Extension  
o Adduction/Abduction  
o Axial (Internal/External Rotation)  
Muscle Forces 
 Quadriceps 
o Rectus Femoris 
o Vastus Lateralis 
o Vastus Medialis 
o Vastus Intermedius 
 Sartorius 
 Biceps Femoris 
 Semitendinosus 
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 Semimembranosus 
 Gastrocnemius 
 Soleus 
 
Statistical Analysis 
Data analysis was performed using SAS software (Version 9 of the SAS System 
for Windows. Copyright 2013 SAS Institute Inc. SAS and all other SAS Institute Inc. 
product or service names are registered trademarks or trademarks of SAS Institute Inc., 
Cary, NC, USA.) A complete SAS program was coded to simplify analysis and to 
facilitate future investigations of similar nature, and it is provided in the Appendices. 
 
Figure 38 – Display of heading code used in AnyBody to drive the musculoskeletal simulations 
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Joint force and joint moment values of interest (e.g. peak Anterior-Posterior knee 
force during late stance) were calculated by determining the minimum, maximum, mean, 
or range of force/moment values within a specific range of the gait cycle. The times 
where minimum and maximum values occurred (in percent gait cycle) were also recorded 
and compared (e.g. peak Anterior-Posterior knee force during late stance was determined 
by finding the maximum value of the Anterior-Posterior knee force between 40% and 
60% of the gait cycle and the moment when that maximum occurred in each trial.) Each 
value of interest was determined for every trial, and comparison of experimental 
conditions (Control vs. Immobilized Knee) and sides (left/right) was performed using 
analysis of variance followed by Fisher’s Pairwise Comparison. A value of α<0.05 was 
considered statistically significant for all measures. 
Results 
Joint forces, joint moments, and muscle forces were quantified, and mean values 
(± standard deviation) for data from Control and Knee Immobilization trials are 
visualized below with respect to the gait cycle. Statistically significant changes to joint 
contact forces, joint moments, and muscle forces were observed when the right knee was 
immobilized. Areas where values of interest were examined are shaded, and the location 
of statistically significant differences are indicated with an (*). Detailed changes are 
described for each joint. 
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Figure 39 – Mean values of the right ankle joint forces (Row 1) and right ankle joint moments (Row 2) in 
three planes through the gait cycle. Mean and standard deviation values are shown for the control and 
immobilized knee trials.  
Statistically significant changes to loading at the right ankle (Figure 39). 
 The maximum posterior joint force occurring between 40% and 60% of the gait cycle 
is increased to a mean of 670.6 N from 471.4 N (p=0.0297)  
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 The maximum forefoot adduction moment occurring between 40% and 60% of the 
gait cycle is decreased to a mean of 6.7 Nm from 10.4 Nm (p=0.0214) and occurs 
later in the gait cycle (p<0.0001) 
 The minimum forefoot adduction moment occurring between 90% and 100% of the 
gait cycle is reduced to a mean of -0.156 Nm from -4.3 Nm  (p=0.0014) 
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Figure 40 – Mean values of the right knee joint forces (Row 1) and right knee joint moments (Row 2) in 
three planes through the gait cycle. Mean and standard deviation values are shown for the control and 
immobilized knee trials. 
Statistically significant changes to loading at the right knee (Figure 40). 
 The peak compression joint force occurring between 5% and 20% of the gait cycle is 
reduced to -1180.0 Nm from -1534.7 Nm (p<0.0001) 
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 The peak compression joint force occurring between 40% and 60% of the gait cycle is 
reduced to a mean of -2208.1 Nm from -2747.9 Nm, but this change is not statistically 
significant (p=0.0679) 
 The peak compressive joint force occurring between 90% and 100% of the gait cycle 
is reduced to a mean of -106.8 Nm from -771.9 Nm (p=0.0063) 
 The peak medial joint force occurring between 5% and 20% of the gait cycle is 
reduced to a mean of 208.8 Nm from 263.65 Nm (p=0.0057) 
 The peak medial joint force occurring between 90% and 100% of the gait cycle is 
reduced to a mean of 20.4 Nm from 114.2 Nm (p=0.0019) and occurs later in the gait 
cycle (p<.0001) 
 The peak posterior joint force occurring between 40% and 60% of the gait cycle is 
reduced to a mean of -318.9 Nm from -454.7 Nm, but this change is not statistically 
significant (p=0.0942), and this peak occurs earlier in the gait cycle (p=0.0068) 
 The maximum flexion moment occurring between 35% and 65% of the gait cycle is 
reduced to an average of 17.5 N from 33.9 N (p=0.0068) and occurs later in the gait 
cycle (p=0.0463) 
 The maximum abduction moment occurring between 40% and 60% is reduced to 39.9 
Nm from 53.2 Nm (p=0.0385) 
 The maximum external rotation moment occurring between 35% and 50% of the gait 
cycle occurs later in the gait cycle (p=0.0080) 
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 The peak internal rotation moment occurring between 50% and 60% of the gait cycle 
is lost. The moment is increased to an 3.7 Nm external rotation moment from a 5.5 
Nm internal rotation moment (p=0.0123)  
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Figure 41 – Mean values of the right hip joint forces (Row 1) and right hip joint moments (Row 2) in 
three planes through the gait cycle. Mean and standard deviation values are shown for the control and 
immobilized knee trials. 
Statistically significant changes to loading at the right hip (Figure 41). 
 The minimum compressive joint load occurring between 10% and 45% of the gait 
cycle was reduced to a mean of 1075.9 N from 1507.8 N (p=0.0096)  
 The maximum compressive joint force occurring between 40% and 60% of the gait 
cycle is reduced to a mean of 2420.9 N from 3341.5 N (p=0.0357) 
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 The maximum anterior joint force occurring between 5% and 20% of the gait cycle 
was reduced to a mean of 42.5 N from 227.5 N (p=0.0059) 
 The minimum A-P joint force occurring between 20% and 40% of the gait cycle 
reversed direction and increased in magnitude to a mean 72.8 N posterior force from 
a 9.9 N anterior force (p=0.0162) 
 The maximum anterior joint force occurring between 40% and 75% of the gait cycle 
occurred later in the gait cycle (p=0.0301) 
 The maximum internal rotation moment occurring between 0% and 20% of the gait 
cycle increased to 23.2 Nm from 17.0 Nm (p=0.0355)  
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Figure 42– Mean values of the left ankle joint forces (Row 1) and left ankle joint moments (Row 2) in 
three planes through the gait cycle. Mean and standard deviation values are shown for the control and 
immobilized knee trials. 
No statistically significant changes to joint loading were observed at the left ankle 
(Figure 42). 
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Figure 43– Mean values of the left knee joint forces (Row 1) and left knee joint moments (Row 2) in three 
planes through the gait cycle. Mean and standard deviation values are shown for the control and 
immobilized knee trials. 
Statistically significant changes to loading at the left knee (Figure 43). 
 The minimum abduction moment occurring between 5% and 20% of the gait cycle is 
reduced to 29.6 Nm from 44.0 Nm (p= 0.0395) and occurs earlier in the gait cycle (p= 
0.0234) 
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 The maximum internal rotation moment occurring between 50% and 60% of the gait 
cycle is reduced to 4.5 Nm from 10.7 Nm (p= 0.0281) and occurs earlier in the gait 
cycle (p= 0.0236) 
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Figure 44– Mean values of the left hip joint forces (Row 1) and left hip joint moments (Row 2) in three 
planes through the gait cycle. Mean and standard deviation values are shown for the control and 
immobilized knee trials. 
Statistically significant changes to loading at the left hip (Figure 44). 
 The maximum anterior joint force occurring between 5% and 20% of the gait cycle is 
reduced to 329.4 N from 391.2 N (p<0.0001) 
 The maximum abduction moment occurring between 0% and 20% of the gait cycle 
was reduced to a mean of 40.6 Nm from 58.0 Nm (p=0.0474) 
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Figure 45 – Mean tensile force of the muscles spanning the right knee during gait. Mean and standard 
deviation are shown for the control and immobilized knee trials. 
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Statistically significant changes to force in muscles spanning the right knee (Figure 45). 
 The maximum force occurring in the right Vastus Lateralis between 0% and 25% of 
the gait cycle was reduced to a mean of 6.0 N from 172.8 N (p=0.0125) 
 The maximum force occurring in the right Vastus Medialis between 0% and 25% of 
the gait cycle was reduced to a mean of 4.5 N from 111.0 N (p= 0.0183) 
 The maximum force occurring in the right Vastus Intermedius between 0% and 25% 
of the gait cycle was reduced to a mean of 2.9 N from 69.5 N (p= 0.0128) 
 The maximum force occurring in the right Sartorius between 40% and 70% of the gait 
cycle was reduced to a mean of 122.7 N from 178.9 N (p=0.0434) 
 The maximum force occurring in the right Sartorius between 90% and 100% of the 
gait cycle was reduced to a mean of 1.9 N from 39.5 N (p=0.0013) 
 The maximum force occurring in the right Biceps Femoris between 0% and 20% of 
the gait cycle was reduced to 208.7 N from 400.5 N (p<.0001) 
 The maximum force occurring in the right Biceps Femoris between 40% and 55% of 
the gait cycle was reduced to null from 114.2 N (p<0.0001) 
 The maximum force occuring in the right Biceps Femoris 3 between 90% and 100% 
of the gait cycle was reduced to 66.7 N from 229.1 N (p=0.0216) 
 The maximum force occurring in the right Semitendinosus between 0% and 15% of 
the gait cycle was reduced to 85.3 N from 234.0 N (p=<.0001) 
 The maximum force occurring in the right Semitendinosus between 25% and 45% of 
the gait cycle was reduced to null from 154.8 N (p=0.0047) 
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 The maximum force occurring in the right Semitendinosus between 90% and 100% of 
the gait cycle was reduced to 29.5 N from 138.1 N (p=0.0137) 
 The maximum force occurring in the right Semimembranosus between 0% and 15% 
of the gait cycle was reduced to 108.8 N from 262.0 N (p<.0001) 
 The maximum force occurring in the right Semimembranosus between 35% and 45% 
of the gait cycle was reduced to null from 201.8 N (p=0.0006) 
 The maximum force occurring in the right Semimembranosus between 90% and 
100% of the gait cycle was reduced to 35.4 N from 154.2 N (p=0.0148) 
 The maximum force occurring in the right Gastrocnemius between 30% and 65% of 
the gait cycle was reduced to 1121.2 N from 1623.8 N (p=0.0093) 
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Figure 46 – Mean tensile force of the muscles spanning the left knee during gait. Mean and standard 
deviation are shown for the control and immobilized knee trials. 
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Statistically significant changes to force in muscles spanning the left knee (Figure 46). 
 The maximum force occurring in the left Biceps Femoris between 0% and 20% of the 
gait cycle was reduced to 314.2 N from 371.6 N (p=0.0346) 
 The maximum force occurring in the left Semimembranosus between 0% and 15% of 
the gait cycle was reduced to 185.6 N from 262.0 N (p=0.0318) 
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Discussion 
The greatest number of significant changes to joint and muscle loading occurred 
in the immobilized (right) leg, with more changes occurring at the right knee than any 
other joint. No statistically significant changes were observed at the left ankle, and only 
two changes each were observed at the left knee and hip, all of which were reductions in 
magnitude. Only two joint loads increased in magnitude when the knee was immobilized 
– the maximum posterior force occurring at the right ankle, and the maximum internal 
rotation moment at the right hip. Two loads reversed direction – during the right stance 
phase of gait, the joint reaction force at the right hip became a posterior force rather than 
an anterior force, and as the subjects neared the Right Toe Off phase of gait, the axial 
rotation moment at the right knee remained an external rotation moment rather than 
reversing direction to peak in an internal rotation moment. The remainder of the 
statistically significant changes to joint and muscle loading were reductions in magnitude.  
These results have positive implications for the concern that immobilized knee 
gait, such as that resulting from knee arthrodesis, induces damage to these joints. This 
damage and joint degradation has been asserted by a number of publications [5], [10], 
[11], [52], but thus far no data has been presented to support it. The present study finds 
that lower body joint loading, which has been linked to osteoarthritis [96], [97], is 
generally reduced as a result of rigid knee immobilization, failing to support the assertion 
that this immobilization induces damage to these joints. It is possible that damage to 
these joints may occur as a result of other factors, including loading rate or impact [98], 
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deviation from normal loading patterns, or a reduced range of motion resulting in load 
concentrations, but these were not investigated and would require further study.  
It is likely that walking speed played a role in these reductions [99]. Subjects 
walked at a self-selected speed in the gait analysis study, and as demonstrated in the 
previous chapter, this resulted in a reduction in speed during the immobilized knee 
condition. Since speed was not a controlled variable, it is impossible to know the exact 
contribution to the reductions in joint and muscle loading – this is irrelevant to the aim of 
the current study, however, the purpose of which was to quantify and determine changes 
to joint and muscle loading due to knee immobilization. Since a reduction in walking 
speed occurs as a result of immobilization, and is likely to similarly occur in patients who 
undergo knee arthrodesis, it was important to incorporate this reduction in speed into the 
simulations. 
Particularly notable among the changes induced by immobilization of the knee 
was the effect on quadriceps forces (Figure 45). Forces in the vastus lateralis, vastus 
intermedius, and vastus medialis muscles were effectively reduced to zero, while loading 
of the rectus femoris took on a dramatically altered pattern. Reduction of vasti forces is 
readily explained; the origin of each lies on the femur, and they all share insertion into 
the tibia via patellar ligament via the patella via the quadriceps tendon. With the femur 
and tibia fused, preempting any degree of knee extension, activation of these muscles 
contributes nothing to kinematics. The altered loading pattern of the rectus femoris, with 
an origin at the anterior inferior iliac spine, is a result of its increased contribution to hip 
flexion (as resistance to hip extension). Comparison to the hip flexion angle of Figure 28 
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in Chapter 6 is illustrative; rectus femoris force increases with eccentric contraction as 
the hip extends, peaking as the hip reaches its peak extension angle and begins to flex.  
While this result makes sense mechanically, and is intuitively predictable when 
using the given musculoskeletal modeling parameters, it is unknown whether it is 
physiologically accurate. Synergistic recruitment of the vasti resulting from paired 
muscle innervation may result in varying levels of vasti interaction, in spite of the 
complete lack of functional benefit. Clinically, patients who undergo knee arthrodesis 
and then subsequent reversal demonstrate an extensive reduction in quadriceps muscle 
strength [12], [44], [45] consistent with muscular disuse atrophy, and supportive of the 
results of the present simulation.  
Surface electromyography could provide some measure of muscle activation for 
comparison against these results; the use of surface electromyography was explored 
during the design of the gait study giving rise to the data used to drive these simulations, 
and it was collected from some subjects, but the data was not ultimately usable. 
Regardless, the muscle activation patterns of subjects who have been temporarily fitted 
with an immobilizing brace are likely to be different from those of patients who have 
undergone long-term knee fusion, making the relevance of such data questionable. One 
potential method of validating the predicted quadriceps activity is the use of surface 
electromyography to measure quadriceps activation during gait in patients who have 
undergone permanent knee arthrodesis, but no data of this type is presently available. 
The present research has significant implications for the clinical decision making 
process regarding knee arthrodesis, as well as the development and testing of rigid knee 
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implants. Concern over subsequent damage to other joints resulting from knee arthrodesis 
may be overblown, a result of conservatives estimates due to a lack of data. These results 
support the reduction of the weight of this concern as a factor weighing against a decision 
to performing knee fusion. In as much as this factor has reduced the incidence of knee 
arthrodesis, as explored in Chapter 5, this work may serve to increase the number of knee 
arthrodesis procedures performed. Joint loading values during gait with an immobilized 
knee have been heretofore unquantified – this data may be used as input parameters for 
the testing of rigid knee implants by means of finite element analysis or benchtop 
mechanical testing. This may help prevent mechanical failure of rigid knee implants, as 
reported in literature, in future implant designs.  
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CHAPTER EIGHT 
DESIGN OF AN IMPLANTABLE DEVICE TO SATISFY THE PROPOSED 
TREATMENT MODEL 
 
A surgical treatment model is designed as an alternative to knee arthrodesis, and 
preliminary development work is undertaken to assist in the licensing and clinical 
translation of said treatment model. 
 
Abstract 
Having identified severe knee dysfunction as an inadequately addressed condition 
in patients, a novel treatment model is proposed. The constraints of this model require 
that it provide a patient with a weakened or missing knee extensor mechanism the 
stability to ambulate independently, such as with knee arthrodesis, while allowing the 
patient to otherwise bend the knee. Design of the proposed treatment model occurred 
over the course of several years, included development of functional prototypes, and was 
guided by the regulatory requirements for the design of medical devices in the United 
States. Two patent applications have been filed with the United States Patent and 
Trademark Office for protection of the intellectual property generated from this work, 
and the Clemson University Research Foundation is actively seeking to license this work 
for clinical translation. 
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Present Need 
Severe knee dysfunction can interfere with patient independence, quality of life, 
and mental health, and current treatment options often leave patients and surgeons to 
choose between poor alternatives. These alternatives, explored in detail in Chapter 4, 
require that patients have adequate remaining anatomy and strength for knee stability 
with a total knee replacement, or else provide complete stability at the expense of 
permanent knee immobilization. While existing total knee replacement designs provide 
varying levels of mechanical stability at the expense of natural knee kinematics, no 
designs compensate for extensor mechanism damage or weakness [100]. When this 
stability is required, the most viable treatment option, arthrodesis, eliminates all 
movement at the knee. The resulting loss of function and poor outcome measures relative 
to unaffected patients often conflict with patients’ expectations for surgery. Patients may 
strongly resist the selection of knee arthrodesis as treatment, in spite of the high risk and 
poor prospects of salvage total knee replacement. This results in an ethical dilemma for 
surgeons, who must weigh the benefits of arthrodesis against the low probability of 
success of salvage total knee replacement in this patient subset [8]. 
Initial collaboration with two practicing orthopedic surgeons, Frank Voss, M.D. 
of USC Medical School in Columbia, SC, and Kim Chillag, M.D. of the Moore Center 
for Orthopedics in Columbia, SC, resulted in the proposal of a theoretically superior 
alternative treatment that would provide both complete stability and an ability to flex the 
knee. Such a treatment could compensate for lost anatomy or strength during ambulation 
 128 
and standing activities, but could otherwise allow a patient to flex the knee so as to 
minimize interference with other activities of daily living.  
The initial proposal, by Kim Chillag, M.D., took the form of a total knee 
replacement that could be locked in full extension to provide the stability necessary to 
walk, but that could otherwise be unlocked to allow the patient to flex the knee. This 
initial concept utilized a “sliding lock pin” which would reside fully within the femoral 
component during knee flexion, and which could, with the assistance of gravity, slide 
down into a recess within the tibial component when the user fully extended their knee 
(Figure 47). This design would require that the patient lift their fully extended leg until 
the tibia was raised above the femur so that the pin could slide back into the femoral 
component with the assistance of gravity, in order to unlock and allow the patient to 
again flex the knee.  
 
Figure 47 – Device Prototype – Preliminary drawing of a total knee replacement with a sliding lock pin, 
as proposed by Kim Chillag, M.D. 
 129 
Design Controls 
While the initially proposed design embodied the core elements of the 
theoretically superior treatment alternative, practical limitations interfered with its 
viability, e.g. the physical capability of a patient with severe knee dysfunction to 
disengage the locking mechanism by lifting his fully extended leg above parallel with the 
ground. In addition to the core design requirements, a clinically viable alternative 
treatment must satisfy a number of additional elements, including requirements of the 
surgeons, patients, and the relevant regulatory authority. One can best account for this by 
using a structured design process. Federal regulations govern the design of medical 
devices in the United States, overseen by the Food and Drug Administration (FDA), and 
these regulations are located in Title 21 of the Code of Federal Regulations, Part 820, 
Subsection 30 - Design Controls. This subsection was used as a guide to assist this work 
throughout the design process.  
Criteria for the physical and performance requirements of the desired design 
solution were developed in collaboration with the clinician partners, and while not 
formalized, were used as a set of Design Inputs [820.30(f)] (Table 12). 
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Example Design Inputs 
Functional / 
Performance 
Must enable patients with deficient or missing quadriceps 
mechanisms to walk 
 Should flex freely when a patient is sitting, lying down, or 
otherwise inactive. 
 Design should not require invasive interaction. 
  
Similar Designs Must provide stable interface suitable for bone-PMMA cement 
adhesion. 
 Must interface with variable length bone augments or 
intramedullary stems. 
 Design should be as durable as existing salvage total knee 
replacement designs. 
  
Regulatory The design should be manufactured from materials used in 
previously cleared or approved medical devices for use in the 
knee. 
  
Output from Risk 
Management 
Implant design should minimize the risk of failure of the 
locking mechanism during walking. 
 The device should remain locked until the patient takes specific 
action to unlock it. It cannot accidentally unlock while walking. 
 Implant geometry should prevent the locking mechanism from 
engaging when the device is not in full extension. 
  
Other Essential Design 
Requirements 
The design should interface with an existing modular total knee 
replacement platform to assist in translation/licensing.  
Table 12 – Design inputs for the proposed treatment model 
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Design Review meetings, as prescribed by 21 CFR 820.30(e), were conducted 
periodically throughout the design process, and included our clinical partners. The 
purpose of these meetings was to ensure that all relevant design requirements were 
identified, that the proposed designs satisfied these requirements, and to prioritize further 
work. Design Review meetings were conducted on the follow dates: 
 Tuesday, August 10, 2010 
 Friday, September 24, 2010 
 Wednesday, October 20, 2010 
 Tuesday, November 9, 2010 
 Friday, January 14, 2011 
 Friday, April 1, 2011 
 Friday, October 21, 2011 
 Friday, January 13, 2012 
 Friday, March 30, 2012 
 Friday, April 27, 2012 
 Friday, October 25, 2013 
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Prior Art Review 
In addition to satisfying the design requirements, the commercial viability of any 
proposed device is highly dependent on the current intellectual property landscape. Any 
similarity of the developed work to existing intellectual property held by others may 
require license of said IP, and could prove to be an insurmountable barrier to 
commercialization. Ideally, the intellectual property of any proposed treatment method 
would also be protectable, providing value and an incentive to commercialization.  
A diligent prior art review was conducted, and similarity to the desired treatment 
model was found in three general categories of technologies: external knee braces, 
prosthetic limbs (for transfemoral amputees), and implantable knee joint replacements. 
There was no more than a moderate degree of similarity between the proposed device and 
existing technology (Table 13).  
The most relevant limitations on device design are those of total knee replacement 
designs, which can be found under US Patent Class 623, “Prosthesis (i.e. artificial body 
members), parts therof, or aids and accessories therefor”, within subclass “Implantable 
Prosthesis” (11.11) and subclass “Joint Bone” (18.11). Here, relevant subclasses include 
“With Magnet” (18.12) and “Knee Joint Bone (20.14). All categories within the 20.14 
parent were searched, including “Constrained Joint” (Class 623/20.24), “Including an 
intermediate member” (20.28), “Movable” (20.29), and “Moveable Bearing” (20.33).  
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Prior Art Review 
Description of Prior 
Art 
Type Degree of 
Similarity 
Primary Differentiator(s) of Our Technology 
Surgically Implantable Devices 
Anatomical Motion 
Hinged Prosthesis / 
US 12/307,102 
Patent 
App. 
Low One example of an industry standard hinge and 
rotating platform design. Other examples can be 
found in 623/20.24, 20.25, 20.28, 20.29. Our 
device locks in extension as an improvement upon 
arthrodesis, negating the purpose for the various 
changes/improvements to hinged/rotating designs. 
Orthopaedic knee 
fusion apparatus / 
5,108,398 
Issued 
Patent 
Low Our device does not assist in bone-to-bone fusion, 
but rather replaces the need for it. 
Knee Arthrodesis 
Implant / US 
13/061,415 
Patent 
App. 
Low This device is one example of many that serve to 
permanently fuse the femur and tibia. Our device 
resembles a total knee replacement, providing 
knee flexion as desired. This prior art offers no 
advantages over a successful knee fusion. 
The Stanmore Knee 
Arthrodesis 
Prosthesis / 2010 
Journal 
Article 
Moderate This device is one many that permanently fuse the 
knee, preventing any motion. Our device 
resembles a total knee replacement, providing 
knee flexion as desired. This prior art offers no 
advantages over a successful knee fusion. 
Surgical Distraction 
Device / US 
6,849,076 
Issued 
Patent 
Low Similarity: Our device will use an internal magnet 
in a knee implant, and will require an external 
magnetic field to actuate the locking mechanism. 
Differentiator: Everything else.  
Prosthetic Limbs for Transfemoral Amputees 
Artificial knee / US 
4,756,713 
Issued 
Patent 
Low Our device is surgically implanted, and the 
locking mechanism is distinct.  
Above-Knee Prosthesis 
With Variable Resistance 
Knee Joint / US 
10/707,732 
Issued 
Patent 
Low Our device is surgically implanted, and the 
locking mechanism is distinct. 
Stabilized artificial knee 
mechanism / US 4,206,519 
Issued 
Patent 
Low Our device is surgically implanted, and the 
locking mechanism is distinct. 
External Knee Braces 
Self-Locking and 
Unlocking Pivot / US 
2646793 
Issued 
Patent 
Low Our device is surgically implanted, and the 
locking mechanism is distinct. 
Locking Knee Joint for 
Orthopaedic Brace / 
3,826,251 
Issued 
Patent 
Low Our device is surgically implanted, and the 
locking mechanism is distinct.  
Automatic locking orthotic 
knee device / 5,267,950 
Issued 
Patent 
Low Our device is surgically implanted, and the 
locking mechanism is distinct. 
Table 13 – Existing intellectual property with a minimum of a low degree of similarity to the proposed 
treatment model. 
 134 
Intellectual property protection of all of the basic design elements is expired. One 
patent covering such attributes includes US Patent 3,934,272 “Knee Prosthesis,” 1976. 
This patent describes the most basic elements of a hinged/constrained knee replacement, 
“upper and lower metal” components to be fixed to the femur and tibia that are connected 
by a lateral axis pin.  
 
Figure 48 - Exploded diagram of the invention described in US Patent 3,934,272 "Knee Prosthesis" 1976. 
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In addition to the basic elements of a hinged/constrained knee design, US Patent 
4,262,368, “Rotating and Hinged Knee Prosthesis,” 1981 describes an implant that 
includes a rotating bearing that allows for internal/external rotation. In addition to the 
essential femoral and tibial components and a lateral axis pin constraining motion outside 
of the flexion/extension axis of the implant, this patent describes a proximal-distal pin 
and bushing that constrain motion outside of the internal-external rotation axis. 
  
Figure 49 - Exploded diagram of the invention described in US Patent 4,262,368 "Rotating and Hinged 
Knee Prosthesis" 1981. 
 
The results of this preliminary prior art review show that intellectual property 
protection the most basic design elements has expired, allowing a wide freedom to 
operate.  
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Prototyping and Preliminary Designs 
The Frank H. Stelling and C. Dayton Riddle Orthopaedic Education and Research 
Laboratory, located within CUBEInC, was the primary base of operations for design of 
the proposed treatment model. Design of an alternative treatment was undertaken within 
the confines of the proposed design inputs, resulting in a number of competing alternative 
proposals. SolidWorks 3D modeling software was used to create and convey 
representations of the proposed device designs, and a ProJect SD 3000 (3D Systems, 
Rock Hill, SC) (Figure 51), located within CUBEInC, was used to create rapid prototypes 
for proof of concept. Several device designs were developed, each of which was intended 
to provide the beneficial stability of knee fusion without the drawbacks associated with a 
permanently fused knee. Several of these designs are described in detail below. 
 
 
Figure 50 – Design work was based in the Frank H. Stelling and C. Dayton Riddle Orthopaedic Education 
and Rearch Laboratory at CUBEInC, in Greenville, South Carolina 
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Figure 51 – Rapid techniques, using the on-site ProJet 3000 system, assisted in the design process 
 
Dropping Pin 
This design, developed by Dr. Kim Chillag, was established prior to the 
collaborative research effort. It uses an internal locking pin and is assisted by gravity 
(Figure 47). The femoral and tibial components of this design have internal channels, 
which hold the pin, and can slide freely along the proximal/distal axis. When the user 
moves his leg to full extension, the pin may translate distally with the assistance of 
gravity, allowing the pin to reside within the femoral and tibial channels simultaneously. 
In this position, the pin prevents flexion of the joint. When the user wishes to resume 
flexion, he may raise his leg above parallel with the ground to allow gravity to assist the 
pin to fully return to the channel of the femoral component. 
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Cam Lock 
The femoral component of this design has the curvature of a cam in the sagittal 
plane, allowing for complete freedom of rotation in flexion, a very tight fit in mid-flexion, 
and a stable fit in complete extension (Figure 52). There are internal springs which 
compress as the hinge component of the design rises vertically. As the femoral 
component (cam) rotates, the variable distances of the articulating surface from the hinge 
axis causes the component to rise and fall. 
In order to move from flexion to extension, the user must overcome the force of 
internal springs. The distance from the hinge axis to the articular surface increases as the 
device moves into midflexion, causing spring compression. As the device continues to 
move into full extension, the distance from the hinge to the articulating surface decreases, 
and spring tension is relieved. In addition to the lower energy state of the spring, the 
increased congruency between the femoral and tibial components (flat on flat) assists in 
maintaining full extension. In order to flex the knee, sufficient rotational force must be 
applied to overcome spring tension to return the device to flexion. 
 
Figure 52 – Device Prototypes - Cam-Lock design utilizing variable flexion radius and spring 
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Proximal-Distal Magnet 
This design is based on a typical hinged knee device, but utilizes magnets to keep 
the femoral and tibial components in contact in full extension. Magnets fully embedded 
in the femoral component line up with magnets embedded within the tibial component 
when the device is rotated into full extension. This generates continuous attractive force 
that serves to pulls the femoral and tibial components together. This results in some 
degree of compression of the conforming articular surfaces, and flexion is countered by 
magnetic attraction. In order the flex the knee, the patient must apply sufficient flexion 
force, which may be supplied by an external brace. 
 
Figure 53 – Device Prototypes – Rapid Prototype of the Proximal-Distal Magnet design 
 
Medial-Lateral Magnet 
This design is also based on a typical hinged knee device, but utilizes magnets to 
keep the femoral and tibial components in full extension. Four magnets are embedded in 
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the femoral and tibial component, two in each, in such a way as to be lined up when the 
device rotation is at full extension. The magnets are rigidly attached to their respective 
knee components. The four magnets are aligned in a single axis when in full extension, 
where the device maintains the most stable position within the magnetic field. The lowest 
energy state of the device is reached when in full extension, allowing the device to resist 
flexion during stiff gait walking. When the user wishes to flex the device, force sufficient 
to overcome the magnetic field is applied. 
 
Figure 54 – Device Prototypes – Rapid prototype of the Medial-Lateral Magnet design 
 
Pushbutton Latch 
Once the user moves this knee design into full extension it mechanically locks, 
requiring actuation of a pushbutton to release the device back into flexion. A spring-
loaded latch rests in the center of the tibial component, between the femoral condyles. As 
the femoral component moves into extension, an angled surface pushes the latch back, 
compressing the spring. In full extension, the latch reaches a recessed area of the femoral 
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component, engaging and locking it in place. A bumper on the tibial component prevents 
hyperextension. A spring-loaded pushbutton on the side of the femoral component is 
actuated by the user by pushing down on the skin in the area over the button, disengaging 
the latch and allowing the user to rotate the device. When implanted, the user would 
actuate the device by pushing down on the skin over the area of the button. 
 
Figure 55 – Device Prototypes – Rapid prototype of the Pushbutton Latch design 
 
Magnetic Latch 
The Magnetic Latch Design is based on hinged total knee replacement designs, 
incorporating a latch mechanism within the femoral component, anterior to the standard 
hinge. The anterior latch consists of two separate cylindrical “locks”, which lie fully 
within a recessed “femoral lock housing” when deactivated. Magnets are embedded 
internally within the “locks,” and the polarities are aligned in axis such that the “locks” 
have a tendency to be drawn together. The “hinge device” lies between the femoral 
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condyles and partially covers the “femoral lock housing”, preventing the “locks” from 
moving beyond the recess of the “femoral lock housing” in the femoral component. 
When the knee is rotated to full extension, the locks line up with a matching “hinge lock 
recess” within the “hinge device.” This prevents the device from locking in place unless 
the user has aligned the knee in extension. 
 
Figure 56 – Device Prototypes – CAD rendering of the Magnetic Latch design 
 
The device may be locked in extension by briefly passing a specially designed 
two-sided magnetic key (Figure 57) within close proximity to both sides of the knee 
(Figure 60). This handheld key contains specifically oriented magnets, and its magnetic 
field serves to actuate the internal locking mechanism of the implant system, which 
contains several fully sealed magnets of its own. Once the “locks” are drawn together on 
either side of the “hinge lock recess bumper”, attraction due to the magnetic field will 
maintain their proximity and the implant will remain locked in extension until the 
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handheld key is reapplied in its reversed polarity orientation (performed by simply 
turning the key over), allowing a patient to walk with the rigid knee with the functional 
equivalence of an arthrodesis. Because the knee system has two internal magnetic levers, 
the locking the mechanism requires simultaneous application of a magnetic field to both 
the medial and lateral sides of the knee. This may be accomplished with the handheld key, 
thus preventing accidental disengagement from unknowingly standing near a strong 
magnetic field.  
 
Figure 57 – Rendering of the Engage Key. Magnets are embedded within the cylindrical endpieces 
 
Design Decision Matrix 
The ability of each proposed design concept to satisfy Design Input criteria was 
evaluated, scored, and weighted in order to select a single design for further development 
work. 
  
 144 
 Design Inputs 
T
o
ta
l 
W
ei
g
h
ti
n
g
 F
a
c
to
r 
R
a
n
k
in
g
 
F
u
n
ct
io
n
al
 /
 
P
er
fo
rm
an
ce
 
S
im
il
ar
 D
es
ig
n
s 
R
eg
u
la
to
ry
 
O
u
tp
u
t 
fr
o
m
 
R
is
k
 
M
an
ag
em
en
t 
O
th
er
 E
ss
en
ti
al
 
R
eq
u
ir
em
en
ts
 
M
u
st
 e
n
ab
le
 p
at
ie
n
ts
 w
it
h
 d
ef
ic
ie
n
t 
o
r 
m
is
si
n
g
 q
u
ad
ri
ce
p
s 
m
ec
h
an
is
m
s 
to
 w
al
k
 
S
h
o
u
ld
 f
le
x
 f
re
el
y
 w
h
en
 a
 p
at
ie
n
t 
is
 s
it
ti
n
g
, 
ly
in
g
 d
o
w
n
, 
o
r 
o
th
er
w
is
e 
in
ac
ti
v
e.
 
D
es
ig
n
 s
h
o
u
ld
 n
o
t 
re
q
u
ir
e 
in
v
as
iv
e 
in
te
ra
ct
io
n
. 
M
u
st
 p
ro
v
id
e 
st
ab
le
 i
n
te
rf
ac
e 
su
it
ab
le
 f
o
r 
b
o
n
e
-P
M
M
A
 c
em
en
t 
ad
h
es
io
n
. 
M
u
st
 i
n
te
rf
ac
e 
w
it
h
 v
ar
ia
b
le
 l
en
g
th
 b
o
n
e 
au
g
m
en
ts
 o
r 
in
tr
am
ed
u
ll
ar
y
 s
te
m
s.
 
D
es
ig
n
 s
h
o
u
ld
 b
e 
as
 d
u
ra
b
le
 a
s 
ex
is
ti
n
g
 s
al
v
ag
e 
to
ta
l 
k
n
ee
 r
ep
la
ce
m
en
t 
d
es
ig
n
s.
 
S
h
o
u
ld
 b
e 
m
an
u
fa
ct
u
re
d
 f
ro
m
 m
at
er
ia
ls
 u
se
d
 i
n
 p
re
d
ic
at
e 
k
n
ee
 i
m
p
la
n
t 
d
es
ig
n
s 
S
h
o
u
ld
 m
in
im
iz
e 
ri
sk
 o
f 
fa
il
u
re
 o
f 
lo
ck
in
g
 m
ec
h
an
is
m
 d
u
ri
n
g
 w
al
k
in
g
. 
D
ev
ic
e 
sh
o
u
ld
 r
em
ai
n
 l
o
ck
ed
 u
n
ti
l 
sp
ec
if
ic
 a
ct
io
n
  
ta
k
en
 t
o
 u
n
lo
ck
 i
t.
 I
t 
ca
n
n
o
t 
ac
ci
d
en
ta
ll
y
 u
n
lo
ck
 w
h
il
e 
w
al
k
in
g
. 
Im
p
la
n
t 
g
eo
m
et
ry
 s
h
o
u
ld
 p
re
v
en
t 
th
e 
lo
ck
in
g
 m
ec
h
an
is
m
 f
ro
m
 e
n
g
ag
in
g
 w
h
en
 
th
e 
d
ev
ic
e 
is
 n
o
t 
in
 f
u
ll
 e
x
te
n
si
o
n
. 
T
h
e 
d
es
ig
n
 s
h
o
u
ld
 i
n
te
rf
ac
e 
w
it
h
 a
n
 e
x
is
ti
n
g
 m
o
d
u
la
r 
to
ta
l 
k
n
ee
 r
ep
la
ce
m
en
t 
p
la
tf
o
rm
 t
o
 a
ss
is
t 
in
 t
ra
n
sl
at
io
n
/l
ic
en
si
n
g
. 
 
Requirement 
Weighting 1
5
%
 
1
5
%
 
1
0
%
 
5
%
 
5
%
 
5
%
 
1
0
%
 
1
0
%
 
1
0
%
 
1
0
%
 
5
%
 
1
0
0
%
 
 
D
es
ig
n
 A
lt
er
n
a
ti
v
es
 1. Dropping Pin 
10 1 5 10 10 8 9 9 9 2 9 
690 4 150 15 50 50 50 40 90 90 90 20 45 
2. Cam Lock 
10 4 4 10 10 5 7 6 6 10 9 
710 3 150 60 40 50 50 25 70 60 60 100 45 
3. P-D Magnet  
10 4 4 10 10 8 9 5 5 5 9 
675 6 150 60 40 50 50 40 90 50 50 50 45 
4. M-L Magnet 
10 4 4 10 10 8 9 5 5 6 9 
685 5 150 60 40 50 50 40 90 50 50 60 45 
5. Pushbutton Latch 
10 8 1 10 10 5 9 9 9 10 9 
820 2 150 120 10 50 50 25 90 90 90 100 45 
6. Magnetic Latch 
10 9 9 10 10 8 9 8 9 10 9 
920 1 150 135 90 50 50 40 90 80 90 100 45 
Table 14 – Decision matrix used to evaluate the proposed implant designs 
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Final Model Development 
The Magnetic Latch design, subsequently named “The Engage,” best satisfied all 
input criteria. Continued design work has resulted in iterative improvements on this basic 
design (Figure 58, Figure 56, Figure 59). 
 
Figure 58 – Photo rendering of the Engage design 
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Figure 59 – Prototype of the Engage design as implanted in SawBones bone analog 
 
 
Figure 60 – Photograph of the Engage Key in use, as it would be used to unlock the device 
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With the Engage, a patient may sit comfortably with a flexible knee. This enables 
sitting in close-quarter spaces, such as a plane or the front seat of a car, and performing 
otherwise difficult or impossible activities, such as tying one’s shoes. When standing or 
walking is desired, a patient extends his leg while sitting and passes the handheld key 
over the knee to lock the device (Figure 61). A video demonstration of these activities 
may be found at: http://www.youtube.com/watch?v=OgxpPxNkgGw& 
 
Figure 61 – Demonstration of use: 1) Patient sits comfortably; 2) Patient extends right knee and 
prepares to use key; 3) Patient passes key over the implant, locking it in extension; 4) Patient ambulates 
with rigid-knee gait; 5) Patient sits, unlocks the device with key in order to sit comfortably again 
 
The use of magnets implanted within orthopedic knee joint replacement devices is 
not novel, but predicate devices have not applied this concept to rigid knee 
immobilization [101], [102]. This should facilitate regulatory clearance or approval of the 
Engage without infringing on existing intellectual property. One such predicate device, 
cleared by the FDA through the 510(k) process (K09218), contains an internally sealed 
magnet used to drive a screw mechanism when an external magnetic field is applied, 
providing a non-invasive post-surgical method of lengthening the femoral shaft of the 
implant. 
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In support of full scale manufacturing, manufacturing cost estimates were 
developed (Table 15). Initial functional prototypes were manufactured through Medcast, 
Inc. (C/O Tom Myers, 596 East 200 North, Warsaw, Indiana 46582, Telephone: (574) 
269-6142, tom@medcast.com, www.medcast.com) and Machining and Technical 
Services (MTS) of Clemson University (C/O Jeff Holliday, Riggs Hall, Clemson, South 
Carolina, 29634, Telephone: (864) 656-3202, jhlia@clemson.edu, 
www.clemson.edu/ces/research/mts/). 
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Estimated Manufacturing Costs 
Individual 
Assembly 
Components 
Material Manufacturing Operations 
Initial 
Tooling & 
Setup ($) 
Marginal 
Unit ($) 
Femoral 
Component 
CoCrMo Lost wax investment cast1 ≈$15,000 ≈$200 
Milling2 
Laser etch (Lot, Part, Unique ID #s) 2  
Shot peening2 
Polishing2 
Tibial Tray CoCrMo Lost wax investment casting1 ≈$15,000 ≈$150 
Milling2 
Laser etch (Lot, Part, Unique ID #s) 2 
Shot peening2 
Tibial Poly Moderately 
Crosslinked 
UHMWPE 
Mill2 ≈$200 ≈$100 
Axle 316L SS Lathe2 ≈$200 ≈$50 
Laser etch (Lot, Part, Unique ID #s) 2 
Polishing2 
Passivation2 
Bushings (x4) Moderately 
Crosslinked 
UHMWPE 
Milling2 ≈$200 ≈$50 
Yoke 316L SS Milling2 ≈$400 ≈$100 
Polishing2 
Passivation2 
Locking 
Mechanism 
(Multiple 
Components) 
316L SS, 
NdFeB 
Lathe2 ≈$500 ≈$100 
Assembly2 
Polishing2 
Laser etch (Lot, Part, Unique ID #s) 2 
Passivation2 
 
Additional Operations 
(Not applicable to prototypes) 
Cleaning2  N/A                                                                         ≈$7 
Packaging3 ≈$20,000 ≈$15 
Labeling3 ≈$10,000 ≈$4 
Sterilization (& 5 year Validation) 4 ≈$30,000 ≈$10 
 
Total Initial Setup and Marginal Unit Costs ≈ $91,500 ≈$776 
 
Per Unit Cost  Prototype Production (Non-Implantable) 10 qty. $3,926 ea. 
  100 qty. $1,691 ea. 
  1,000 qty. $868 ea. 
  10,000 qty. $785 ea. 
Table 15 – Contract Manufacturing Suppliers with appropriate Quality Assurance Systems. (1. Medcast, 
Inc., Warsaw, Indiana - ISO 13485 Certification; 2. Micropulse, Inc., Columbia City, Indiana – ISO 13485 
Certification; 3. Tegra Medical, Franklin, Massachusetts – ISO 13485 Certification; 4. Steris, Inc., 
Spartanburg, South Carolina – ISO 13485 Certification) 
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Intellectual Property Protection 
The above design work was presented to the Clemson University Research 
Foundation (CURF). Upon review, CURF approved funding for the pursuit of intellectual 
property protection. Myers Bigel Sibley & Sajovec, P.A. (4140 Parklake Ave, Suite 600, 
Raleigh, NC 27612, Telephone: (919) 854-1400, Fax: (919) 854-1401, 
www.myersbigel.com) was selected as the representative law firm, and a provisional 
patent application was filed on July 17, 2012 (Lockable Knee Implants and Related 
Methods, U.S. Provisional Patent Application 61/672,352). The provisional patent 
application was subsequently converted to two full patent applications on July 17, 2013, 
additionally incorporating the use in other joints of the body: 
 Eric M. Lucas, John DesJardins, Kim Chillag, Frank Voss, 2013, Lockable 
Implants and Related Methods, U.S. Patent Application 13/944,606 
 Eric M. Lucas, John DesJardins, Kim Chillag, Frank Voss, 2013, Lockable 
Knee Implants and Related Methods, U.S. Patent Application 13/944,161  
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Figure 62 – First two figures of Utility Patent, “Lockable Knee Implants and Related Methods” 
 
Commercial Outreach 
A number of commercial outreach activities were undertaken in support of 
external licensing of the intellectual property generated as part of this work. 
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April 6, 2011 Preliminary discussion of the technology and the potential for 
collaboration was initiated with Carlos Sanchez of Stryker 
Orthopaedics (Mahwah, NJ) 
September 26, 2012  Kevin Cook of Zimmer Orthopaedics was contacted by email. 
November 16, 2012 Mutual NDAs were signed with Biomet (Warsaw, IN), and the 
technology was presented by teleconference. Biomet requested an 
update after completion of the research studies proposed as a part 
of this body of work.  
December 5, 2012 Commercialization of the Engage through the formation of a 
startup company was proposed by Eric M. Lucas at the LaunchPad 
SC competition. The proposal received second place. 
July 9, 2013 License of the intellectual property was proposed to John 
Vinciguerra of DJO Surgical during a visit to Clemson University. 
Mr. Vinciguerra requested an update after feedback from a 
previously submitted grant application.  
July 29, 2013 The Engage was presented to an audience at CUBEInC put on by 
Michael Gara.  
November 15, 2013 The Engage was presented during the Elevator Pitch Competition 
of SC BIO annual meeting in Charleston, South Carolina. 
January 30, 2014 The work was presented by teleconference to the management 
team of DJO Surgical. 
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February 20, 2014 The Engage was presented to a visiting group of investors from 
Net Scientific at CUBEInC. 
 
The current status of commercialization efforts is positive, but confidential, and 
may be out of date at the time of publication of this document. Lisa Perpall, of the 
Clemson University Research Foundation, recommends the following statement: “We are 
in tentative talks with a prospective licensee, which happens to be a global orthopedic 
OEM, so we are very hopeful we may soon have a partner in commercialization to bring 
this technology to market.”  
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CHAPTER NINE 
DISCUSSION 
 
In which the preceding body of research is discussed. 
 
Surgical treatment options are limited in patients whose knee dysfunction 
preempts salvage by means of total knee replacement. While total knee replacement 
designs with varying degrees of mechanical stability have been developed to compensate 
for anatomic deficiencies, no such designs compensate for a missing or severely 
compromised knee extensor mechanism. Knee arthrodesis may salvage the limb and 
provide the stability necessary to ambulate independently, but the resulting inability to 
bend the knee affects gait biomechanics and can cause restrictive functional problems. 
These limitations contribute to the undesirability of knee arthrodesis among patients and 
surgeons alike [8]. In spite of these limitations, however, it is apparent from the large 
number of recently published case reports that the procedure is still the most clinically 
appropriate treatment in many cases.  
It is proposed that an alternative treatment could provide these patients with 
increased function over the current standard of care. Such a treatment could incorporate 
aspects of existing approaches to provide patients with maximum stability while 
minimizing functional limitations. The inclusion criteria for this approach can be defined 
as dysfunction of the knee with contraindication for existing total knee replacement 
designs. This includes, but is not limited to, patients who currently undergo knee 
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arthrodesis. In spite of the number of published case reports, however, the total number 
of affected patients has not been previously quantified, and thus the need for such an 
alternative treatment is unknown.  
In Chapter 5, this dissertation establishes the overall incidence of knee arthrodesis 
in the United States over the past two decades, and thus a measure of the need for an 
alternative treatment. The Nationwide Inpatient Sample, the largest all-payer inpatient 
database in the United States, was acquired to facilitate estimates of this patient subset. A 
significant portion of the time and effort for this work went into the creation of a custom 
database analysis tool, programmed using SAS (Cary, NC, USA). This tool allowed for 
custom database searches by ICD-9-CM procedural code, and performed appropriate 
statistical analysis on the queried data. The results of this work show that in spite of the 
severe functional limitations and undesirability of the procedure, its incidence averaged 
over 1,000 cases annually. And while the total number of knee arthrodesis cases has not 
risen with the increased incidence of total knee replacement, it has also not seen a 
significant decline, suggesting that increased awareness and improvements in current 
treatment alternatives are not sufficient to address the significant number of affected 
patients. The age and method of reimbursement of this patient group indicates a high 
incidence of Social Security Disability, which may, in turn, suggest that existing 
treatment methods have been unable to restore these patients to sufficient function to 
participate in the workforce. Knee arthrodesis procedures are concentrated in teaching 
hospitals and in urban areas, suggesting that these patients are increasingly driven to seek 
out surgeons outside of their local area, and most likely a result of a selection for or 
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referrals to orthopedic surgeons who specialize in knee reconstruction. This same 
concentration may also serve to facilitate targeting of this patient subset, both in the 
dissemination of knowledge of a novel treatment and the physical outlays required for 
such a treatment.  
These results demonstrate a compelling opportunity for the proposed alternative 
treatment model. One of the primary benefits of knee arthrodesis is joint stability, 
enabling patients to ambulate independently. Fusing the knee, however, necessarily 
affects the biomechanics of gait, and the temporary stability of the proposed treatment 
model would induce biomechanical changes similar or equivalent to those of knee 
arthrodesis treatment. Knee arthrodesis itself is contraindicated in patients with 
contralateral hip arthritis or replacement, and it has been suggested that knee arthrodesis 
may induce pain in other joints and the spine. In spite of these clinical concerns, the 
changes to gait kinematics and kinetics induced by knee arthrodesis have not been 
directly explored. The importance of understanding the changes to gait kinematics and 
kinetics induced by knee immobilization is discussed in Chapter 4.  
In Chapter 6, these gait changes are simulated and quantified by studying the gait 
of normal, healthy subjects with an artificially immobilized knee. In order to account for 
this potential limitation, the work of Chapter 6 was conducted over the course of an 
extended period of knee immobilization, and the effects of increased acclimation time 
was also studied. This work suggests that allowing a subject to acclimate to an 
immobilized knee for a minimum of 0.25 miles of walking is not significantly different 
from acclimation over 24+ hours. It is possible that longer term immobilization induces 
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additional changes, but ethical considerations precluded such study. An analysis of the 
gait changes induced by knee immobilization shows that gait changes primarily result in 
order to assist ground clearance of the immobilized limb and to minimize excess energy 
expenditures. Complete quantification of the specific changes in joint angle, net joint 
moment, and net joint reaction force are provided, and will assist in the development of 
future hypotheses regarding the effects of knee arthrodesis. The increase in reaction 
forces at the contralateral hip may be of particular consequence, as it has been suggested 
that this joint is associated with early induced arthritis after knee arthrodesis. The 
complete characterization of rigid knee gait is also important for the design and testing of 
an implantable device that would be subjected to these gait changes, such as the proposed 
treatment model.  
One significant limitation of gait analysis and the resulting calculations of net 
joint moment and net reaction force, however, is the neglect of musculature. This 
approach underestimates joint loading, and does not provide a picture of the muscular 
changes that are induced by rigid knee immobilization. A musculoskeletal model was 
developed and used, in conjunction with motion capture data from the previous gait 
analysis study, to run simulations comparing normal and immobilized knee gait. A 
complete characterization of joint forces, joint moments, and muscle forces is provided in 
Chapter 7. These results showed that while the loading patterns were sometimes altered, 
there was generally a reduction in the peak magnitude of joint forces, joint moments, and 
muscle forces. Of particular note was the near-complete reduction of quadriceps forces. 
Aside from the rectus femoris, which spans the hip and can serve as a hip flexor, the 
 158 
vastus medialis, vastus intermedius, and vastus lateralis do not functionally contribute 
when the knee is rigidly immobilized. This is an important consideration for the 
estimation of joint loading at the knee, and provides insight into muscular disuse atrophy 
after knee arthrodesis. The full characterization of loading patterns provided in Chapter 7 
can be used in the development and testing of existing and future orthopedic implants 
subjected to such conditions, driving computational, wear, or mechanical testing 
conditions.  
Design of an alternative treatment model occurred with the assistance of the 
practicing clinical collaborators, and occurred in parallel with the preceding research 
studies. This design process was guided by the requirements of medical device 
development regulations in the United States, as outlined in 21 CFR 820.30, facilitating 
translation of the device to clinical use. The proposed design is a variant of a total knee 
replacement, satisfying the material, functional, regulatory, and risk requirements of such 
designs. The novelty of the proposed treatment lies in the engagement of a temporary 
locking mechanism, which is actuated by means of the application of an external 
magnetic field. This actuation method is not novel, having been used in orthopedic knee 
joint replacement applications that have been cleared for market by the FDA through the 
less stringent 510(k) process. This locking mechanism compensates for a lost or 
weakened quadriceps extensor mechanism, maintaining the knee in extension to enable a 
patient to stand or ambulate independently with the functional equivalence of knee 
arthrodesis. Unlike arthrodesis, this locking mechanism can be disengaged to facilitate 
knee bending. Applications for protection of the intellectual property created out of this 
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work have been filed, and are assigned to Clemson University. The inventors have 
engaged industry members in support of the license of said intellectual property. 
The preceding body of work represents the identification and elimination of gaps 
in knowledge in diverse areas relating to knee dysfunction and arthrodesis, through which 
the common thread is support for a proposed device design. These advances call attention 
to the previously unrecognized significance of the clinical need, and provide insight into 
the biomechanical effects of knee immobilization (as in knee arthrodesis). In addition to 
the scientific and clinical value of the individual research components, the synergism of 
this work provides a cohesive package supporting translation of the proposed treatment 
model to clinical and commercial use. Components of this work are critical to many 
commercialization processes, including market analysis, market strategy, and design 
control, and the intellectual property generated from this work enables industry-
University partnership through licensing. In advancing knowledge in these areas, this 
work also creates opportunities for further study, and recommendations for building upon 
it are made in the next chapter. 
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CHAPTER TEN 
RECOMMENDATIONS FOR FUTURE WORK 
 
In which recommendations are made for subsequent researchers to build upon the results 
of this body of work. 
 
The focus of this work is severe knee dysfunction and its treatment. The research 
methods utilized within the work are varied, but interrelated, and were necessary to build 
and defend a robust case for an alternative treatment model. This collection of work 
forms a robust and cohesive dissertation, containing the elements necessary to achieve its 
stated objectives. With that said, there are a number of opportunities to further 
development or build upon the work contained within. 
The total number of patients undergoing knee arthrodesis in the United States was 
estimated in Chapter 5, using the Nationwide Inpatient Sample. This patient 
subpopulation had never been quantified before, and in spite of the detailed 
characterizations provided within this work, these results provides fertile ground for 
further analysis. The underlying etiologic reasons for undergoing knee arthrodesis are 
diverse, as discussed in Chapter 4, and include the failure of total knee replacements. The 
author was intrigued by the fact that the number of knee arthrodesis procedures remained 
relatively constant, in spite of a significant increase in the number of total knee 
replacement surgeries over the same time period. Further study into the reasons for 
undergoing knee arthrodesis may provide insight into the question of why the number of 
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knee arthrodesis procedures has not changed over time. Longitudinal analysis using the 
Nationwide Inpatient Sample, however, is impossible, as identifying patient information 
is stripped from the data, and each record represents a single discharge. A patient 
hospitalized twice will show up as two different records, with no possible way to connect 
them. One reason given for undergoing knee arthrodesis is infection, and one possible 
approach using the Nationwide Inpatient Sample is to document the number of 
procedures performed with an associated diagnosis of infection[47]. This requires, 
however, that one assumes that the presence of infection is always the direct cause of 
failure and the reason for surgery. Another promising approach, though one that was not 
open to the author, is to supplement the present national estimates with longitudinal 
patient data from a different data source, such as the registry of a large scale research 
institute [28]. 
Normal, healthy subjects with a rigidly immobilized knee were used as a proxy 
for patients with knee arthrodesis in Chapter 5. This approach has precedents in the 
literature, and it provided reliable control trials for direct comparison. While the present 
work showed that short term immobilization (after walking 0.25 miles) was not 
significantly different from longer term immobilization (24+ hours), there is no evidence 
that this approach effectively simulates gait after immobilization over a much longer term, 
as would be the case in patients with an actual knee arthrodesis. In spite of the 
confounding factors involved, a future study of patients with an actual arthrodesis may be 
considered. The number and dispersion of such patients, in addition to exclusion criteria 
resulting from varying etiologies, however, may make such a study difficult. The design 
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of such a study would require a reliable control group, utilizing age or otherwise matched 
control variables. The author suggests that such a study also collect surface 
electromyography data, particularly monitoring the activity of the vastus lateralis, vastus 
intermedius (if plausible), vastus medialis, and rectus femoris. This data can then be 
compared against the estimation of muscle activity in Chapter 7. 
If those estimations are accurate, they serve as a potential source of difference 
between short and long term knee immobilization. When the knee is rigidly immobilized, 
the computational model estimated that quadriceps muscle forces drop to near-zero, with 
the exception of the rectus femoris, which spans the hip and acts as a hip flexor. It is 
likely that over the long term, such as in a patient with a permanent knee arthrodesis, the 
quadriceps muscles would atrophy due to functional disuse. We used Dual-energy Xray 
Absorptiometry to characterize the lean muscle mass, among other things, of the subjects 
in Chapter 6. This technique could similarly be used in patients with a permanent knee 
arthrodesis, allowing for a comparison of the lean muscle mass of the thigh in the 
operated vs. non-operated legs. It may be hypothesized that differences in lean muscle 
mass are a result of atrophy due to functional disuse. 
As has been mentioned previously in this work, several authors of articles in 
clinical journals have asserted a link between knee arthrodesis and pain and arthritis in 
other joints of the lower body. While this link has been suggested or hypothesized, no 
studies have established or even explored either correlation or causation. The muscle and 
joint loading patterns established by the computational modeling of Chapter 7 suggest a 
potential source of such a link, and provide a unique opportunity for further investigation. 
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One possible method to establish correlation would be a longitudinal clinical study, 
documenting radiographic evidence for arthritis in other joints at the time of knee fusion 
and for a period of subsequent years. It would be more difficult to establish causation 
clinically, but the results of Chapter 7 the use of similar musculoskeletal modeling 
techniques may provide evidence for such a link. 
Failure Mode and Effects Analysis (FMEA) entails the use of methods to pre-
emptively detect causes of failure. One such method is the use of finite element analysis 
techniques, and they have seen extensive adoption in design and reliability studies. 
Meaningful output from FEA studies is dependent on meaningful and accurate 
assumptions, however, such as an accurate estimation of the loading conditions of an 
orthopedic implant. Utilization of FEA to test any implantable, rigid-knee orthopedic 
device, including the proposed treatment method of Chapter 8, is made possible through 
the reporting of loading patterns provided in Chapter 7. The author recommends that 
future work utilize this technique to predict potential causes of failure of the proposed 
treatment model, and to thus assist in the refinement of design parameters. This 
recommendation has already, in fact, been taken; this work is currently being performed 
as the focus of the Master’s thesis of a current graduate student, John P. O’Donnell.  
Given the purpose of the preceding research, the investigation and proposal of 
clinical treatment models, it is not surprising that the methods utilized are diverse. 
Inpatient database analysis, motion capture, human subject testing, computational 
modeling, and FDA guided design and development techniques were required to achieve 
the stated objective. As the preceding dissertation shows, this research successfully 
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accomplishes its stated aims. In accomplishing these aims, however, the previously 
uninvestigated research areas broached by this work have demonstrated the potential for 
future work, and the techniques employed leave fertile ground for subsequent researchers. 
The author has documented several of his approaches in “Standard Operating Procedures” 
and has, in some cases, created automated programs to assist in this work; It is his hope 
that future researchers will continue to build upon the foundation laid in this work. The 
author and his collaborators have also secured intellectual property on the development 
work. This dissertation provides strong support for the licensing and translation of this 
intellectual property.  
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APPENDIX A – ADDITIONAL DATA FROM THE NATIONWIDE INPATIENT 
SAMPLE  
 
Data from the Nationwide Inpatient Sample that hasn’t been developed far enough to 
merit an individual chapter. 
 
The SAS program developed in Chapter 5 to query and analyze the Nationwide 
Inpatient Sample, documented in the Appendix B, was used to procure additional data on 
orthopedic knee joint procedures for comparison against knee arthrodesis. 
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While the relative number of primary and revision total knee replacement procedures has 
grown since 1993, no such increase has occurred with knee arthrodesis. 
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Aside from a dramatic reduction in the length of stay for all procedures occurring 
between 1993 and 1997, this measure has not continued to decrease for knee arthrodesis 
in subsequent years. 
 
The cost of all procedures has risen in the United States over the past two decades. These 
costs have increased at a greater rate for revision total knee replacement and knee 
arthrodesis. 
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A greater percentage of revision total knee replacements than primary total knee 
replacements are performed in metropolitan areas. An even greater percentage of knee 
arthrodesis procedures are performed in metropolitan areas. 
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The increasing complexity of revision total knee replacement and knee arthrodesis, as 
compared to primary total knee replacement, is reflected in the greater number of 
procedures performed at teaching hospitals.  
 
Prior to 2005, a single ICD-9-CM Procedural code (Revision TKR – Not Otherwise 
Specified) was used to classify any and all revision total knee replacements. In that year, 
new codes were introduced to allow for a more detailed description of the revision work, 
i.e. whether only some or all of the previously implanted components were replaced. 
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The number of diagnoses of knee stiffness has increased over the past two decades. 
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TKR by age/gender trends (reproduction of previous publications, but required for further 
breakdown)  
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APPENDIX B – SAS CODE FOR ANALYZING THE NATIONWIDE INPATIENT 
SAMPLE 
1 – MasterNISCode.sas 
 
/****************************************************************** 
 ******  Statistical analysis - Nationwide Inpatient Sample   ***** 
 ******  Eric Montgomery Lucas, 2013-2014                     ***** 
 ******************************************************************/ 
/* This code will output analysis to Excel files in "E:\NIS Studies\"*/ 
 
/* What is the ICD-9-CM code you are interested in? */ 
%LET FilterCode = 8154; 
 
/* Is that a procedural code (PRCODE) or diagnostic code (DXCODE)?  */ 
%LET SEARCHPARAM = PRCODE; 
 
/* Give your study a short nickname, less than 8 characters long. */ 
%LET StudyName = TKR8154; 
 
/* What are your desired age cutoffs? First group is 0 to one BELOW 
Agebin1. */ 
%LET Agebin1 = 55;  /* This age starts the second group. */ 
%LET Agebin2 = 60; /* This age starts the third group. */ 
%LET Agebin3 = 65; /* This age starts the fourth group. */ 
%LET Agebin4 = 70; /* This age starts the fifth group. */ 
%LET Agebin5 = 75; /* The sixth group includes everyone this age 
and older. */ 
 
/* What year would you like to start your search? */ 
%LET StartYear = 1993 ; 
 
/* What year would you like to end your search? */ 
%LET EndYear = 1995; 
 
/* Do you want to further break down output by a domain? "No"=0 ; 
"Yes"=1 */ 
/* %LET ByDomain = 0 ; */ 
/* If so, which domain do you want to add? Gender is "FEMALE" */ 
/* %LET DomainValue = Female ; */  
 
/********************************************************************** 
 ********************************************************************** 
 ********************************************************************** 
 **********   Mess with the code below at your own risk...   ********** 
 ********************************************************************** 
 ********************************************************************** 
 *********************************************************************/ 
 
/* The code below automatically sets the directory containing the data 
& SAS files. */  
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X "cd 
""%substr(%sysget(SAS_EXECFILEPATH),1,%eval(%length(%sysget(SAS_EXECFIL
EPATH))-%length(%sysget(SAS_EXECFILENAME))))"""; 
 
/* Imports census data to make appropriate estimates. */ 
%INCLUDE "2-ImportCensusData.sas"; 
 
/* Big ol' Macro to run my data */ 
%macro DataProcessing; 
 %do i=&StartYear %to &EndYear; 
  %INCLUDE "3-PrepareNISData.sas"; 
  %INCLUDE "4-GenerateOutput.sas"; 
  %INCLUDE "4-GenerateOutput xDomain.sas";   
  %INCLUDE "5-ProcessData.sas"; 
 %END; 
%mend DataProcessing; 
%DataProcessing; 
 
%INCLUDE "6-PoissonAnalysis.sas";  
 
ODS TAGSETS.EXCELXP  
 file="E:\NIS Studies\&studyname._info_general.xls" 
 STYLE=minimal 
 OPTIONS ( Orientation = 'landscape' 
 FitToPage = 'yes' 
 Pages_FitWidth = '1' 
 Pages_FitHeight = '100' ); 
 Title "&Studyname Information on Demographics"; 
 PROC PRINT DATA=Yearstest; 
 Run; 
ods tagsets.excelxp close;  
Run;  
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2–ImportCensusData.sas 
 
/* Import US Census data broken down by age, gender. */ 
PROC IMPORT datafile="CensusYearAgeGender.csv" 
 out=Census 
 dbms=csv 
 replace; 
 getnames=yes; 
RUN; 
 
/* Creates a new variable to describe which age group each age is in.*/ 
DATA CensusBinned; 
 set Census; 
 AGEBIN = 0; 
 IF (.< AGE < &AgeBin1 ) THEN AgeBin = 1; 
 IF (&Agebin1. <= AGE < &AgeBin2.) THEN AGEBIN = 2; 
 IF (&Agebin2. <= AGE < &Agebin3.) THEN AGEBIN = 3; 
 IF (&Agebin3. <= AGE < &Agebin4.) THEN AGEBIN = 4; 
 IF (&Agebin4. <= AGE < &Agebin5.) THEN AGEBIN = 5; 
 IF (AGE >= &Agebin5.) THEN AGEBIN = 6; 
RUN; 
/* Sorts the data to prepare for summing it. */ 
PROC SORT; 
 by year AGEBIN; 
 
/* Sums the appropriate age groups and puts the total into a new 
variable. */ 
PROC MEANS NOPRINT; 
 by year AGEBIN; 
 var N MaleN FemaleN; 
 output out=CensusN sum=AgeBinSum MaleNSum FemaleNSum; 
Run; 
 
Data YearsTest; 
 set CensusN; 
Run; 
Data YearsTestMale; 
 Set YearsTest; 
 Female=0; 
Run; 
Data YearsTestFemale; 
 Set YearsTest; 
 Female=1; 
Run; 
Data YearsTest; 
 Set YearsTestMale YearsTestFemale; 
Run; 
 
PROC SORT DATA=YearsTest ; 
 BY YEAR AGEBIN FEMALE ; 
RUN;  
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3–PrepareNISData.sas 
 
/* Prepare a year if NIS data for analysis. */ 
LIBNAME NIS&i "E:\NIS Data\&i\"; 
Run; 
   
DATA NIS_&StudyName._&i; 
 SET NIS&i..NIS_trends_supplemental_&i.; 
 RETAIN DISCHGS 1; 
 RETAIN YEAR &i; 
 &StudyName = 0; 
 /*PR1&StudyName = 0;  
 IF  pr1="&FilterCode" 
  THEN PR1&StudyName = 1; */ 
 IF  pr1="&FilterCode" OR  
  pr2="&FilterCode" OR  
  pr3="&FilterCode" OR  
  pr3="&FilterCode" OR  
  pr4="&FilterCode" OR  
  pr5="&FilterCode" OR  
  pr6="&FilterCode" OR  
  pr7="&FilterCode" OR  
  pr8="&FilterCode" OR 
  pr9="&FilterCode" OR  
  pr10="&FilterCode" OR  
  pr11="&FilterCode" OR  
  pr12 ="&FilterCode" OR  
  pr13 ="&FilterCode" OR 
  pr14="&FilterCode" OR  
  pr15="&FilterCode" 
   THEN &StudyName = 1; 
  AGEBIN = 0; 
  IF (.< AGE < &AgeBin1 ) THEN AGEBIN = 1; 
  IF (&Agebin1 <= AGE < &AgeBin2 ) THEN AGEBIN = 2; 
  IF (&Agebin2 <= AGE < &Agebin3 ) THEN AGEBIN = 3; 
  IF (&Agebin3 <= AGE < &Agebin4 ) THEN AGEBIN = 4; 
  IF (&Agebin4 <= AGE < &Agebin5 ) THEN AGEBIN = 5; 
  IF (AGE >= &Agebin5 ) THEN AGEBIN = 6; 
 
/* Includes formatting files to make data from the NIS readable. */ 
%INCLUDE "E:\NIS Studies\Sas Code\HCUP_FORMATS.sas"; 
%INCLUDE "E:\NIS Studies\Sas Code\I9_Formats.sas"; 
 
PROC FORMAT; 
   VALUE  AGEBIN   
   0="Missing" 
   1="0 to &Agebin1 minus 1"  
   2="&Agebin1 to &Agebin2 minus 1" 
   3="&Agebin2 to &Agebin3 minus 1" 
   4="&Agebin3 to &Agebin4 minus 1" 
   5="&Agebin4 to &Agebin5 minus 1" 
   6="&Agebin5 and up"; 
RUN;  
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4-GenerateOutput.sas 
 
/* Run the data analysis and create a PDF for each year. */ 
 
ODS TAGSETS.EXCELXP  
 file="E:\NIS Studies\&studyname._CountData_&i.Total.xls" 
 STYLE=statistical 
 OPTIONS ( Orientation = 'landscape' 
 FitToPage = 'yes' 
 Pages_FitWidth = '1' 
 Pages_FitHeight = '100' ); 
 Title "&Studyname Information &i."; 
 
PROC SURVEYMEANS MISSING SUM MEAN STDERR; 
 WEIGHT discwt ; 
 CLASS  
  agebin  
  FEMALE 
  died 
  pay1 
  elective 
  hosp_teach 
  hosp_locteach 
  hosp_location 
  hosp_region; 
 CLUSTER hospid ; 
 STRATA  NIS_stratum ; 
 VAR  
  dischgs  
  /*PR1&StudyName*/ 
  agebin 
  died 
  pay1 
  elective 
  hosp_teach 
  hosp_locteach 
  hosp_location 
  hosp_region 
  NPR  
  LOS  
  totchg ; 
 DOMAIN &StudyName.; 
RUN; 
 
ods tagsets.excelxp close; 
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4-GenerateOutput xDomain.sas 
/* Run the data analysis and create a PDF for each year. */ 
 
ODS TAGSETS.EXCELXP  
 file="E:\NIS Studies\&studyname._CountData_&i.GenderAge.xls" 
 STYLE=minimal 
 OPTIONS ( Orientation = 'landscape' 
 FitToPage = 'yes' 
 Pages_FitWidth = '1' 
 Pages_FitHeight = '100' ); 
 Title "&Studyname Information &i."; 
 
PROC SURVEYMEANS MISSING SUM MEAN STDERR; 
 WEIGHT discwt ; 
 CLASS  
  agebin  
  FEMALE 
  died 
  pay1 
  elective 
  hosp_teach 
  hosp_locteach 
  hosp_location 
  hosp_region; 
 CLUSTER hospid ; 
 STRATA  NIS_stratum ; 
 VAR  
  dischgs  
  /*PR1&StudyName*/ 
  agebin 
  died 
  pay1 
  elective 
  hosp_teach 
  hosp_locteach 
  hosp_location 
  hosp_region 
  NPR  
  LOS  
  totchg ; 
 DOMAIN &StudyName.*FEMALE; 
RUN; 
 
ods tagsets.excelxp close;  
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5-ProcessData.sas  
/* Delete all observations that don't satisfy the searched code. */ 
DATA NIS_&StudyName._&i; 
 SET NIS_&StudyName._&i; 
 IF &StudyName = 1; 
/* Prepare each dataset for a Poisson analysis. */ 
PROC SORT; 
 BY YEAR AGEBIN FEMALE ; 
 title1 "Set with desired data from all years."; 
RUN; 
/* Delete gender values that are not 0 or 1 (Male or Female)*/  
Data NIS_&StudyName._&i ; 
 Set NIS_&StudyName._&i ; 
 IF Female ^= 1 AND Female ^=0 THEN delete ; 
Run; 
/* Output a dataset with the weighted counts for each year */ 
PROC MEANS DATA=NIS_&StudyName._&i NOPRINT ; 
 by YEAR AGEBIN FEMALE; 
 VAR DISCWT; 
 OUTPUT out=a&i sum=countwt;  
RUN; 
/* Sort the dataset to be merged */ 
PROC SORT DATA=a&i ; 
 BY YEAR AGEBIN FEMALE ; 
RUN; 
/* Merge the datasets into a single dataset 'YearsTest' to be read and 
analyzed */ 
Data YearsTest ; 
 Set YearsTest ; 
 Merge YearsTest a&i ; 
 By Year Agebin Female ; 
Run; 
/* Add variable DemographicN so that the male and female counts can be 
analyzed */ 
Data YearsTest ; 
 Set YearsTest ; 
 IF Female = 0 THEN DemographicN = MaleNSum ; 
 IF Female = 1 THEN DemographicN = FemaleNSum ; 
Run; 
/* Create a new variable 'CountMil' so that the data can be read in the 
poisson analysis (sig figs) */ 
Data YearsTest ; 
 Set YearsTest ; 
 Count = countwt*1 ; 
 CountMil = count * 1000000 ; 
Run; 
/* Format the table 'YearsTest' in this order for easy comparison */ 
Data YearsTest ; /*(Drop = countwt); */ 
 Set YearsTest ; 
 Format Year Agebin Female _FREQ_ AgeBinSum DemographicN Count 
CountMil ; 
Run;
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6-PoissonAnalysis.sas  
 
/* Prep data for Poisson Analysis */ 
Data Yearstest; 
 SET Yearstest; 
 ln = log(DemographicN); 
Run; 
 
/* Poisson Analysis */ 
PROC GENMOD DATA=Yearstest ; 
 class Agebin Female Year; 
model CountMil = Female Agebin Year / dist = poisson  
link  = log 
offset = ln 
Type1 
Type3; 
 
estimate "Rate: Agebin=1 Sex=male"  intercept 1 Agebin 1 0 0 0 0 
0 Female 1 0; 
estimate "Rate: Agebin=2 Sex=male"  intercept 1 Agebin 0 1 0 0 0 
0 Female 1 0; 
estimate "Rate: Agebin=3 Sex=male"  intercept 1 Agebin 0 0 1 0 0 
0 Female 1 0; 
estimate "Rate: Agebin=4 Sex=male"  intercept 1 Agebin 0 0 0 1 0 
0 Female 1 0; 
estimate "Rate: Agebin=5 Sex=male"  intercept 1 Agebin 0 0 0 0 1 
0 Female 1 0; 
estimate "Rate: Agebin=6 Sex=male"  intercept 1 Agebin 0 0 0 0 0 
1 Female 1 0; 
estimate "Rate: Agebin=1 Sex=female"  intercept 1 Agebin 1 0 
0 0 0 0 Female 0 1; 
estimate "Rate: Agebin=2 Sex=female"  intercept 1 Agebin 0 1 
0 0 0 0 Female 0 1; 
estimate "Rate: Agebin=3 Sex=female"  intercept 1 Agebin 0 0 
1 0 0 0 Female 0 1; 
estimate "Rate: Agebin=4 Sex=female"  intercept 1 Agebin 0 0 
0 1 0 0 Female 0 1; 
estimate "Rate: Agebin=5 Sex=female"  intercept 1 Agebin 0 0 
0 0 1 0 Female 0 1; 
estimate "Rate: Agebin=6 Sex=female"  intercept 1 Agebin 0 0 
0 0 0 1 Female 0 1; 
 
/*estimate "1994 from 1993 Rate Ratio" year -1 1 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 ; 
estimate "1995 from 1993 Rate Ratio"  year -1 0 1 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 ; 
estimate "1996 from 1993 Rate Ratio"  year -1 0 0 1 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 ;*/ 
 
estimate "male/female Rate Ratio" Female 1 -1; 
estimate "female/male Rate Ratio" Female -1 1; 
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estimate "Agebin (&Agebin1. to one year less than &Agebin2.)/(0 
to one year less than &Agebin1. ) Rate Ratio" agebin -1 1 0 0 0 
0 ; 
estimate "Agebin (&Agebin2. to one year less than &Agebin3.)/(0 
to one year less than &Agebin1. ) Rate Ratio" agebin -1 0 1 0 0 
0 ; 
estimate "Agebin (&Agebin3. to one year less than &Agebin4.)/(0 
to one year less than &Agebin1. ) Rate Ratio" agebin -1 0 0 1 0 
0 ; 
estimate "Agebin (&Agebin4. to one year less than &Agebin5.)/(0 
to one year less than &Agebin1. ) Rate Ratio" agebin -1 0 0 0 1 
0 ; 
estimate "Agebin (&Agebin5. and up)/(0 to one year less than 
&Agebin1. ) Rate Ratio"     agebin -1 0 0 0 0 1 ; 
 
lsmeans agebin / diff exp cl; 
lsmeans Female / diff exp cl; 
lsmeans year / diff exp cl; 
 
output out=poissonoutput xbeta=xb stdxbeta=std; 
 
run;   
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APPENDIX C – SAS CODE FOR ANALYZING KINEMATIC AND KINETIC 
VALUES OF INTEREST 
1 – BraceGait Master SAS Code.sas 
 
/****************************************************************** 
 *********  Running statistics on gait analysis data.    ********** 
 ******************************************************************/ 
 
/* The code below allows you to select which values to examine (From 
File#3) */ 
%LET StartNumber = 1 ; 
%LET EndNumber = 70 ; 
 
/* The code below automatically sets the directory containing the data 
& SAS files. */  
X "cd 
""%substr(%sysget(SAS_EXECFILEPATH),1,%eval(%length(%sysget(SAS_EXECFIL
EPATH))-%length(%sysget(SAS_EXECFILENAME))))"""; 
/* If the above doesn't work, you will have to comment it out and copy 
the directory below.  */  
/* X "cd C:\Users\LUCAS8\Dropbox\Clemson\Lucas Shared\2 Gait 
Analysis\Data\SAS Code";    */ 
 
/* Import the data files and then combines them into one database. 
Print the contents. */ 
%INCLUDE "2 - ImportAndMergeData.sas"; 
 
/* Identify specific point of interest */ 
%INCLUDE "3 - Identify Points of Interest.sas"; 
 
/* Data Analysis Step */ 
%INCLUDE "4 - Data Analysis.sas"; 
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2 - ImportAndMergeData.sas 
 
/*Import the three data files and then combine them into one database. 
*/ 
proc import datafile="DataX.csv" 
 out=DataX 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="DataY.csv" 
 out=DataY 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="DataZ.csv" 
 out=DataZ 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="DataPelvicCGxz.csv" 
 out=PelvicCGxy 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="DataForcesMomentsX.csv" 
 out=DataMomentsX 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="DataForcesMomentsY.csv" 
 out=DataMomentsY 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="DataForcesMomentsZ.csv" 
 out=DataMomentsZ 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
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/***** Combine the above datasets. *****/  
data GaitData; 
 set DataX DataY DataZ PelvicCGxy DataMomentsX DataMomentsY 
DataMomentsZ ; 
run; 
 
Data GaitData; 
 set GaitData; 
 TRIALBIN = "A"; 
 IF TRIAL="C1" THEN TRIALBIN="C" ; 
 IF TRIAL="B1" THEN TRIALBIN="B" ; 
 IF TRIAL="B2" THEN TRIALBIN="B" ; 
 IF TRIAL="B3" THEN TRIALBIN="B" ; 
Run; 
 
/***** Copies the data to a new database and *****  
 ***** prints its contents for verification. *****/   
data a; 
 set GaitData; 
Run; 
PROC contents; 
 title1 'Data Contents'; 
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3 - Identify Points of Interest.sas 
 
/************************************ 
*Identify specific point of interest* 
************************************/ 
 
%LET JointInfo1 = PelvicCGRight ; 
%LET JointInfo2 = PelvicCGLeft ; 
%LET JointInfo3 = PelvicCGRange ; 
%LET JointInfo4 = PelvicZLeftSwing ; 
%LET JointInfo5 = PelvicZRightSwing ; 
%LET JointInfo6 = PelvicZAfterLHS ;  
%LET JointInfo7 = PelvicZAfterRHS ; 
 
%LET JointInfo8 = PelvicRotationCCW ; 
%LET JointInfo9 = PelvicRotationCW ; 
%LET JointInfo10 = PelvicObliquityLTO ; 
%LET JointInfo11 = PelvicObliquityLeftSwing ; 
%LET JointInfo12 = PelvicObliquityRTO ; 
%LET JointInfo13 = PelvicObliquityRightSwing ; 
%LET JointInfo14 = PelvicTiltLTO ; 
%LET JointInfo15 = PelvicTiltPeakRTO ;  
%LET JointInfo16 = PelvicMeanTiltRightSwing ;  
 
%LET JointInfo17 = HipExtensionStart ; 
%LET JointInfo18 = HipFlexionStart ; 
%LET JointInfo19 = HipAdductionMean ; 
%LET JointInfo20 = HipAdductionFirstTO ; 
%LET JointInfo21 = HipAdductionSecTO ; 
%LET JointInfo22 = HipAddMeanSLimbSup ; 
%LET JointInfo23 = HipRotationMean ; 
%LET JointInfo24 = HipRotMean ; 
 
%LET JointInfo25 = KneeFlexionTO ; 
%LET JointInfo26 = KneeFlexionSwing ; 
%LET JointInfo27 = KneeAdductionMax ; 
%LET JointInfo28 = KneeAdductionMin ; 
%LET JointInfo29 = KneeRotMin ;  
 
%LET JointInfo30 = AnkleFlexionTO ; 
%LET JointInfo31 = AnkleFlexionContraTO ; 
%LET JointInfo32 = AnkleMaxInversion ; 
%LET JointInfo33 = AnkleMeanInversion ; 
%LET JointInfo34 = AnkleMaxAdduction ; 
%LET JointInfo35 = AnkleAdductionHS ; 
%LET JointInfo36 = AnkleAddCTO ;  
 
%LET JointInfo37 = HipExtensionMoment ; 
%LET JointInfo38 = HipFlexionMoment ; 
%LET JointInfo39 = KneeFlexionMoment ; 
%LET JointInfo40 = KneeExtensionMoment ; 
%LET JointInfo41 = AnklePlantarMom ; 
%LET JointInfo42 = AnkleDorsiMom ; 
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%LET JointInfo43 = HipAddMom1 ; 
%LET JointInfo44 = HipAddMom2 ; 
%LET JointInfo45 = KneeAbdMom1 ; 
%LET JointInfo46 = KneeAbdMom2 ; 
%LET JointInfo47 = AnkleInvMom ; 
%LET JointInfo48 = AnkleEvMom ; 
%LET JointInfo49 = HipIntRotMom ; 
%LET JointInfo50 = HipExtRotMom ; 
%LET JointInfo51 = KneeIntRotMom ; 
%LET JointInfo52 = KneeExtRotMom ; 
%LET JointInfo53 = MeanFFAdductionMom ; 
 
%LET JointInfo54 = HipForceXStart ; 
%LET JointInfo55 = HipForceXTO ; 
%LET JointInfo56 = HipForceXSS ; 
%LET JointInfo57 = HipForceXHS ; 
%LET JointInfo58 = KneeForceXTO ; 
%LET JointInfo59 = KneeForceXHS ; 
%LET JointInfo60 = AnkleForceXTO ; 
%LET JointInfo61 = AnkleForceXHS ; 
%LET JointInfo62 = HipForceYTO ; 
%LET JointInfo63 = HipForceYSS ; 
%LET JointInfo64 = HipForceYHS ; 
%LET JointInfo65 = KneeForceYTO ; 
%LET JointInfo66 = AnkleForceYTO ; 
%LET JointInfo67 = AnkleForceYHS ; 
%LET JointInfo68 = HipForceZTO ; 
%LET JointInfo69 = HipForceZSS ; 
%LET JointInfo70 = HipForceZHS ; 
%LET JointInfo71 = KneeForceZTO ; 
%LET JointInfo72 = KneeForceZSS ; 
%LET JointInfo73 = KneeForceZHS ; 
%LET JointInfo74 = AnkleForceZTO ; 
%LET JointInfo75 = AnkleForceZSS ; 
%LET JointInfo76 = AnkleForceZHS ; 
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4 - Data Analysis.sas 
 
%macro JointAnalysis; 
%do i=&StartNumber. %to &EndNumber.; 
 
/* Reference out to each of the Joint Info Files. */ 
%INCLUDE "&&JOINTINFO&i...sas" ; 
Run; 
 
/* And here begins the analysis, which is run on each Joint Info File. 
*/ 
DATA B; 
 set GaitData; 
 if joint="&SetJoint." and plane="&SetPlane." ; 
 if gaitcycle < &StartMargin or gaitcycle > &StopMargin then 
delete; 
 
PROC SORT; 
 by subject joint side plane trial repetition; 
 
%MACRO MinMaxOrOther; 
 %if &FindType = MINIMUM %then 
  %do; 
   PROC MEANS NOPRINT; 
   by subject joint side plane trial repetition; 
   var degrees; 
   output out=c min=targetdegree 
minid(Degrees(gaitcycle))=CycleDegMinMax ; 
   %put Type used: MINIMUM ; 
  %end; 
 %else %if &FindType = MAXIMUM %then 
  %do; 
   PROC MEANS NOPRINT; 
   by subject joint side plane trial repetition; 
   var degrees; 
   output out=c max=targetdegree 
maxid(Degrees(gaitcycle))=CycleDegMinMax ; 
  %put Type used: MAXIMUM ; 
  %end; 
 %else %if &FindType = MEAN %then 
  %do; 
   PROC MEANS NOPRINT; 
    by subject joint side plane trial repetition; 
    var degrees; 
    output out=c mean=targetdegree; 
  %put Type used: MEAN ; 
  %end; 
 %else %if &FindType = RANGE %then 
  %do; 
   PROC MEANS NOPRINT; 
    by subject joint side plane trial repetition; 
    var degrees; 
    output out=c range=targetdegree  ; 
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  %put Type used: MAXIMUM ; 
  %end; 
 %else %put &FindType Something messed up. Look through your work 
and try again.; 
%MEND MinMaxOrOther; 
%MinMaxOrOther; 
   
*PROC PRINT; 
 
%MACRO PelvisOrOther; 
 %if &SetJoint = Pelvis OR &SetJoint = PelvisCG  
 %then %do;      
 /* Does this if pelvis (because "Side" messes it up.) */ 
  /*proc freq;  
   by subject; 
   tables trial/norow nocol nopercent;    
  proc freq;  
   tables trial/norow nocol nopercent;  
   tables trial*subject/norow nocol nopercent;  
   tables subject/norow nocol nopercent;  
  proc sort;  
   by side; 
  proc freq;  
   by side; 
   tables subject*trial/norow nocol nopercent;  
  */ 
  proc sort data=c;  
   by joint plane; 
 
  title1 "&Description. (&FindType. DEGREES between 
&StartMargin. and &StopMargin. )"; 
  proc glimmix nobound data=c;      
    
   *plots=residualpanel;  /* Max, Min, or Mean 
Degrees */ 
   by joint plane;       
   class subject trial ; 
   model targetdegree =  trial ; 
   random subject subject*trial ; 
   lsmeans trial /diff lines; 
   output out=res1 residual=rtargetdegree; 
    ods select lsmeans; 
    ods trace on; 
      ods show; 
  proc univariate plot normal data=res1;  
   var rtargetdegree; 
    ods select 'Tests for Normality'; 
     ods trace on; 
      ods show; 
  proc glm data=res1;  
   class trial;  
   model rtargetdegree=trial;  
   means trial/hovtest=levene; 
    ods select "Levene's HoV Test"; 
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     ods trace on; 
      ods show;  
  RUN; QUIT; 
 
  title1 "&Description. (% Gait Cycle where &FindType. 
between &StartMargin. and &StopMargin. occurs.)";   
  proc glimmix nobound data=c;      
    
   *plots=residualpanel;  /* % Gait Cycle where 
above occurs */ 
   by joint plane;       
   class subject trial ; 
   model CycleDegMinMax =  trial; 
   random subject subject*trial; 
   lsmeans trial /diff lines; 
   output out=res2 residual=rtargetdegree; 
    ods select lsmeans; 
    ods trace on; 
      ods show; 
  proc univariate plot normal data=res2;  
   var rtargetdegree; 
    ods select 'Tests for Normality'; 
     ods trace on; 
      ods show; 
  proc glm data=res2;  
   class trial;  
   model rtargetdegree=trial;  
   means trial/hovtest=levene; 
    ods select "Levene's HoV Test"; 
     ods trace on; 
      ods show;  
  RUN; QUIT; 
 
  %put Joint: Pelvis ; 
 %end; 
 %else %do; 
  /* Everything except pelvis. */  
 
  /*proc freq; by subject;      
     
  tables trial*side/norow nocol nopercent;  
     
  proc freq;  
   tables trial*side/norow nocol nopercent;  
   tables trial*subject/norow nocol nopercent;  
   tables subject*side/norow nocol nopercent;  
  proc sort; by side; 
   proc freq; by side; 
   tables subject*trial/norow nocol nopercent;  
  */  
  proc sort;  
   by joint plane; 
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  title1 "&Description. (&FindType. DEGREES between 
&StartMargin. and &StopMargin. )"; 
  proc glimmix nobound  data=c ;  
   *plots=residualpanel;  /* Max, Min, or Mean 
Degrees */  
   by joint plane;       
   class subject trial side; 
   model targetdegree =  trial side trial*side; 
   random subject subject*trial subject*trial*side; 
   lsmeans trial side trial*side/diff lines; 
   output out=res3 residual=rtargetdegree; 
    ods select lsmeans; 
    ods trace on; 
      ods show; 
  data res3 ;  
   set res3;  
   trialside=trial||side; 
  proc univariate plot normal data=res3 ;  
   var rtargetdegree; 
    ods select 'Tests for Normality'; 
     ods trace on; 
      ods show;  
  proc glm data=res3 ;  
   class trialside;  
   model rtargetdegree=trialside;  
   means trialside/hovtest=levene;  
    ods select "Levene's HoV Test"; 
     ods trace on; 
      ods show;  
  RUN; QUIT; 
 
  title1 "&Description. (% Gait Cycle where &FindType. 
between &StartMargin. and &StopMargin. occurs.)"; 
  proc glimmix nobound data=c; 
   *plots=residualpanel;  /* % Gait Cycle where 
above occurs */ 
   by joint plane;       
   class subject trial side; 
   model CycleDegMinMax =  trial side trial*side; 
   random subject subject*trial subject*trial*side; 
   lsmeans trial side trial*side/diff lines; 
   output out=res4 residual=rtargetdegree; 
    ods select lsmeans; 
     ods trace on; 
      ods show; 
  data res4;  
   set res4;  
   trialside=trial||side; 
  proc univariate plot normal data=res4;  
   var rtargetdegree; 
    ods select 'Tests for Normality'; 
     ods trace on; 
      ods show;  
  proc glm data=res4;  
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   class trialside;  
   model rtargetdegree=trialside;  
   means trialside/hovtest=levene;  
    ods select "Levene's HoV Test"; 
     ods trace on; 
      ods show;  
  RUN; QUIT; 
 
  %put Joint: Not Pelvis ; 
 %end; 
%MEND PelvisOrOther; 
%PelvisOrOther; 
 
%end; 
%mend JointAnalysis; 
%JointAnalysis; 
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Below is just one example of the 60+ Joint Info files used to examine particular 
points of interest. Each file took the same format, but the Description, StartMargin, 
Stop Margin, FindType, SetJoint, SetPlane, and SetSide values differed. 
 
 
PelvicCGRight.sas 
/************************************************* 
 ***** Identify a specific point of interest ***** 
 *************************************************/ 
%LET Description = Pelvic Sway Right ;       
/* Describe point of interest   */ 
%LET StartMargin = 1 ;         
/* Start looking at this % gait cycle */ 
%LET StopMargin = 55 ;         
/* Stop looking at this % gait cycle */ 
%LET FindType = MINIMUM ;        
/* All Caps MINIMUM, MAXIMUM, or RANGE */ 
%LET SetJoint = PelvisCG ;        
/* Which joint is of interest   */ 
%LET SetPlane = x ;         
/* Which plane is of interest   */ 
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APPENDIX D – SAS CODE FOR ANALYZING JOINT AND MUSCLE LOADING 
1 – Stat Analysis Master Program.sas 
 
/*********************************************************** 
 *****  Running statistical analysis on AnyBody data.  ***** 
 ***********************************************************/ 
 
/* Which points of interest would you like to analyze? Enter the first 
and last numbers, and this program will analyze them along with every 
value in between. You need to look in the third include file (#3) in 
order to get the correct numbers. */ 
%LET StartValue = 1; 
%LET EndValue = 1; 
 
/* The code below automatically sets the directory containing the data 
& SAS files. */  
X "cd 
""%substr(%sysget(SAS_EXECFILEPATH),1,%eval(%length(%sysget(SAS_EXECFIL
EPATH))-%length(%sysget(SAS_EXECFILENAME))))"""; 
/* If the above doesn't work, you will have to comment it out and copy 
the directory below.  */  
/* X "cd C:\Users\LUCAS8\Dropbox\Clemson\Lucas Shared\2 Gait 
Analysis\Data\SAS Code";    */ 
 
/* Import the data files and then combines them into one database. 
Print the contents. */ 
%INCLUDE "2 - Import And Merge Data.sas"; 
 
/* Identify specific point of interest */ 
%INCLUDE "3 - Identify Points of Interest.sas"; 
 
/* Data Analysis Step */ 
%INCLUDE "4 - Data Analysis.sas"; 
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2 – Import and Merge Data.sas 
 
/*Import the three data files and then combine them into one. */ 
 
proc import datafile="S05SAScontrol.csv" 
 out=S05Control 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S05SASbraceright.csv" 
 out=S05BraceRight 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S05SASbraceleft.csv" 
 out=S05BraceLeft 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S06SAScontrolright.csv" 
 out=S06ControlRight 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S06SASbraceright.csv" 
 out=S06BraceRight 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S06SASbraceleft.csv" 
 out=S06BraceLeft 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S08SAScontrolright.csv" 
 out=S08ControlRight 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
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proc import datafile="S08SAScontrolleft.csv" 
 out=S08ControlLeft 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S08SASbraceright.csv" 
 out=S08BraceRight 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S08SASbraceleft.csv" 
 out=S08BraceLeft 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S09SAScontrolright.csv" 
 out=S09ControlRight 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S09SAScontrolleft.csv" 
 out=S09ControlLeft 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S09SASbraceright.csv" 
 out=S09BraceRight 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S09SASbraceleft.csv" 
 out=S09BraceLeft 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S10SAScontrolright.csv" 
 out=S10ControlRight 
 dbms=csv 
 replace; 
 getnames=yes; 
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run; 
 
proc import datafile="S10SAScontrolleft.csv" 
 out=S10ControlLeft 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S10SASbraceright.csv" 
 out=S10BraceRight 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="S10SASbraceleft.csv" 
 out=S10BraceLeft 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="AllSubjectLeftMuscle.csv" 
 out=LeftMuscle 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
proc import datafile="AllSubjectRightMuscle.csv" 
 out=RightMuscle 
 dbms=csv 
 replace; 
 getnames=yes; 
run; 
 
/***** Combine the above datasets. *****/  
data AnyBody; 
 set S05Control  
 S05BraceRight  
 S05BraceLeft  
 S06ControlRight  
 S06BraceRight  
 S06BraceLeft 
 S08ControlRight  
 S08ControlLeft 
 S08BraceRight  
 S08BraceLeft 
 S09ControlRight  
 S09ControlLeft 
 S09BraceRight  
 S09BraceLeft 
 S10ControlRight  
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 S10ControlLeft 
 S10BraceRight  
 S10BraceLeft 
 LeftMuscle 
 RightMuscle ; 
run; 
 
/***** Copies the data to a new database and *****  
 ***** prints its contents for verification. *****/   
data a; 
 set AnyBody; 
Run; 
PROC contents; 
 title1 'Data Contents';  
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3 – Identify Points of Interest.sas  
 
/************************************ 
*Identify specific point of interest* 
************************************/ 
 
%LET Info1 = 1RightAnkleForceAP ; 
%LET Info2 = 2RightAnkleMomentSE1 ; 
%LET Info3 = 3RightAnkleMomentSE2 ; 
%LET Info4 = 4RightAnkleMomentAxial1 ; 
%LET Info5 = 5RightAnkleMomentAxial2 ; 
%LET Info6 = 6RightKneeForcePD1 ; 
%LET Info7 = 7RightKneeForcePD2 ; 
%LET Info8 = 8RightKneeForcePD3 ; 
%LET Info9 = 9RightKneeForceML1 ; 
%LET Info10 = 10RightKneeForceML2 ; 
%LET Info11 = 11RightKneeForceML3 ; 
%LET Info12 = 12RightKneeForceAP1 ; 
%LET Info13 = 13RightKneeForceAP2 ; 
%LET Info14 = 14RightKneeMomentF1 ; 
%LET Info15 = 15RightKneeMomentF2 ; 
%LET Info16 = 16RightKneeMomentAb1 ; 
%LET Info17 = 17RightKneeMomentAb2 ; 
%LET Info18 = 18RightKneeMomentAxial1 ; 
%LET Info19 = 19RightKneeMomentAxial2 ; 
%LET Info20 = 20RightKneeMomentAxial3 ; 
%LET Info21 = 21RightKneeMomentAxial4 ; 
%LET Info22 = 22RightHipForcePD1 ; 
%LET Info23 = 23RightHipForcePD2 ; 
%LET Info24 = 24RightHipForceML1 ; 
%LET Info25 = 25RightHipForceML2 ; 
%LET Info26 = 26RightHipForceML3 ; 
%LET Info27 = 27RightHipForceAP1 ; 
%LET Info28 = 28RightHipForceAP2 ; 
%LET Info29 = 29RightHipForceAP3 ; 
%LET Info30 = 30RightHipMomentAb1 ; 
%LET Info31 = 31RightHipMomentAb2 ; 
%LET Info32 = 32RightHipMomentEx ; 
%LET Info33 = 33LeftAnkleForceAP ; 
%LET Info34 = 34LeftAnkleMomentSE1 ; 
%LET Info35 = 35LeftAnkleMomentSE2 ; 
%LET Info36 = 36LeftAnkleMomentAxial1 ; 
%LET Info37 = 37LeftAnkleMomentAxial2 ; 
%LET Info38 = 38LeftKneeForcePD1 ; 
%LET Info39 = 39LeftKneeForcePD2 ; 
%LET Info40 = 40LeftKneeForceML1 ; 
%LET Info41 = 41LeftKneeForceML2 ; 
%LET Info42 = 42LeftKneeForceML3 ; 
%LET Info43 = 43LeftKneeForceAP1 ; 
%LET Info44 = 44LeftKneeForceAP2 ; 
%LET Info45 = 45LeftKneeMomentF1 ; 
%LET Info46 = 46LeftKneeMomentF2 ; 
%LET Info47 = 47LeftKneeMomentAb1 ; 
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%LET Info48 = 48LeftKneeMomentAb2 ; 
%LET Info49 = 49LeftKneeMomentAxial1 ; 
%LET Info50 = 50LeftKneeMomentAxial2 ; 
%LET Info51 = 51LeftKneeMomentAxial3 ; 
%LET Info52 = 52LeftKneeMomentAxial4 ; 
%LET Info53 = 53LeftHipForcePD1 ; 
%LET Info54 = 54LeftHipForcePD2 ; 
%LET Info55 = 55LeftHipForceML1 ; 
%LET Info56 = 56LeftHipForceML2 ; 
%LET Info57 = 57LeftHipForceML3 ; 
%LET Info58 = 58LeftHipForceAP1 ; 
%LET Info59 = 59LeftHipForceAP2 ; 
%LET Info60 = 60LeftHipForceAP3 ; 
%LET Info61 = 61LeftHipMomentAb1 ; 
%LET Info62 = 62LeftHipMomentAb2 ; 
%LET Info63 = 63LeftHipMomentEx ; 
%LET Info64 = 64LeftHipMomentEx2 ; 
%LET Info65 = 65LeftHipMomentEx3 ; 
%LET Info66 = 66MuscleRectusFemoris ; 
%LET Info67 = 67MuscleVastusLateralis ; 
%LET Info68 = 68MuscleVastusMedialis ; 
%LET Info69 = 69MuscleVastusIntermedius ; 
%LET Info70 = 70MuscleSartorius1 ; 
%LET Info71 = 71MuscleSartorius2 ; 
%LET Info72 = 72MuscleBicepsFemoris1 ; 
%LET Info73 = 73MuscleBicepsFemoris2 ; 
%LET Info74 = 74MuscleBicepsFemoris3 ; 
%LET Info75 = 75MuscleSemitendinosus1 ; 
%LET Info76 = 76MuscleSemitendinosus2 ; 
%LET Info77 = 77MuscleSemitendinosus3 ; 
%LET Info78 = 78MuscleSemimembranosus1 ; 
%LET Info79 = 79MuscleSemimembranosus2 ; 
%LET Info80 = 80MuscleSemimembranosus3 ; 
%LET Info81 = 81MuscleGastrocnemius ; 
%LET Info82 = 82MuscleSoleus ;  
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3 – Data Analysis.sas  
 
%macro JointAnalysis; 
%do i=&StartValue. %to &EndValue.; 
 
/* Reference out to each of the Joint Info Files. */ 
%INCLUDE "Points of Interest\&&INFO&i...sas" ; 
Run; 
 
/* And here begins the analysis, which is run on each Joint Info File. 
*/ 
DATA B; 
 set AnyBody; 
 if joint = "&SetJoint." and plane = "&SetPlane." ; 
 if gaitcycle < &StartMargin or gaitcycle > &StopMargin then 
delete; 
 
PROC SORT; 
 by subject joint side plane trial repetition; 
Run; 
 
/* Define and run a macro that determines whether we are searching 
 for a Minimum, Maximum, Mean, or Range. It pulls this information 
 for each point of interest file. */ 
%MACRO MinMaxOrOther; 
 %if &FindType = MINIMUM %then 
  %do; 
   PROC MEANS NOPRINT; 
   by subject joint side plane trial repetition; 
   var Value; 
   output out=c min=targetdegree 
minid(Value(gaitcycle))=CycleDegMinMax ; 
   %put Type used: MINIMUM ; 
  %end; 
 %else %if &FindType = MAXIMUM %then 
  %do; 
   PROC MEANS NOPRINT; 
   by subject joint side plane trial repetition; 
   var Value; 
   output out=c max=targetdegree 
maxid(Value(gaitcycle))=CycleDegMinMax ; 
  %put Type used: MAXIMUM ; 
  %end; 
 %else %if &FindType = MEAN %then 
  %do; 
   PROC MEANS NOPRINT; 
    by subject joint side plane trial repetition; 
    var Value; 
    output out=c mean=targetdegree; 
  %put Type used: MEAN ; 
  %end; 
 %else %if &FindType = RANGE %then 
  %do; 
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   PROC MEANS NOPRINT; 
    by subject joint side plane trial repetition; 
    var Value; 
    output out=c range=targetdegree  ; 
  %put Type used: MAXIMUM ; 
  %end; 
 %else %put &FindType Something messed up. Look through your work 
and try again.; 
%MEND MinMaxOrOther; 
%MinMaxOrOther; 
   
*PROC PRINT; 
 
%MACRO OneOrBothSides; 
 %if &SetSide = Right OR &SetSide = Left 
 %then %do;      
  
 /* Delete all observations from opposite side. */ 
  DATA C ; 
   set C; 
   if Side ^= "&SetSide." then delete; 
  Run;  
 
/* Does this because some of the left and right values are inverted. 
  This only compares one side against itself. */ 
/* And here begins the analysis, which is run on each Joint Info File. 
*/ 
  proc freq;  
   by subject; 
   tables trial/norow nocol nopercent;    
  proc freq;  
   tables trial/norow nocol nopercent;  
   tables trial*subject/norow nocol nopercent;  
   tables subject/norow nocol nopercent;  
  proc sort;  
   by side; 
  proc freq;  
   by side; 
   tables subject*trial/norow nocol nopercent;  
 
  title1 "&Description. (&FindType. VALUE (N or Nm) between 
&StartMargin. and &StopMargin. )"; 
/**********************************************************************  
We FIRST look at the Maximum/Minimum/Mean/Range with the following code.  
**********************************************************************/ 
  proc glimmix nobound data=c;      
    
   *plots=residualpanel;  /* Max, Min, or Mean 
Value */ 
   by joint plane;       
   class subject trial ; 
   model targetdegree =  trial ; 
   random subject subject*trial ; 
   lsmeans trial /diff lines; 
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   output out=res1 residual=rtargetdegree; 
/*    ods select lsmeans; 
    ods trace on; 
      ods show; 
*/ 
  proc sort;        
   by joint plane subject trial; 
 
  proc means noprint;       
   by joint plane subject trial; 
   var rtargetdegree; 
   output out=res11 mean=rtargetdegree;  
 
  proc univariate plot normal data=res11;  
   var rtargetdegree; 
/*    ods select 'Tests for Normality'; 
     ods trace on; 
      ods show; 
*/ 
  proc glm data=res11;  
   class trial;  
   model rtargetdegree=trial;  
   means trial/hovtest=levene; 
/*    ods select "Levene's HoV Test"; 
     ods trace on; 
      ods show;  
*/ 
  RUN; QUIT; 
 
  title1 "&Description. (% Gait Cycle where &FindType. 
between &StartMargin. and &StopMargin. occurs.)";   
/*****************************************************************  
We NEXT look at the % of the gait cycle where the Maximum/Minimum 
occurs. 
If we are looking at a Mean or Range, this code will error out but 
that's okay.  
********************************************************************/ 
  proc glimmix nobound data=c;      
    
   *plots=residualpanel;  /* % Gait Cycle where 
above occurs */ 
   by joint plane;       
   class subject trial ; 
   model CycleDegMinMax =  trial; 
   random subject subject*trial; 
   lsmeans trial /diff lines; 
   output out=res2 residual=rCycleDegMinMax; 
/*    ods select lsmeans; 
    ods trace on; 
      ods show; 
*/ 
  proc sort;         
   by joint plane subject trial; 
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  proc means noprint;      
   by joint plane subject trial; 
   var rCycleDegMinMax; 
   output out=res22 mean=rCycleDegMinMax;  
 
  proc univariate plot normal data=res22;  
   by joint plane;  
   var rCycleDegMinMax; 
/*    ods select 'Tests for Normality'; 
     ods trace on; 
      ods show; 
*/ 
  proc glm data=res22;   
   by joint plane; 
   class trial;  
   model rCycleDegMinMax=trial;  
   means trial/hovtest=levene; 
/*    ods select "Levene's HoV Test"; 
     ods trace on; 
      ods show;  
*/ 
  RUN; QUIT; 
 
  %put No comparison of sides (Left/Right) ; 
 %end; 
 %else %do; 
/* Left and Right sides together. */  
 
  /*proc freq; by subject;      
     
  tables trial*side/norow nocol nopercent;  
     
  proc freq;  
   tables trial*side/norow nocol nopercent;  
   tables trial*subject/norow nocol nopercent;  
   tables subject*side/norow nocol nopercent;  
  proc sort; by side; 
   proc freq; by side; 
   tables subject*trial/norow nocol nopercent;  
  */  
  proc sort;  
   by joint ; 
 
  title1 "&Description. (&FindType. Value between 
&StartMargin. and &StopMargin. )"; 
/**********************************************************************  
We FIRST look at the Maximum/Minimum/Mean/Range with the following code.  
*********************************************************************/ 
  proc glimmix nobound  data=c ;  
   *plots=residualpanel;  /* Max, Min, or Mean 
Value */  
   by joint plane;       
   class subject trial side; 
   model targetdegree =  trial side trial*side; 
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   random subject subject*trial subject*trial*side; 
   lsmeans trial side trial*side/diff lines; 
   output out=res3 residual=rtargetdegree; 
/*    ods select lsmeans; 
    ods trace on; 
      ods show; 
*/ 
  proc sort;  
   by joint plane subject trial side; 
 
  proc means noprint;  
   by joint plane subject trial side; 
   var rtargetdegree; 
   output out=res33 mean=rtargetdegree;  
 
  data res33 ;  
   set res33;  
   trialside = trial||side; 
 
  proc univariate plot normal data=res33 ;   
   by joint plane; 
   var rtargetdegree; 
/*    ods select 'Tests for Normality'; 
     ods trace on; 
      ods show;  
*/ 
  proc glm data=res33 ;  
   by joint plane;  
   class trialside;  
   model rtargetdegree=trialside;  
   means trialside/hovtest=levene;  
/*    ods select "Levene's HoV Test"; 
     ods trace on; 
      ods show; 
*/  
  RUN; QUIT; 
 
  title1 "&Description. (% Gait Cycle where &FindType. 
between &StartMargin. and &StopMargin. occurs.)"; 
/********************************************************************  
We NEXT look at the % of the gait cycle where the Maximum/Minimum 
occurs. 
If we are looking at a Mean or Range, this code will error out but 
that's okay.  
*********************************************************************/ 
  proc glimmix nobound data=c; 
   *plots=residualpanel;  /* % Gait Cycle where 
above occurs */ 
   by joint plane;       
   class subject trial side; 
   model CycleDegMinMax =  trial side trial*side; 
   random subject subject*trial subject*trial*side; 
   lsmeans trial side trial*side/diff lines; 
   output out=res4 residual=rCycleDegMinMax; 
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/*    ods select lsmeans; 
     ods trace on; 
      ods show; 
*/ 
  proc sort;  
   by joint plane subject trial side; 
 
  proc means noprint;  
   by joint plane subject trial side; 
   var rCycleDegMinMax; 
   output out=res44 mean=rCycleDegMinMax;  
 
  data res44;  
   set res44;  
   trialside = trial||side; 
 
  proc univariate plot normal data=res44 ;  
   by joint plane; 
   var rCycleDegMinMax; 
/*    ods select 'Tests for Normality'; 
     ods trace on; 
      ods show;  
*/ 
  proc glm data=res44;  
   by joint plane; 
   class trialside;  
   model rCycleDegMinMax=trialside;  
   means trialside/hovtest=levene;  
/*    ods select "Levene's HoV Test"; 
     ods trace on; 
      ods show;  
*/ 
  RUN; QUIT; 
 
  %put Comparison of Left vs. Right Included ; 
 %end; 
%MEND OneOrBothSides; 
%OneOrBothSides; 
 
%end; 
%mend JointAnalysis; 
%JointAnalysis;  
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Below is just one example of the 43+ Point of Interest files used to examine 
particular values of interest. Each file took the same format, but the Description, 
StartMargin, Stop Margin, FindType, SetJoint, SetPlane, and SetSide values 
differed. 
 
LeftAnkleMomentAxial1.sas  
/************************************************* 
 ***** Identify a specific point of interest ***** 
 *************************************************/ 
 
/* Describe point of interest.    */ 
%LET Description = LeftAnkleMomentAxial1 ;  
/* Start looking at this % gait cycle  */ 
%LET StartMargin = 40 ;    
/* Stop looking at this % gait cycle  */ 
%LET StopMargin = 60 ;    
/* All Caps MINIMUM, MAXIMUM, or RANGE  */ 
%LET FindType = MINIMUM ;   
/* Which joint is of interest    */ 
%LET SetJoint = Anklemom ;   
/* Which plane is of interest    */ 
%LET SetPlane = z ;    
/* Which side is of interest    */ 
%LET SetSide = Both ; 
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